5th Congress of the Spanish Proteomics Society. Time to Imagine Barcelona by Sociedad Española de Proteómica
5th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
Barcelona, 5-8 February, 2013
www.seprot2013.org
Pictures: Eugeni Gay Marín www.eugenigay.com
Congress logo creation: Lu Garriga lugarriga.blogspot.com.es/
Graphic design & layout: Montse Farré


SEDE SOCIAL:
Instituto de Biomedicina de Valencia, C.S.I.C.
c/ Jaime Roig 11, 46010 Valencia
Tel.: 96 339 1778. Fax.: 96 369 0800
C.I.F. G97465629
Nº Registro Nacional de Asociaciones: 584.180
www.cbm.uam.es/seprot
JUNTA DIRECTIVA:
Presidente:
Fernando J. Corrales
CIMA-Universidad de Navarra, Pamplona
fjcorrales@unav.es
Secretario:
Manuel M. Sánchez del Pino
Centro de Investigación Príncipe Felipe, Valencia
mspino@cipf.es
Vocal:
Ignacio Casal
CIB, CSIC, Madrid
icasal@cib.csic.es
Vocal:
Juan Pablo Albar
CNB-UAM-CSIC, Madrid
jpalbar@cnb.csic.es
Vocal:
Jesús Vázquez
CBM SO-UAM-CSIC, Madrid
jvazquez@cbm.uam.es
Vocal:
Ángel García
Universidad de Santiago de Compostela
angel.garcia@usc.es
Vocal:
Montserrat Carrascal
IIBB-CSIC-IDIBAPS, Barcelona
montserrat.carrascal.csic@uab.cat
Vicepresidente:
Fernando Vivanco
Universidad Complutense, 
Fundación Jiménez Diaz, Madrid
FVivanco@fjd.es
Tesorera:
Eliandre de Oliveira
Plataforma de Proteómica, 
Parc Cientific de Barcelona
eoliveira@pcb.ub.cat
Vocal:
Concha Gil
Universidad Complutense de Madrid
conchagil@farm.ucm.es
Vocal:
Jesús Jorrín
Universidad de Córdoba
bf1jonoj@uco.es
Vocal:
Juanjo Calvete
IBV-CSIC, Valencia
jcalvete@ibv.csic.es
Vocal:
Lucía Monteoliva
Universidad Complutense de Madrid
luciamon@farm.ucm.es

55th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
ABSTRACT BOOK of the
5th Congress of the 
Spanish Proteomics Society. 
Time to Imagine
Chairs 
Montserrat Carrascal, CSIC/UAB Proteomics Laboratory, IIBB-CSIC, Barcelona
Eliandre de Oliveira, Proteomics Platform, PCB, Barcelona
Marina Gay, Mass Spectrometry Core Facility, IRB Barcelona

75th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
INDEX
Committees ............................................................................................................................ 9
Welcome Address of the Spanish Proteomics Society (SEProt) ............................................... 11
Welcome Address of the Organizing Committee ..................................................................... 12
Honorary Members of the Spanish Proteomics Society .......................................................... 13
Convocatoria del quinto premio de la Sociedad Española de Proteómica ............................... 15
Programme Overview ............................................................................................................. 17
Scientific Programme .............................................................................................................. 19
Opening & Closing Lectures ................................................................................................... 27
Plenary Lectures ..................................................................................................................... 31
Oral Communications ............................................................................................................. 43
HPP (Human Proteome Project) .............................................................................................. 63
Posters ................................................................................................................................... 69
Last minute Abstracts ............................................................................................................. 129
COST Workshop: Farm animal & food proteomics  ................................................................. 137
List of authors  ........................................................................................................................ 145
Poetómica  ............................................................................................................................. 152 

95th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
COMMITTEES 
Chairs
Montserrat Carrascal, CSIC/UAB Proteomics Laboratory, IIBB-CSIC, Barcelona
Eliandre de Oliveira, Proteomics Platform, PCB, Barcelona
Marina Gay, Mass Spectrometry Core Facility, IRB Barcelona
Scientific Committee
Fernando Corrales, CIMA, Universidad de Navarra, Pamplona
Fernando Vivanco, UCM, Fundación Jiménez Díaz, Madrid
Manuel M. Sánchez del Pino, Universidad de Valencia, Valencia
Ignacio Casal, CIB, CSIC, Madrid
Concha Gil, UCM, Madrid
Juan Pablo Albar, CNB-UAM-CSIC, Madrid
Jesús Jorrín, Universidad de Córdoba, Córdoba
Jesús Vázquez, CNIC, Madrid
Juanjo Calvete, IBV-CSIC, Valencia
Ángel García, Universidad de Santiago de Compostela
Lucía Monteoliva, UCM, Madrid

11
5th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
Most welcome to Barcelona 2013
It is my great pleasure to welcome you all to the Spanish Proteomics Society, the 5th  SEProt Scientific 
Meeting that is hosted this time in the cosmopolitan city of Barcelona. 
Under the title of “Time to Imagine”, the main topic areas chosen for the meeting are: Quantitative 
Proteomics, PTMs, Disease Proteomics, Networks/Protein-Protein Interactions, Bioinformatics, and 
Emerging Technologies. The organizers headed by the three chair ladies Monserrat Carrascal, Eliandre 
de Oliveira and Marina Gay have made a superb job putting together an excellent program including 
the most relevant issues in proteomics that will be presented and discussed by international experts in 
the field. The educational program as a pre-Congress event is also remarkable. Hot spots on sample 
proteomics research, from sample preparation to applications in biomedicine will be illustrated.
As in previous editions, I’m pleased to announce the SEProt awards to the best poster presentation 
and to the best publication in proteomics by an investigator working in a Spanish laboratory. Proteo-
mics has experienced great progress in our country in the last few years and is a rewarding work for 
the SEProt to contribute recognizing this merit to scientists who make this possible. The support from 
Bruker Daltonics is deeply acknowledged.
The principal honour of the SEProt is its panel of most relevant scientists in proteomics that agreed 
to join us as Honorary Members. In Barcelona, the SEProt wants to pay tribute to Professor Richard 
Caprioli for his seminal work in imaging mass spectrometry. It is a great privilege having Professor 
Caprioli among us as Honorary Member.
I am certain that the 5th SEProt Congress will offer you the opportunity to meet with your colleagues 
for scientific interactions, discussions and debates in an exciting educational and professional envi-
ronment. It is time now to start imagining the future based on the reality we imagined just a while ago.
 
Fernando J. Corrales
SEProt President
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Welcome Address of the Organizing Committee
Dear colleagues, dear friends,
The Organizing Committee welcomes you to Barcelona for the 5th biannual SEProt congress.
This congress comprises an outstanding scientific programme, featuring sessions in state-of-the-art 
proteomics, plenary lectures, posters, oral communications, which along with the presence of very 
relevant researchers, will allow for thought-provoking, sharing and discussion of the latest scientific 
advances in the field.
Barcelona was chosen to host this congress because of the very important role it plays in proteomics 
research, having 10 different proteomics laboratories and a very diverse scientific community that 
benefits from private and public research clusters and facilities. Also, Barcelona has long been asso-
ciated with cultural and industrial innovation, the most renowned example being Gaudi, but also with 
other very prominent geniuses such as Salvador Dalí, Narcís Monturiol, Pau Casals or Ferran Adrià. 
This edition’s title, “Time to Imagine”, aims to acknowledge that legacy and uses it to inspire new ways 
of building in our field.
The Organizing and Scientific Committees of the 5th SEProt Congress have worked with great enthu-
siasm in the preparation of this event. We would like to thank you for your participation as presenter, 
sponsor or attendee and we invite you to get involved in the scientific program and to enjoy the warm 
and vibrant city of Barcelona.
Kind regards,
Montserrat Carrascal Eliandre de Oliveira Marina Gay
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Professor Richard Caprioli Honorary  
Member of the SEProt
The Spanish Proteomics Society is proud to announce the appointment 
as Honorary Member of Professor Richard Caprioli for his eminent contri-
butions in the field of proteomics.
Professor Caprioli received his B.S. in 1965 from Columbia University in New York, where he got his 
Ph.D. in Biochemistry in 1969 with Professor David Rittenberg. After a one-year postdoctoral fellows-
hip he was appointed as Assistant Professor of Biochemistry at Purdue in 1970. Then he moved to the 
University of Texas Medical School in Houston in 1975 where he was Professor of Biochemistry and 
Molecular Biology and Director of the Analytical Chemistry Center. He moved to Vanderbilt University 
in 1998 where he is currently Professor in the Departments of Biochemistry, Chemistry, Pharmacology 
and Internal Medicine and is the Stanley Cohen Professor of Biochemistry and Director of the Mass 
Spectrometry Research Center at the School of Medicine. 
Professor Caprioli has pioneered techniques such as imaging mass spectrometry to study the loca-
tion and movement of proteins that are potential drug targets or biomarkers for disease. His general 
research interests lie in discovery of temporal and spatial processes in biological systems using mass 
spectrometry. This work has included technology developments in the areas of electrospray and laser 
desorption ionization mass spectrometry and their applications to intact tissues and in live animal 
systems, achieving ultra-high sensitivity detection of endogenous compounds (e.g., neuropeptides). 
Recent work involves the development of Imaging Mass Spectrometry, a technology whereby mo-
lecular images of peptides, proteins, drugs and other compounds are localized in tissue sections 
with molecular weight specificity. Richard made notorious contributions to specific research areas 
deciphering the spatial distributions of molecules in both health and disease. Of special interest are 
the molecular distributions, spatial rearrangement, and abundance of biological molecules in cancer 
tissues including human glioblastomas, breast cancer, colorectal cancer, prostate cancer and lung 
cancer. He has published over 300 scientific papers, including three books and holds 12 US patents 
involving mass spectrometry technologies.
Prof. Caprioli has been a member of the American Society for Mass Spectrometry since 1975; he 
served two years each as President of the Society and Vice-President for Programs. He is a member 
of the American Society for Biochemistry and Molecular Biology, the American Association for Cancer 
Research, and the American Chemical Society. Professor Caprioli has been the Editor-in-Chief of the 
Journal of Mass Spectrometry since 1990. He is currently Series Editor of The Encyclopedia of Mass 
Spectrometry and additionally has edited several volumes in this encyclopedia. Prof. Caprioli is cu-
rrently serving a 3-year term on the Board of Directors of the HUPO and has been a member of the 
Board of Directors of the US HUPO since its inception.
Professor Richard Caprioli
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In 2003, Dr. Caprioli received the Thomson Medal Award from the International Mass Spectrometry 
Society for “for outstanding achievements in mass spectrometry and for distinguished service to in-
ternational mass spectrometry.” He was named one of the “Pioneers in Proteomics” by the National 
Institutes of Health and received the Donald H. Coffey Award from the Society for Basic Urologic 
Research in 2005. He received the Field and Franklin Award from the American Chemical Society in 
April, 2006 for Outstanding Achievement in Mass Spectrometry, the Eastern Analytical Society 2010 
Award for Achievements in Mass Spectrometry and the HUPO Distinguished Achievement Award in 
Proteomic Sciences for 2010.
It is a privilege and a great honour for the Spanish Proteomics Society Professor Richard Caprioli 
having accepted the nomination to become Honorary Member and to deliver a Plenary Lecture at its 
5th Congress.
 
Fernando J. Corrales
SEProt President
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Convocatoria del quinto premio de la Sociedad Española 
de Proteómica
Barcelona, Enero del 2013
La Sociedad Española de Proteómica (SEProt) convoca la quinta edición del PREMIO SOCIEDAD 
ESPAÑOLA DE PROTEÓMICA destinado a reconocer la labor en el campo de la Proteómica de un 
científico que desarrolle su actividad en España. El premio, patrocinado por Bruker BioSciences 
Española S.A. (http://www.bruker.es), está dotado con 2000 € y será entregado por un represen-
tante de Bruker Española durante el 5º Congreso de la SEProt, Time to Imagine, que se celebrará en 
el Auditorio Axa en Barcelona entre los días 5- 8 de Febrero de 2013 (http://www.seprot2013.org/). 
En la presente convocatoria se otorgarán dos galardones que en ningún caso podrán ser compar-
tidos. Una mitad del premio (1000 € y diploma acreditativo) será para una publicación científica 
relacionada con cualquier desarrollo o aplicación de la Proteómica. La otra mitad del premio (1000 € y 
diploma acreditativo) será para una contribución en forma de panel al 5º Congreso de la SEProt. Las 
decisiones de los jurados serán inapelables. Los Premios no podrán concederse al mismo científico 
dos veces y podrán quedar desiertos si así lo decidiese el jurado.
La elección de la publicación científica merecedora del galardón será realizada por un jurado de ex-
pertos designado a tal efecto por el Presidente de la SEProt. Solo podrán optar al Premio científicos 
españoles que sean o no socios de la SEProt. La labor investigadora deberá haber sido realizada en 
España y haber sido publicada entre Enero de 2011 y Diciembre de 2012. Los candidatos deberán 
remitir 1 copia del trabajo en formato electrónico al Secretario de la SEProt (Manuel Sánchez del 
Pino, sandelpi@uv.es). Deberán, asimismo, adjuntarse los datos personales y profesionales del can-
didato, y un breve resumen de las razones que, a juicio del candidato, debieran ser consideradas 
por el jurado. La fecha límite para la recepción de los trabajos será el 25 de Enero 2013. La 
resolución se dará a conocer el día 01 de Febrero de 2013 a través del portal electrónico de la SEProt 
y del Congreso. El galardonado será invitado a participar en el 5º Congreso de la SEProt exento del 
pago de las tasas de inscripción y a publicar un artículo en la revista Proteómica. 
La elección del ganador(a) del Premio SEProt a la contribución en formato panel presentada al 5º 
Congreso de la SEProt se efectuará entre los primeros firmantes del estudio por un jurado designado 
a tal efecto por el Presidente de la Sociedad Española de Proteómica. Solo podrán optar al Premio 
científicos españoles sean o no socios de la SEProt. La labor investigadora considerada deberá haber 
sido realizada en España y ser inédita o, en todo caso, no haber sido publicada con anterioridad a 
Diciembre de 2012. 
Fernando J. Corrales
Presidente de la SEProt
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HPP 
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Tuesday, February 5
 Proteomics: basics and applications. Educational Day
 Chairs: Joaquin Abian, Anabel Marina
09.00-09.50h Introduction to the course. Basic concepts, sample preparation and separation 
technologies
 Joaquin Abián (LP CSIC/UAB, Barcelona)
09.50-10.40h Label-free quantitative proteomics: advantages and disadvantages
 Miren Josu Omaetxebarria (UPV-EHU, Bizkaia)
10.40-11.00h Coffee break
11.00-11.50h Quantitative proteomics using isotopic labeling
 Francesc Canals (IRVH, Barcelona)
11.50-12.40h Targeted proteomics using selected reaction monitoring (SRM)
 Eduard Sabidó (CRG, Barcelona)
12.40-13.30h The phosphoproteome analysis
 Anabel Marina (CBMSO, Madrid)
13.30-14.30h Lunch time
14.30-15.20h Study of protein structure by mass spectrometry
 Ignasi Forné (Ludwig-Maximilians-University, München)
15.20-16.10h Clincal Proteomics
 Fernando Corrales (CIMA, Pamplona)
16.10-17.00h Bioinformatics
 Salvador Martínez-Bartolomé (CNB-CSIC, Madrid)
17.00-17.10h Concluding remarks
 Joaquin Abian (LP CSIC/UAB, Barcelona), Anabel Marina (CBMSO, Madrid)
16.00h Registration opens
 
 Welcome and Opening Lecture
 Chair: Fernando Corrales
 Welcome
18.00-18.30h   Fernando Corrales, Montserrat Carrascal, Eliandre de Oliveira, Marina Gay
 Opening Lecture
18.30-19.30h  MALDI Imaging Mass Spectrometry: molecular mapping beyond the microscope 
 Richard M. Caprioli (Vanderbilt University School of Medicine, Nashville, TN, USA)
19.30-21.00h  Welcome Reception
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Wednesday, February 6
 Session 1: Quantitative Proteomics
 
 Sponsored by: 
 Chairs: Carme Quero and Eduard Sabidó
 Plenary Lecture
09.00-09.40h Breast cancer proteomics using high resolution mass spectrometry and super-SILAC
 Tamar Geiger (Tel Aviv University, Tel Aviv, Israel) 
 
 Oral Communications
09.40-10.00h SILAC-based quantitative analysis of human bone marrow mesenchymal stem cells 
secretome during chondrogenesis
 Beatriz Rocha (INIBIC-CHUAC, A Coruña, Spain)
10.00-10.20h Determination of protein turnover in primary culture of fish myocytes by dynamic 
SILAC and shotgun proteomics    
 Miguel Martin-Perez (Fisiologia i Immunologia, UB, Barcelona, Spain)
10.20-10.40h Enabling the next generation of Mass Spectrometry-based Quantitation Workflows
 Antonio Serna Sanz (ABSCIEX)
10.40-11.00h Development of a new proteomic tool with SILAC combined with hydrazide 
glycoprotein isolation to characterize degradome in breast cancer cells
 Gemma Reverter-Branchat (Laboratori de Proteòmica, VHIO, Barcelona, Spain)
11.00-11.30h Coffee break offered by:
 
 Session 2: PTMs
 
 Sponsored by: 
 Chairs: Joaquin Abian, Miren Josu Omaetxebarria
 Plenary Lectures
11.30-12.10h Proteomics strategies for the characterization of Post-Translational Modifications of 
proteins
 Martin R. Larsen (University of Southern Denmark, Odense, Denmark)
12.10-12.50h Phosphorylation and ubiquitylation crosstalk in protein degradation
 Judit Villen (Dept. Genome Sciences, University of Washington, Seattle, WA, USA)
 Oral Communications
12.50-13.10h High-throughput mitochondrial redox proteomics analysis of the effects of oxidative 
stress in cellular and animal models of cardiovascular disease
 Jesús Vázquez (CNIC, Madrid, Spain)
13.10-13.30h Thiol redox proteomics in hypoxia cell signalling
 Antonio Martínez-Ruiz (Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria 
Princesa, Madrid, Spain)
23
5th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
13.30-14.30h Lunch time
14.30-15.30h Poster Session
  
 HPP
 Chair: Fernando Corrales
15.30-16.10h The human proteome project interconnected with large scale biobanking
 György Marko-Varga (Lund University, Lund, Sweden)
16.10-16.50h Nextprot: the human protein-centric knowledge platform, status and future 
developments
 Amos Bairoch (SIB and University of Geneva, Geneva, Switzerland)
16.50-17.30h Human Proteome Project: Characterization of the proteins encoded by the 
Chromosome-16 protein coding genes
 Juan Pablo Albar (ProteoRed-ISCIII, CNB-CSIC, Madrid, Spain)
 
Thursday, February 7
 Session 3: Disease Proteomics
 
 Sponsored by: 
 Chairs: Dolores Jaraquemada and Jaime Sancho
 Plenary Lecture
09.00-09.40h Host-pathogen interaction: insights from proteomics
 Concepción Gil (Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain)
 Oral Communications
09.40-10.00h High resolution, accurate mass approaches for the quantification of target peptides
 Sigrid Baumgarten (Thermo Fisher Scientific, Paris, France)
10.00-10.20h A new fast method for peptide biomarker discovery in human serum by mass 
spectrometry
 Carolina Fernández-Costa (INIBIC-CHUAC, A Coruña, Spain)
10.20-10.40h Discovery, accurate inclusion mass screening and label-free quantification of potential 
biomarkers for colorectal cancer in serum of human patients 
 Marta Mendes  (CIB-CSIC, Madrid. Spain)
10.40-11.00h Functional Proteomics approaches for high-throughput determination of small 
molecules interactions on cKIT
 Manuel Fuentes (CIC, Universidad de Salamanca-CSIC, Salamanca,  Spain)
11.00-11.30h Coffee break offered by: 
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 Session 4: Networks/Protein-Protein Interactions
 
 Sponsored by: 
 Chairs: Marta Vilaseca and Ignacio Casal
 Plenary Lectures
11.30-12.10h Protein structure and dynamics: what can ion mobility spectrometry-mass 
spectrometry tell us?
 Alison E Ashcroft (Astbury Centre for Structural Molecular Biology University of Leeds, Leeds, UK)
12.10-12.50h Proteomics and interactomics of carboxypeptidases and their proteinaceous 
substrates
 Francesc Xavier Aviles (IBB, UAB, Bellaterra, Barcelona, Spain)
 
 Oral Communications
12.50-13.10h Investigation of protein monomerization by capillary electrophoresis and ion mobility 
mass spectrometry. Application to superoxide dismutase 1 and lateral amyotrophic 
sclerosis 
 V. Sanz-Nebot (Department of Analytical Chemistry, UB, Barcelona, Spain) 
13.10-13.30h Hydrogen-deuterium exchange for protein structure analysis
 Robert Tonge (Waters Corporation, Manchester, UK) 
13.30-13.50h Cyclodextrin- and methyl jasmonate-mediated resveratrol accumulation in grapevine 
cell cultures: an omics approach
 Roque Bru-Martínez (Faculty of Science, University of Alicante, Alicante, Spain) 
13.50-15.00h Lunch time
15.00-16.00h Poster Session
 
 Session 5: Bioinformatics
 
 Sponsored by: 
 Chairs: Manuel Sanchez del Pino and Felix Elortza 
 Plenary Lectures
16.00-16.40h MaxQuant: computational mass spectrometry based proteomics for the masses
 Jürgen Cox (Max Planck Institute of Biochemistry, Munich, Germany)
16.40-17.20h Complete proteomics data workflow using the proteored MIAPE-extractor tool
 Salvador Martínez-Bartolomé (ProteoRed-ISCIII, CNB - CSIC, Madrid, Spain)
 Oral Communications
17.20-17.40h A new approach for systems biology analysis of high-throughput quantitative 
proteomics experiments
 Marco Trevisan-Herraz (CNIC, Madrid, Spain)
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17.40-18.00h On the feasibility of 2D high pH / low pH liquid chromatography coupled to mass 
spectrometry in label-free intensity-based quantification
 Alex Campos (PCB, Barcelona, Spain & Integromics, Madrid, Spain)
18.00-18.30h Coffee break
18.30-19.30h SEProt Awards and General Meeting
21.30h  Congress Dinner
 
 
Friday, February 8
 Session 6: Emerging Technologies
 Chairs: Francesc Canals and Lucia Monteoliva
 Plenary Lectures
09.45-10.25h Identifying and quantifying 10,000 proteins in 10 hours – feasible, possible, done?...
 Roman A. Zubarev (Karolinska Institutet, Stockholm, Sweden & Science for Life Laboratory, 
Stockholm, Sweden)
10.25-11.05h Advances in middle-down and top-down proteomics
 Yury O. Tsybin (École Polytechnique Fédérale de Lausanne, Switzerland)
 Oral Communications
11.05-11.25h Antibody colocalization microarray: a scalable technology for multiplex protein 
analysis in complex samples
 Mateu Pla-Roca (Institute for Bioengineering of Catalonia, Barcelona, Spain)
11.25-11.45h Conservation of peptide extracts from trypsin digestion of proteins in a hospital 
biobank facility
 Jesús Mateos (INIBIC- CHUAC, A Coruña-Spain)
11.45-12.05h Proteogenomics of bacteria and archaea: a romper la piñata!
 Jean Armengaud (CEA, DSV, iBEB, Lab Biochim System Perturb, Bagnols-sur-Cèze, France)
12.05-12.30h Coffee break
 
 Closing Lecture
 Chair: Montserrat Carrascal, Eliandre de Oliveira and Marina Gay
12.30-13.30h  Hypothesis-driven omics to understand snake venoms and fight a neglected disease
 Juan J. Calvete (Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain)
13.30-14.00h Farewell 
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MALDI IMAGING MASS SPECTROMETRY: MOLECULAR MAPPING BEYOND 
THE MICROSCOPE 
Richard M. Caprioli
Departments of Biochemistry, Chemistry, Pharmacology and Medicine
Vanderbilt University School of Medicine, Nashville, TN, U.S.A.
MALDI Imaging MS produces molecular maps of peptides, proteins, lipids and metabolites present 
in intact tissue sections.  It employs desorption of molecules by direct laser irradiation to map the 
location of specific molecules from fresh frozen and formalin fixed tissue sections without the need of 
target specific reagents such as antibodies. Molecular images of this nature are produced in specific 
m/z (mass-to-charge) values, or ranges of values, typically covering the MW range 200-100,000. We 
have also developed a similar approach for the analysis of targeted areas of tissues by integrating 
mass spectrometry and microscopy, termed histology-directed molecular analysis, whereby only se-
lected areas of cells in the tissue are ablated and analyzed.  
We have employed Imaging MS in studies of a variety of biologically and medically relevant research 
projects.  One area of special interest is the molecular mapping of changes observed in diabetes in 
both a mouse model and in the human disease.  Major molecular alterations have been recorded in 
advanced diabetic nephropathy.  Other applications include developmental studies of embryo implan-
tation is mouse, renal cancers as well as that in other organs, and neurodegenerative disease.  Mole-
cular signatures have been identified that are differentially expressed in diseased tissue compared to 
normal tissue and also in differentiating different stages of disease. These signatures typically consist 
of 10-20 or more different proteins and peptides, each identified using classical proteomics methods. 
In addition, Imaging MS has been applied to drug targeting and metabolic studies both in specific 
organs and also in intact whole animal sections following drug administration.  
This presentation will focus on recent technological advances both in sample preparation and instru-
mental performance to achieve images at high spatial resolution (1-10 microns) and at high speeds 
so that a typical sample tissue once prepared can be imaged in just a few minutes.  Finally, new bio-
computational approaches will be discussed that deals with the high data dimensionality of Imaging 
MS and our implementation of ‘image fusion’ in terms of predictive integration of MS images with 
microscopy and other imaging modalities.  
Opening Lecture
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HYPOTHESIS-DRIVEN OMICS TO UNDERSTAND SNAKE VENOMS AND FIGHT 
A NEGLECTED DISEASE
Juan J. Calvete
Instituto de Biomedicina de Valencia, CSIC, Valencia (Spain) 
Research on venoms has been continuously enhanced by advances in technology. The emergence 
of “omic” technologies in the field of toxinology at the turn of the 21st century offered the unprece-
dented possibility to explore global biological trends and expand our understanding of the clinical 
correlation of the global toxin composition of venoms. The strength of these technologies (genomics, 
transcriptomics, and proteomics) rely in their complementarity, and thus the combined application to 
explore venoms generates novel perspectives in molecular toxinology. Accurate venomic data provide 
clues for correlating venom composition and the pathological effects of envenoming. In addition, the 
identification of evolutionary and immunological trends among venoms may aid replacing the tradi-
tional phylogenetic-driven hypothesis by a more rationale approach based on proteome phenotype 
and immunological profile similarities to produce effective polyvalent antivenoms, and to expand the 
clinical range of currently existing antidotes. These statements will be illustrated with recent studies 
on different snake taxa.
The physicist Freeman Dyson is reported to have remarked that ‘scientific revolutions are more often 
driven by new tools than new concepts’. High-throughput “omic” technologies have changed the face 
of biological research, and many high-tech laboratories in industrialized countries have changed their 
paradigm of doing research from a “hypothesis-driven” to a “technology-driven” approach, the “hun-
ters” and the “gatherers”, respectively, in Sydney Brenner’s words. The ‘gatherers’, with no immediate 
questions in mind, are the Lords of many superbly organized “omic” technology-driven facilities across 
the world. The gatherers’ biology has been described as (patentable) ‘discovery science’. In compa-
rison, the hypothesis-driven science of the “hunters” seems to represent a curiously inefficient aca-
demic exercise. None of these approaches seem appropriate for systems biology venomics. A new 
paradigm has to be adopted. The new paradigm must rely on a strong biological ground elaborated 
on a deep knowledge of the system gained through the combined use of expensive and sophisticated 
“omic” technologies. 
References: 
[1] Calvete, J.J. Proteomic tools against the neglected pathology of snakebite envenoming. Exp. Rev. Proteomics 8 (2011) 739-758
[2] Williams, D.J., Gutiérrez, J.M., Calvete, J.J., Wüster, W., Ratanabanangkoon, K., Paiva, O., Brown, N.I., Casewell, N.R., Harrison, R.A., 
Rowley, P.D., O’Shea, M., Jensen, S.D., Winkel, K.D. & Warrell, D.A. Ending the drought: new strategies for improving the flow of affordable, 
effective antivenoms in Asia and Africa. J. Proteomics 74 (2011) 1735-1767.
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BREAST CANCER PROTEOMICS USING HIGH RESOLUTION MASS SPECTROMETRY AND 
SUPER-SILAC
Stefka Tyanova1, Yair Pozniak2, Juergen Cox1 Matthias Mann1 and Tamar Geiger2
1Max Planck Institute of Biochemistry, Martinsried, Germany; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 
Israel 
Application of proteomics technologies to basic cancer research as well as clinical research is a long 
lasting goal of the community. While cancer cell lines share multiple features with their tumor of origin, 
they don’t represent the complexity of the tumor micro-environment and the heterogeneity that is 
associated with the tissue and whole body environment. Application of proteomics to tissues poses 
additional challenges related to the quantification methods, the small amounts of material, tissue 
availability and the internal tumor heterogeneity. For accurate quantification we previously developed 
the super-SILAC technology, which is mixture of five breast cancer cell lines that represents the tumor 
variability. It is used as a spike-in standard and enables accurate protein quantification. We combine 
the super-SILAC technology with the FFPE-FASP procedure that allows protein extraction and di-
gesion from formalin-fixed paraffin embedded tumor samples with high efficiency. Last, to eliminate 
the effects of various cell types in the tissue we dissect the tissues to highly enrich the content of the 
cancer cells in the tissue. 
We applied these methods to find a proteomic signature that discriminates between the three main 
breast cancer subtypes: Estrogen receptor or progesterone receptor positive (ER+/PR+) tumors, 
Her2/ErbB2 positive (Her2+) tumors or triple negative tumors. Deep quantitative proteomic analysis 
identified in total more than 12,000 proteins, and more than 8,000 proteins in each tumor sample. 
Bioinformatic analysis revealed a signature that discriminates between the subtypes and highlights the 
protein networks that distinguish between them. 
This work shows the power of super-SILAC based proteomics combined with advanced bioinfor-
matics to highlight key regulatory mechanisms in cancer. In the future these can be translated into 
improved diagnosis and therapeutics. 
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PROTEOMICS STRATEGIES FOR THE CHARACTERIZATION OF POST-TRANSLATIONAL 
MODIFICATIONS OF PROTEINS
Martin R. Larsen
Department of Biochemistry and Molecular Biology, University of Southern Denmark
Virtually all cellular processes are tightly regulated by proteins with distinct functions. One of the fas-
test ways to alter the function of a protein is by post-translational modifications (PTMs). These can 
modulate many properties: conformational state, stability, activity, interaction partners and subcellular 
distribution. Many of the control mechanisms involved in the dynamic regulation of cellular expression 
patterns in health and disease are dependent on specific PTMs within key proteins. Therefore, the de-
termination and quantitative assessment of PTMs on proteins is fundamentally important for elucida-
tion of the complex processes that govern cellular events such as cell growth, division, differentiation 
and migration. As PTMs are usually mediated by tightly regulated, low abundance proteins, a small 
change in their expression or activity will result in a significant change in PTMs. This will likely be asso-
ciated with a change in activity, partners, or cell location of the affected proteins and consequently a 
change in the dynamics and stability of the cell. 
In the recent years methods, which allow researchers to specifically isolate and characterize proteins 
and peptides carrying several kinds of PTMs, such as phosphorylation, glycosylation and acetylation, 
have been developed. With these methodological development researches now have the tools to 
elucidate complex cellular signalling events, the effect of various PTMs on the dynamic of cells and 
complex combinatorial PTM cross talk in cellular signalling. 
Here novel comprehensive multidimensional proteomics and PTMomics strategies, which allow quan-
titative assessment of non-modified peptides, phosphopeptides, sialylated glycopeptides and ace-
tylated peptides, will be presented. Examples of the application of these strategies to study depola-
rization dependent signalling in isolated nerve-endings (synaptosomes), ischemic hearts and mouse 
brain development will be given.
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PHOSPHORYLATION AND UBIQUITYLATION CROSSTALK IN PROTEIN DEGRADATION
Danielle Swaney1, Pedro Beltrao2, Lea Starita1, Nevan Krogan2, Stanley Fields1 and Judit Villen1 
1Dept. Genome Sciences, University of Washington, Seattle, WA (USA)
2Dept. Cellular and Molecular Pharmacology, UCSF, San Francisco, CA (USA)
Protein post-translational modifications (PTMs) function as highly versatile signaling units capable of 
modulating protein activity, concentration, sub-cellular localization, and are critical in maintaining ho-
meostasis. Aberrant regulation of PTMs, such as phosphorylation, has been implicated in the onset 
and progression of numerous diseases, most notably in cancer. Over two hundred different protein 
PTMs have been described. These PTMs do not exist in isolation -crosstalk between different types 
of modifications on the same protein molecule is utilized to add specificity and combinatorial logic to 
signal processing. The principles underlying PTM crosstalk -how does the presence of one modifica-
tion influence the appearance of others, and how widespread is this crosstalk between modifications- 
remain unknown. 
While proteomic technologies are now available to globally study individual PTMs, the study of PTM 
crosstalk has been a major challenge because methods are lacking to determine whether two PTMs 
co-occur on the same protein. We have develop two novel proteomic approaches to identify co-
occurring PTMs, and applied them on a proteome-wide basis to interrogate the effects of protein 
phosphorylation on ubiquitylation. 
Our results highlight the widespread usage of PTM crosstalk throughout the proteome, greatly ex-
panding our knowledge of protein regulation. We find that phosphorylation events that co-occur with 
ubiquitin play unique roles, are more highly conserved, and are likely more functional than average 
phosphorylation events. We find a significant enrichment of ubiquitylation events in conserved regions 
of kinases, revealing a novel mechanism of how ubiquitylation can act to mediate signaling. The 
methods developed will find widespread applications in the study of crosstalk between any PTM pair. 
Furthermore, the conclusions derived from our work should influence the way we think about protein 
regulation and become the basis for future studies of protein post-translational modifications.
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HOST-PATHOGEN INTERACTION: INSIGHTS FROM PROTEOMICS
J.A. Reales-Calderón, V. Cabezón, A. Gil de Bona, V. Vialás, A. Pitarch, M. Ramsdale*, Marc Sylvester**, Ole 
Jensen**, L. Monteoliva, G. Molero and C. Gil.
Departamento de Microbiología II, Unidad de Proteómica UCM-Parque Científico de Madrid, Facultad de Farmacia, 
Universidad Complutense de Madrid, Madrid. *Biosciences, University of Exeter, UK, **Protein Research Group, University 
of Southern Denmark, Odense, Denmark.
Host-pathogen interaction studies open interesting opportunities in the search of new virulence de-
terminants and new targets for antimicrobial therapies. We are studying the Candida albicans-ma-
crophages interaction, because together with neutrophils are the first line of host immune defenses. 
We have analyzed protein differential expression of the ingested yeast using gel (DIGE- Differential 
In-Gel Electrophoresis) and non-gel proteomics (ITRAQ - Isobaric Tagging for Relative and Absolute 
Quantification). We provide evidence of a rapid protein response of the fungus to adapt to the new 
environment inside the phagosome by changing the expression of proteins belonging to different 
pathways. Network analyses allowed us generate a hypothetical model of Candida cell death after 
macrophage interaction, highlighting the interconnection between actin cytoskeleton, mitochondria 
and autophagy in the regulation of apoptosis. Different apoptotic markers like DNA fragmentation, 
ROS production, and caspase activity were assayed and our hypothesis was confirmed. 
In addition we are analyzing the macrophage protein expression in response to C. albicans. We 
have employed SILAC (Stable Isotope Labeling by Amino acids in cell Culture) to study changes in 
macrophage proteins and phosphopeptides expression in response to the yeast. For the phospho-
proteomic enrichment we used SIMAC (IMAC and Ti02) and CPP (Calcium Phosphate Precipitation 
and Ti02) as complementary techniques. 71 macrophage proteins showed differential expression in 
response to the yeast. These included proteins involved in the immune response, phagocytosis, anti-
apoptosis and cytoskeletal rearrangement. Using SIMAC and CPP, we report the identification of 841 
nonredundant phosphorylation sites from 522 proteins. The response of the macrophage phospho-
proteome to C. albicans reflects changes in 191 phosphopeptides related with innate and adaptive 
immunity, protein kinases, cytoskeletal rearrangement as well as other cellular processes. Some pro-
teins and phosphorylation sites were validated using Western Blotting. Moreover, apoptotic status of 
macrophages during the response to Candida was measured using different apoptotic markers. Our 
results suggest that C. albicans has an anti-apoptotic effect in macrophages, anti-apoptotic signals 
prevails over pro-apoptotic, this idea is also reinforced by the fact that Caspase-3 is not cleaved, TU-
NEL assays are negative, chromatin condensation after 24h of interaction is lower than 15%.
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PROTEIN STRUCTURE AND DYNAMICS: WHAT CAN ION MOBILITY SPECTROMETRY-
MASS SPECTROMETRY TELL US?
Alison E Ashcroft
Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, UK.
The term “structural proteomics” has been used to describe research aimed at determining how pro-
teins carry out their unique functions. This area of proteomics involves the study of the 3D structures 
of proteins in order to uncover clues about a protein’s function that are not detectable from sequence 
analysis alone. Such structural analyses can also indicate how drug candidates bind to proteins and 
provide information about protein-protein interactions.
The recent commercialisation of ion mobility spectrometry – mass spectrometry (IMS-MS) instrumen-
tation has provided the means of measuring the mass-to-charge ratio and cross-sectional area of 
biomolecules in a single, rapid experiment. This technology has proved successful for separating and 
characterising individual protein conformers and oligomers when co-populated within heterogeneous 
solutions, and for studying the assembly and architecture of non-covalently bound protein complexes. 
The application of IMS-MS to study the tertiary and quaternary structure of proteins and biomolecular 
complexes is the focus of this paper. 
Monitoring protein folding, and unfolding is particularly important in the study of amyloid-related disea-
ses whereby unfolded or misfolded proteins undergo self-aggregation into insoluble fibrillar structures. 
Data showing the separation of protein conformers arising from amyloidogenic proteins will be presen-
ted. The use of IMS-MS as a screening test for small molecule inhibitors, in which the mode of binding 
of different inhibitors with individual protein conformers can be discerned, is illustrated. Comparing the 
assembly pathways of different amyloidogenic proteins by monitoring protein aggregation into amyloid 
fibrils in real-time is discussed. 
30 - 50% of proteins in eukaryotic cells are thought to lack a unique 3D structure but can undergo a 
folding event to form well-defined tertiary structure on binding to their physiological targets. An exam-
ple of this is the intrinsically disordered protein bovine osteocalcin. Using IMS-MS to monitor changes 
in the charge state distribution and cross-sectional area of the protein during metal ion binding events 
is shown to provide information on the method of function of the protein.
The assembly pathways of biomolecular complexes of fixed stoichiometry and architecture are of 
intrigue. To illustrate this, the use of IMS-MS to unravel viral baseplate assembly is presented.
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PROTEOMICS AND INTERACTOMICS OF CARBOXYPEPTIDASES AND THEIR 
PROTEINACEOUS SUBSTRATES
Aviles F. X1., Tanco S.1, Tort O.1, Covaleda G.1, Alonso del Ribero M.2, Chavez M.A.2, Vendrell J1 and Lorenzo J.1 
1Institute for Biotechnology & Biomedicine and Dept. Biochemistry & Mol Biol, Universitat Autonoma de Barcelona,
 Bellaterra, Barcelona (Spain)  
2Center for the Study of Proteins, Fac. Biology, Univ. La Habana (Cuba)
The increase in the number of metallocarboxypeptidases (MCPs) evidenced in the last decade that 
their not fully understood simultaneous action on substrates as well their restrictions by natural mo-
dulators and inhibitors probably require, in regulated cases, a high complementation and tuning in 
their binding interactions. The fact that such substrates, as well the efectors, generally are of protei-
naceous nature, add extra degrees of sophistication in these interactions (i.e. at the chemo-physical, 
discrimination capability and kinetic levels). Not to forget that, to achieve full specificity, the help of 
other factors (compartimentation, temporal expression and localization, degradation ...etc) from living 
organisms is required (1-3). 
Nowadays we could count between 25 and 30 the number of variants of such MCP enzymes, clas-
sified between the M14A, B and C forms, to which we should add the recently emerging cytosolic 
ones (CCPs or Nna-likes) for the M14D subfamily in the MEROPS database (4,5). Giving that all of them 
seems to keep the “canonical” metallo-carboxypeptidase domain and equivalent recognition sites, it 
is a real challenge to understand the complex interplay between them, their discriminative interaction 
with natural substrates (peptidic or proteic, since are proteases), and with the environmental proteina-
ceous inhibitors. It is also a challenge for drug-designers to generate synthetic ligands that specifically 
control them (2).
Coincidentally, MCPs (as other proteases, in general) have another characteristic interactomics fea-
ture: they act transiently on proteinaceous substrates, promoting cleavages on them which severely 
effects their conformation and functionality. How to detect such transient interactions is not always an 
easy task by using standard proteomics-interactomics approaches or addapted variants of them (6-8), 
in spite that frequently the promoted changes are very large (i.e. in size and other properties).  We shall 
discuss several recent study cases of MCPs to clarify their interactomics with natural substrates and 
inhibitors and the strategies followed for their characterization.
1 Arolas, JL, Vendrell, J, Avilés, F.X &  Fricker LD (2007) Curr Pharm Des 13, 349-366.
2 Fernandez D, Pallares I, Vendrell J & Aviles FX (2010) Biochimie 92, 1484-1500.
3 Covaleda G, Alonso-del-Rivero MA, Chávez MA, Avilés FX, Reverter D. (2012) JBiolChem. 287, 9250-9258.
4 Rodriguez de la Vega M, Sevilla RG, Hermoso A, Lorenzo J, Tanco S, Diez A, Fricker Ll D, Bautista JM & Aviles FX (2007) FASEB J. 20, 
851-865 //  Rodriguez de la Vega M., Lorenzo J., Aviles F.X. & Bautista JM (2012) FASEB J, in press.
5 Otero A., Rodriguez de la Vega M, Tanco S., Lorenzo J, Aviles FX & Reverter D (2012) FASEB J  26, 3754-3764.
6 Yanes O, Villanueva J, Querol E & Aviles FX  (2007) Nature Protoc 2, 119-130.
7 Morell M, Czihal P, Otvos L, Aviles FX & Ventura S (2008) Proteomics 8, 3433-3442.
8 Van Damme P, et al & Aviles FX & Gevaert K (2010) Nature Meth. 7, 512-515.
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MAXQUANT: COMPUTATIONAL MASS SPECTROMETRY BASED PROTEOMICS FOR THE 
MASSES
Jürgen Cox
Core Developer of MaxQuant. Department of Proteomics and Signal Transduction
Max Planck Institute of Biochemistry
Systems biology requires comprehensive data at all molecular levels. Until recently the determination 
of cellular protein levels was lagging behind the corresponding mRNA measurements. Now it is beco-
ming feasible to extract system-wide quantitative data for nearly the complete proteome and for ten-
thousands of posttranslational modifications. Underlying the recent success of the field are develop-
ments in computational proteomics, which now allow highly sophisticated and completely automatic 
analysis of raw MS data and streamlined bioinformatic and systems-level interpretation of the results. 
MaxQuant is an all-encompassing end-to-end computational workflow solution for quantitative pro-
teomics. In this presentation the structure of MaxQuant and its crucial algorithmic parts are described 
as well as a perspective for future developments will be given and challenges will be discussed. 
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COMPLETE PROTEOMICS DATA WORKFLOW USING THE PROTEORED 
MIAPE-EXTRACTOR TOOL
Martínez-Bartolomé S1, Medina-Aunon JA1, López-García MA1, González-Tejedo C1, Gharbi SI1,  Navajas R1, 
Albar JP1
1 ProteoRed-ISCIII, Centro Nacional de Biotecnología - CSIC, Madrid, Spain
Increased sensibility in large-scale proteomics experiments is reached when using sample fractiona-
tion techniques, which results in the generation of multiple raw data files. Each one is usually inde-
pendently analyzed and the results from these analyses are generally merged by simply appending 
excel tables in a single one. In this way, global analyses of the data are commonly performed manually, 
which emphasizes on the current lack of tools for complex proteomics datasets analysis.
Additionally, the complexity of the analyses increases enormously in a multi-laboratory environment in 
which large scale experiments are performed from different technological platforms, and where com-
parison between different results becomes of great interest.
The ProteoRed Miape Extractor tool has been developed based on proteomics data representation 
standards and the minimal reporting requirements (MIAPE: Minimum Information About a Proteomics 
Experiment) developed by the Proteomics Standard Initiative (PSI) from the Human Proteome Organi-
zation (HUPO). Taking advantage of these standards, the MIAPE Extractor tool is able to compile and 
curate huge amount of protein and peptide identification data, also allowing a visual inspection and 
comparison of the data in an easy and intuitive way.
The last step of the workflow consists in the generation of compatible files needed for data submission 
to a proteomics data repository such as the ProteomeXchange consortium, which will be required for 
publication in specialized proteomics journals.
 
The ProteoRed MIAPE Extractor is currently being used by all the participants of the Spanish consor-
tium of the Human Proteome Project (spHPP), compiling, analyzing and sharing shot-gun identifica-
tion data.
More than 160 experiments, containing almost 10 million PSMs, 750.000 different peptide sequences 
and 38.000 different proteins have been currently stored in the ProteoRed MIAPE repository using this 
tool (data from Dec 2012). 
The tool is freely available at: http://www.proteored.org/MIAPEExtractor
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IDENTIFYING AND QUANTIFYING 10,000 PROTEINS IN 10 HOURS – FEASIBLE, POSSIBLE, 
DONE?..
Konstantin Chingin1, Juan Astorga-Wells1,2,  Mohammad Pirmoradian Najafabadi1,2, 
Harshavardhan Budamgunta1, Thorleif Lavold2, and Roman A. Zubarev1,3*
1 Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 
Sweden, 2 Biomotif AB, Stockholm, Sweden, 3 Science for Life Laboratory, Stockholm, Sweden
It took proteomics more than 15 years from its inception to reach the bottom of the proteome – that 
is, to observe whole or almost whole expressed proteome (≥10,000 proteins). The very few reports on 
this achievement published so far have exercised almost no restrain on the amount of used material, 
labor or instrumental cost. Despite the recent advances in mass spectrometric instrumentation, it is 
clear that routine application of the whole-proteome analysis will require development of instruments 
and methods going far beyond the current state of the art. In particular, the very large dynamic range 
of cellular proteome – some seven orders of magnitude – is by at least 100 times exceeding the dy-
namic range of the most advanced proteomics instruments. 
Traditionally, dealing with the dynamic range problem required extensive separation of proteins and 
peptides before the LC/MS analysis, which is one of the limitations of proteomics as it is currently 
practiced. Analysis of recent publications where detection of >5000 proteins is claimed revealed that, 
while half-proteome (ca. 5000 proteins) can be analyzed “in no time” (4-6 h), deeper analysis takes 
on average one hour of LC gradient for every 15-20 new detected proteins [1]. Therefore, useful data 
on the second half-proteome are accumulated at a rate comparable to that that of false positive rate.
The task is therefore to reduce the pre-LC/MS separation to a bare minimum. In principle, a well-de-
signed LC/MS experiment can analyze over 1000 unique proteins per hour of LC gradient. Therefore, 
aiming at detecting and quantifying 10,000 proteins in 10 h is a realistic (although at the moment of 
writing this abstract not yet reached) goal.   
In our laboratory, we pursue different approaches that separately or in combination should in princi-
ple be capable of delivering the desired number of proteins within the given time limit. One of them 
is using a novel device for fractionation of peptides in ESI-friendly solution by their pI values [2]. The 
other approaches will be described; their relative advantages will be discussed, and the most recent 
results presented.  
 
References
1 Zubarev, R. A. The challenge of the proteome dynamic range and its implications for in-depth proteomics, Proteomics, in press.
2 Chingin, K.; Astorga-Wells, J.; Pirmoradian Najafabadi, M.; Lavold, T.; Zubarev, R. A. Separation of polypeptides by isoelectric point focusing 
in electrospray-friendly solution using multiple-junction capillary fractionator, Anal. Chem. 2012, 84, 6856-6862.
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ADVANCES IN MIDDLE-DOWN AND TOP-DOWN PROTEOMICS 
Yury O. Tsybin, Luca Fornelli, Anton N. Kozhinov, Kristina Srzentic, Anna Lobas, and Ünige A. Laskay 
Biomolecular Mass Spectrometry Laboratory, Ecole Polytechnique Fédérale de Lausanne, Switzerland
Traditional bottom-up proteomics (BUP) relies on analysis of short, ~10 amino acid long, peptides. 
Modern mass spectrometers allow efficient structural analysis of significantly larger peptides on the 
LC time-scale. Middle-down and top-down proteomics (MDP and TDP, respectively) approaches are 
considered as the near future alternative and complementary emerging technologies that shall allow 
addressing BUP limitations. We will present selected recent attempts to advance MDP and TDP ap-
proaches. 
In regard to the MDP development, we will discuss the applicability of novel proteases and chemical 
methods of in-solution peptide backbone fragmentation to yield mixtures of peptides and proteins 
with rationally designed distinct molecular weight distributions, defined as: 0.6-3 kDa range for BUP, 
3-7 kDa for BUP+, 7-15 kDa for MDP, and >15 kDa for TDP. Specifically, we will present the use of 
dibasic site-specific proteases that cleave at adjacent K and/or R sites resulting in longer peptides ca-
rrying multiple charges, including charges at one or both termini. To increase the efficiency of LC-MS/
MS experiments we generate ion supercharging post-column to reduce the interference of superchar-
ging reagents with the chromatographic separation. Furthermore, structural analysis of larger peptides 
demands a substantial increase in the acquisition speed of high-resolution and high mass accuracy 
MS and MS/MS data. We advocate for the use of super-resolution signal processing methods for 
FTMS, e.g., filter diagonalization method (FDM). We will present the envisioned benefits of both FT and 
FDM MS for the MDP development and for the targeted TDP structure analysis of large intact proteins, 
including the monoclonal antibodies. 
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SILAC-BASED QUANTITATIVE ANALYSIS OF HUMAN BONE MARROW MESENCHYMAL 
STEM CELLS SECRETOME DURING CHONDROGENESIS
B. Rocha1, V. Calamia1, V. Casas2, L. Lourido1, C. Fernández1, J. Mateos1, P. Fernández-Puente1, M. Carrascal2, 
F. J. Blanco1, C. Ruiz-Romero1,3
1Osteoarticular and Aging Research Laboratory, Proteomics Unit-Associated Node to ProteoRed-ISCIII, INIBIC-CHUAC, 
A Coruña, SPAIN, 2Laboratorio de Proteómica CSIC/UAB, Barcelona, SPAIN.3CIBER-BBN, INIBIC-CHUAC, A Coruña, 
SPAIN
Purpose: A major limiting factor for the application of human bone marrow mesenchymal stem cells 
(hBMSCs) in cartilage tissue engineering is the understanding of the multi-step process by which 
cartilage is developed, termed chondrogenesis. It is regulated by a variety of growth factors and 
modulated by extracellular matrix (ECM) proteins. Considering that the functional role for the majority 
of the proteins secreted during chondrogenesis is not fully established, we have applied the SILAC 
(Isotope Labeling by Amino Acids in Cell Culture) technique to analyze the extracellular protein expres-
sion profile of hBMSCs undergoing chondrogenic differentiation. Methods: hBMSCs isolated from 3 
ostearthritic (OA) patients were grown in SILAC DMEM with two different isotope variants (medium 
and heavy) of lysine and arginine between 4-6 weeks. The fully labelled cell populations were then 
subjected to chondrogenesis using a home-made chondrogenic medium for 14 days. 24 h before 
collecting the secretome, the micromasses were carefully washed and changed to serum-free labeling 
media containing also chondrogenic inducers. Expression of cartilage-specific genes such as type I 
and II collagen and proteoglycans were used to verify the chondrogenicity of hBMSCs. Proteins in 
the CM harvested on day 2 and 14 of differentiation were precipitated and combined at a 1:1 ratio. 
Each mixture was then separated by 1D-SDS-PAGE and subjected to in-gel trypsin digestion using 
an automatic digester. The resulting peptide mixtures were analyzed by nanoLC coupled on-line to an 
LTQ-Orbitrap XL mass spectrometer and quantified using the MaxQuant software. Results: A pro-
gressive increase of type II collagen, agreccan and chondroitin-6-sulfate during the course of 14 days 
of differentiation was detected by inmunohistochemical assays, suggesting that hMSCs maintain their 
chondrogenic capacity in SILAC medium. Using the metabolic labeling strategy, we compared the 
secretomes at two different time points of chondrogenesis. More than 1000 proteins were identified 
with high confidence parameters. 20% of them were previously known ECM-related proteins. Among 
these, 34 exhibited a significant modulation of their levels during the process of chondrogenesis, in-
cluding cartilage ECM proteins such as COMP, lumican, prolargin, fibromodulin and matrix gla protein 
(MGP), which could be involved in the organization and/or stabilization of cartilage matrix. All these 
proteins were increased at day 14 of chondrogenesis. Finally, pentraxin-related protein (PTX3), which 
plays a role in the regulation of inflammatory response, resulted decreased at day 14. Conclusions: 
This study was focused on characterizing the specific modulations in the secretome of hBMSCs 
undergoing chondrogenesis using the SILAC method. The identification and quantification of these 
secreted proteins provide information about the changes in the ECM synthesis during the differentia-
tion process. Moreover, these findings enhance our knowledge on the extracellular regulation of this 
process and allow the identification of extracellular markers of chondrogenesis, which might have 
potential value in cartilage regeneration strategies.
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DETERMINATION OF PROTEIN TURNOVER IN PRIMARY CULTURE OF FISH MYOCYTES BY 
DYNAMIC SILAC AND SHOTGUN PROTEOMICS
M. Martin-Perez1, A. Millan-Cubillo1, J. Fernandez-Borras1, T. Ibarz1, J. Gutierrez1, MA. Odena2, R. Diaz2, 
E. de Oliveira2, and J. Blasco1
1Dept. Fisiologia i Immunologia, Universitat de Barcelona (UB), Spain, 2Proteomics Platform, Parc Cientific de Barcelona 
(PCB), Spain
Understanding fish growth regulation at the molecular and cellular levels is especially needed for im-
proving aquaculture. Bearing in mind that muscle growth will determine the final size of the animal and 
that normal cell growth and development requires a well-controlled balance between protein synthesis 
and degradation, the knowledge of protein turnover in muscle cells acquires special interest. We have 
studied protein dynamics in fish myocytes through a proteomics based strategy to determine the rate 
of turnover of individual proteins by “dynamic SILAC”1 (Stable Isotope Labeling with Amino acids in 
cell Culture). Primary cultures of muscle satellite cells of sea bream (Sparus aurata) fingerlings were 
incubated in triplicate with DMEM medium containing a stable isotope-labeled amino acid ([13C6
15N2] 
L-lysine) (heavy medium) until the stage of myotube (12 days)2. The cells were then “chased” with 
unlabelled light-Lys medium, taking samples at different time-points (0, 1, 2, 4 and 8 h) (Fig.1). Protein 
samples from each time-point were digested with trypsin using FASP (Filter Aided Sample Prepara-
tion) protocol, and then analyzed by LC/MS-MS. Raw data from MS were analyzed with MaxQuant 
software (v1.3.0.5) for protein identification and for determination of the ratio between ‘heavy’ and 
‘light’ peptides (RIA = Relative Isotope Abundance). Preliminary results shows that incorporation of 
heavy-Lys in cells at day 12 was above 85% in average (RIA = 0.86 ± 0.02) and 171 proteins were 
shared among biological replicates (Fig 2). Ongoing analysis with the entire dataset will allow us to 
identify those proteins with greater differences in turnover rate. This work has addressed a number of 
technical challenges and represents the first study to use proteomic approaches to measure individual 
protein turnover in primary culture of fish tissues. Moreover, this strategy could be very useful to pro-
gress on identification of proteins that are major parts of protein turnover in myocytes under different 
nutritional or physiological conditions.
References: 1Doherty et al., Journal of Proteome Research, 2009, 8, 104-112
 2Monserrat et al., Cell and Tissue Research, 2007, 330, 503–513
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ENABLING THE NEXT GENERATION OF MASS SPECTROMETRY-BASED QUANTITATION 
WORKFLOWS
Antonio Serna Sanz
ABSCIEX
Proteomics-based Mass Spectrometry has turned in the last years from untargeted to targeted analy-
sis. Quantitation data have become more relevant to nowadays research as clearly reflected in the 
amount of projects that demand these kinds of workflows. Likewise technology did evolve to increase 
throughput in the analysis of complex proteomes, so must do to enable the quantitation of large 
numbers of protein sets in the best possible fashion. Here we will introduce a new workflow for Mass 
Spectrometry that is enabling this step forward. This workflow is based in a Data Independent Acquisi-
tion with discrete transmission windows across broad mass ranges. The type of information generated 
is facilitating the rapid generation of methods for quantitating numbers of proteins so far unreachable 
through classical targeted approaches.
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DEVELOPMENT OF A NEW PROTEOMIC TOOL WITH SILAC COMBINED WITH HYDRAZI-
DE GLYCOPROTEIN ISOLATION TO CHARACTERIZE DEGRADOME IN BREAST CANCER 
CELLS 
Gemma Reverter-Branchat, Joan-Josep Bech-Serra, Marta Monge, Núria Colomé, Francesc Canals 
Laboratori de Proteòmica, Vall d’Hebron Institute of Oncology (VHIO), Barcelona
ADAM10 and ADAM17 (TACE) are enzymes with metalloprotease activity and a disintegrin domain in 
their structure, localized in the cellular membrane. Several of their substrates have been implicated 
in the pathogenesis or progression of breast cancer. For instance, it has been described that they 
promote cancer progression by releasing HER/EGFR ligands that culminates in increased cell proli-
feration, migration and survival. Therefore, a deeper knowledge of the substrate repertoire of these 
proteases will be helpful to better elucidate their role in tumor growth and metastasis and to evaluate 
their potential use as therapeutic targets.
The aim of this study was to develop a method to identify and characterize new substrates of pro-
teases in breast cancer. MCF-7 cells were seeded in SILAC medium supplemented with normal or 
isotopically labeled amino acids. Cells were treated 48 hours with a non-specific metalloprotease 
inhibitor (BB-94). Then, extracellular media (ECM) was collected and compared with the opposite 
metabolic label without treatment. Sample was enriched in glycoproteins by specific oxidation of their 
carbohydrates followed by their covalent union to immobilized hydrazide. Glycosylated peptides were 
recovered by specific enzymatic digestion with a glycopeptidase. Finally, these peptides were analy-
zed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS).
Our results show a wider substrate profile when compared with previous approaches. This protocol 
allows identification of more than one-hundred protease substrates in a single experiment. Moreover, 
it unravels potential new roles of those proteins in tumor development not deeply studied yet. Indeed, 
we find a relevant number of shed proteins involved in cell-to-cell signaling, cell adhesion and cell 
migration processes whose function most probably could be affected by ADAMs activity.
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HIGH-THROUGHPUT MITOCHONDRIAL REDOX PROTEOMICS ANALYSIS OF THE EFFECTS 
OF OXIDATIVE STRESS IN CELLULAR AND ANIMAL MODELS OF CARDIOVASCULAR
DISEASE
Estefanía Núñez1, Marta Loureiro-López1, Enrique Calvo1, Pablo Martínez-Acedo4, Adela Guarás1, 
Ester Perales-Clemente1, Elisabeth Miró-Casas2, Antonio Martínez-Ruiz3, David García-Dorado2, José Antonio 
Enríquez1 and Jesús Vázquez1
1Centro Nacional de Investigaciones Cardiovasculares, Madrid, 2Hospital Vall d’Hebron (Barcelona), 3Hospital Universitario 
La Princesa, Madrid and 4The Scripps Research Institute, Florida, USA
Reactive nitrogen and oxygen species-mediated protein modifications are associated with patho-
physiological states, but can also convey physiological signals. In spite of their biological relevance, 
little is known about the nature of specific oxidative modifications that are produced in situations of 
oxidative stress. We have recently developed GELSILOX, a new method for the simultaneous, high-
throughput quantitative analysis of the total and thiol redox proteomes (Martínez-Acedo et al, Mol. Cell 
Proteomics, 2012). In this work, we describe results obtained from the application of GELSILOX to the 
analysis of oxidative thiol modifications that take place in the mitochondrial proteome in several cellular 
and animal models of cardiovascular disease. 
We demonstrate that episodes of ischemia-reperfusion (IR) performed in isolated rat hearts produce 
an increase in oxidative damage in mitochondrial proteins, mainly in those belonging to oxidative 
phosphorylation complexes and to the Krebs cycle. 
The majority of the Cys sites affected belong to iron-sulfur centers or are known to modulate protein 
functionality in a redox-dependent manner. Ischemic preconditioning (IP) of the heart, induced by 
previous short episodes of IR, inhibited the oxidative damage induced by full IR in subsarcolemmal 
(SSM) but not interfibrillar mitochondria (IFM), paralleling the effect of IR on oxidative phosphorylation 
activity. Both the effect of IR and the protection by IR in SSM could be reproduced in mitochondria 
isolated from normoxic hearts, demonstrating for the first time that preconditioning may take place 
in mitochondria in absence of cytosolic signals. The molecular mechanism of oxidative damage in 
mitochondria was further assessed in a mouse KO model of complex I degradation induced by the 
absence of complex IV. Complex I was stabilized by hypoxia and was degraded when mitochondria 
were subjected to reoxygenation. By combining GELSILOX with DiS, a novel, data-independent se-
mitargeted quantitative proteomics strategy, we have been able to follow the time-course of protein 
abundance changes and oxidative modifications induced by reoxygenation. Structural analysis of 
protein changes and oxidative modifications showed that complex I was degraded as a consequence 
of oxidative alterations in critical Cys sites. We have also demonstrated the existence of oxidative 
mitochondrial modifications in a model of maladaptive cardiac hypertrophy produced in an EndoG 
KO mice model and also in aged animals, and are now establishing a detailed molecular model of the 
relation between oxidative state in mitochondria and pathology. 
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THIOL REDOX PROTEOMICS IN HYPOXIA CELL SIGNALLING
Alicia Izquierdo-Álvarez1, Elena Ramos1, Pablo Hernansanz-Agustín1, Pablo Martínez-Acedo2, Estefanía 
Núñez2,3, Joan Villanueva4, Margoth Moreno2, Raquel Mesa2,3, Montserrat Carrascal4, Jesús Vázquez2,3, 
Antonio Martínez-Ruiz1
1Servicio de Inmunología, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, 
Spain, 2Centro de Biología Molecular “Severo Ochoa”, CSIC-UAM, Madrid, Spain, 3Centro Nacional de Investigaciones 
Cardiovasculares Carlos III (CNIC), Madrid, Spain, 4Laboratorio de Proteómica-CSIC/UAB, IIBB-CSIC, IDIBAPS, Barce-
lona, Spain
Adaptation to decreased oxygen availability (hypoxia) is crucial for proper cell function and survival. In 
acute hypoxia, there is an increased production in reactive oxygen species (ROS), which can transdu-
ce signals by reversibly oxidizing cysteine thiols in certain proteins. We aimed to identify proteins that 
could be oxidized when subjected to acute hypoxia that could serve as early signals for adaptation 
to hypoxia.
We have developed novel thiol redox proteomic approaches, based on high-throughput LC-MS/MS 
peptide identification (GELSILOX) and fluorescence 2-DE (“redox fluorescence switch”, RFS). Both 
techniques rely on specific derivatization of reversibly oxidized thiols and differential analysis without 
purifying modified peptides/proteins, which allow simultaneous analysis of variations in abundance at 
the single protein level. 
With both techniques we have observed a general increase in cysteine oxidation in endothelial cells 
during acute hypoxia (2 hours, 0.5% O2). We have also identified specific proteins that are differentially 
oxidized in those conditions. By using complementary methods, we have studied the oxidation of indi-
vidual proteins in different conditions, and identified the cysteine residues that are reversibly oxidized.
Most thiol redox proteomics techniques have been used to identify proteins that are differentially oxi-
dized after strong oxidative treatments, related to oxidative stress. We show that the techniques we 
have developed can be useful for studying physiological treatments producing reversible oxidation in 
specific proteins, which can be involved in cell signalling. In addition, our results provide an important 
basis for future studies of the functional relevance of these oxidative modifications in the acute adap-
tive response to hypoxia.
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HIGH RESOLUTION, ACCURATE MASS APPROACHES FOR THE QUANTIFICATION OF TAR-
GET PEPTIDES
Sigrid Baumgarten1, Claire Dauly1, Michaela Scigelova2, Madalina Oppermann3
Thermo Fisher Scientific 1 Paris, France, 2Bremen, Germany 3 Stockholm, Sweden
Mass spectrometry has become an essential tool for understanding various aspects of biological 
systems.  Putative biomarkers need to be quantitatively analyzed across large numbers of samples 
from multiple biological sources and conditions, either for understanding of signaling regulation or for 
verification and selection of final biomarkers. A fast, robust and cost-effective platform is required at 
this verification stage. A targeted MS approach, selected reaction monitoring (SRM), has been used 
as a gold standard methodology for quantitative analysis of peptide candidates improving performan-
ce over traditional ELISA assays. However, several intrinsic limitations remain, such as the extensive 
need for method development and difficulties associated with work in highly complex matrices, where 
signal interference is limiting performance. High resolution, accurate mass (HR/AM) methods provi-
de an attractive alternative for targeted peptide analyses. High resolution on a Q Exactive benchtop 
mass spectrometer can resolve peptide species differing in mass by as little as 5 ppm, providing high 
selectivity. High Resolution methodology gives concrete benefits: more distinct features are measured 
in a given dataset, and their detection, in a combination of resolving LC-MS/MS strategies, leads to 
precise signal integration and confident peptide quantification, where interferences from matrix or from 
co-eluting species, are removed. 
Here we describe a targeted HR/AM peptide quantitation workflow on the Q Exactive mass spectro-
meter, where peptide targets present in complex mixtures were quantified using multiplexing strate-
gies.
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A NEW FAST METHOD FOR PEPTIDE BIOMARKER DISCOVERY IN HUMAN SERUM BY 
MASS SPECTROMETRY
Carolina Fernández-Costa1, Lucia Lourido1, Beatriz Rocha1, Valentina Calamia1, Patricia Fernández-Puente1, 
Jesús Mateos1, Cristina Ruiz-Romero1,3, Jose-Luis Capelo-Martínez2, Francisco Javier Blanco1 
1Osteoarticular and Aging Research Laboratory, Proteomics Unit-ProteoRed/ISCIII, INIBIC-CHUAC, A Coruña, 
2Physical Chemistry Department. University of Vigo at Ourense Campus, Ourense, 3CIBER-BBN, INIBIC-CHUAC, 
A Coruña  
The field of biomarker discovery is currently acquiring greater importance, especially with the recent 
emergence of new technologies, such as proteomics-based approaches. In proteomics, search for 
biomarkers in biological fluids such as human serum is a challenging issue, mainly due to the high 
dynamic range of proteins present in these types of samples. Therefore, removal of the most abundant 
proteins (depletion) is necessary. The basic scheme for proteomics relies on the depletion followed by 
the separation of a large number of proteins and their identification by mass spectrometry (MS). Prior 
to mass spectrometry, most common strategy used is depletion with inmunoaffinity columns followed 
by two-dimensional (2D) liquid chromatograpy (LC) separation. The drawbacks of these techniques 
are that they are expensive, laborious and spend much time. 
In this work, we report a novel fast strategy based in a chemical sequential depletion, protein digestion 
accelerated with ultrasounds and a peptide sequential separation in a micro-solid phase extraction 
(SPE) cartridge of C18 media. Individual serum samples, 20 of each condition, were subjected to a 
chemical sequential depletion protocol involving two precipitation steps, first with DTT and then with 
ACN, previously described by our group1,2. Then, the samples were digested with trypsin and this 
process was accelerated with ultrasonic energy. The peptides were retained in a commercial tip with 
a C18 chromatographic media, and were eluted in four different amounts of acetonitrile (ACN), from 
low to high percentage of ACN. Each eluted fraction was analysed by MALDI-TOF/TOF spectrometry 
by quintuplicate. The reproducible peptides masses of each condition were used to create a bioinfor-
matics software to discriminate between conditions.
This workflow was followed with 60 serum samples from patients suffering different rheumatic disea-
ses (OA, AR and APS) and 20 healthy donors. We were able to differentiate between the four condi-
tions by the peptides masses, and we created a new bioinformatics tool to classify the samples into 
these different conditions and to identify novel peptide biomarkers of these diseases.
Figure: Comprehensive scheme of the workflow followed in this research.
1 C. Fernández, HM. Santos, C. Ruiz-Romero, F.J. Blanco, J.L. Capelo. Electrophoresis; 2011.
2 C. Fernandez, V. Calamia, P. Fernández-Puente, J.L. Capelo, C. Ruiz-Romero, F.J. Blanco, Proteome Sci. (2012) 10:55.
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DISCOVERY, ACCURATE INCLUSION MASS SCREENING AND LABEL-FREE 
QUANTIFICATION OF POTENTIAL BIOMARKERS FOR  COLORECTAL CANCER IN SERUM 
OF HUMAN PATIENTS 
Marta Mendes1, Roi Villar-Vázquez1, María López-Lucendo2, Alberto Peláez1, Sofia Torres1, 
Rubén A. Bartolomé1, J. Ignacio Casal1
1 Functional Proteomics Laboratory. Centro de Investigaciones Biológicas (CIB-CSIC). Madrid. Spain, 
2 Proteomics Facility. Centro de Investigaciones Biológicas (CIB-CSIC). Madrid. Spain.
Colorectal cancer (CRC) is the second leading cause of cancer related death in developed countries. 
Most of these deaths result of the appearance of metastasis as a consequence of the late diagnosis 
of the disease. Although there are some biomarkers like CEA (Carcinoembryonic antigen), mostly 
adequate for advance stages and for monitoring recurrence of the disease, the efforts to discover 
new biomarkers to detect metastasis and CRC recurrence more accurately have not been very suc-
cessful to the date. Proteomics is a very powerful tool widely used in the discovery of biomarkers. 
Recently, using a SILAC based proteomic approach, we characterized the secretome of colorectal 
cancer metastatic cells identifying several proteins that might be potential CRC biomarkers. To confirm 
such possibility and furthermore identify new possible biomarkers for CRC, we performed a discovery 
proteomics analysis to characterize the serum from healthy patients and patients within all Duke’s 
stages which will then allow us to perform accurate inclusion mass screening (AIMS) of some can-
didates and further quantify those candidates in the different stages using a label free approach. For 
that purpose, pools from serum of healthy and Dukes A, B, C and D stages patients were prepared. 
First, samples were depleted of the 12 most abundant proteins that would  difficult the identification 
of the lower abundant proteins, in-solution digested with trypsin and fractionated by OffGel IEF in 24 
fractions in order to decrease sample complexity of the peptide mixture and therefore maximizing the 
detection of lower abundant proteins. Finally samples were analyzed in a linear ion trap Orbitrap Velos. 
Peptides were eluted using a linear gradient of 120 min from 0-40% B (A: 0.1%FA/2%ACN; B:0.1% 
FA in ACN)  at 200 nl/min. Mass spectra were acquired using a “top 15” method for the acquisition of 
a MS full scan followed by the fragmentation of the 15 most abundant precursors. Mass spectra were 
searched against the human human SwissProt/Uniprot database using both Sequest search engine 
through Proteome Discoverer and Andromeda search engine. Peptide identification was performed 
at a FDR of 1%.     
In total, 1816 proteins were identified in patients’ serum, from which 43 were coincident with proteins 
characterized in the secretome of KM12SM metastatic cells. Furthermore, 130 proteins were present 
only in serum from healthy patients while 289 proteins were present only in serum of patients with 
Dukes D. We are currently performing AIMS experiments to confirm the presence of these potential 
biomarkers in all Dukes stages and will further perform label free quantification to confirm diagnostic 
value.  
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FUNCTIONAL PROTEOMICS APPROACHES FOR HIGH-THROUGHPUT DETERMINATION 
OF  SMALL MOLECULES INTERACTIONS ON CKIT
María Jara-Acevedo1, Ricardo Jara-Acevedo2, María Gonzalez-Gonzalez2, Luis Escribano4, Joshua LaBaer5, 
Alberto Orfao1,3 & Manuel Fuentes 1,3
1 Servicio de Citometría. Centro de Investigación del Cáncer. Universidad de Salamanca-CSIC. Salamanca. Spain, 
2 ImmunoStep. Campus Miguel de Unamuno. Universidad de Salamanca-CSIC. Salamanca. Spain, 3 Departamento de 
Medicina. Centro de Investigación del Cáncer. Universidad de Salamanca-CSIC. Salamanca. Spain, 
4 Centro de Estudios de Mastocitosis. Hospital Virgen del Valle. Servicio de Salud de Castilla-La Mancha (SESCAM). 
Toledo. Spain, 5.- Biodesign Institute. Personalized Diagnostic Department Arizona State University. Tempe, AZ. USA     
cKIT is a trans-membrane receptor  with tyrosin-kinase activity. Aberrant levels of cKIT activity have 
been associated with several hematopoietic disorders and gastrointestinal stromal tumors (GIST). 
Several point mutations of cKIT have been described in a cohort of 150 patients, mostly of them are 
related to tyrosin-kinase activity and interactions with Stem Cell Factor (SCF). As a consequence, 
more than 75% of the patients are resistant to conventional treatments, so new ones are needed. 
Here, we have designed and developed a Nucleic Acids Programmable Array (NAPPA), which content 
wild-type cKIT and all clinical point mutations, in order to discover new inhibitors of cKIT activity and 
deep into cKit-SCF interaction. By this approach, novel molecules have been discovered as useful for 
inhibition of aberrant cKIT activity. 
Funding: Ministerio de Sanidad y Política Social TRA-023, Ministerio de Sanidad ISCII, FIS PI11/02114. Junta Castilla-Leon SA198A12-2. 
M.G.G. is supported by a PhD scholarship of ISCIII FI08/00721. 
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INVESTIGATION OF PROTEIN MONOMERIZATION BY CAPILLARY ELECTROPHORESIS 
AND ION MOBILITY MASS SPECTROMETRY. APPLICATION TO SUPEROXIDE DISMUTASE 
1 AND LATERAL AMYOTROPHIC SCLEROSIS
F. Benavente1, M. Borges-Alvarez1, M. Vilaseca2, E. Giménez1, J. Barbosa1, V. Sanz-Nebot1 
1Department of Analytical Chemistry. University of Barcelona. Barcelona, Spain, 
2Institute for Research in Biomedicine (IRB Barcelona). Barcelona, Spain.
The native form of superoxide dismutase (SOD-1) is a homodimer that coordinates one Cu2+ and one 
Zn2+ per monomer (Cu2,Zn2-dimer SOD-1). SOD-1 aggregates are characteristic of amyotrophic late-
ral sclerosis (ALS), a fatal neurodegenerative disease in humans. As only a minor percentage of ALS 
cases can be explained by SOD-1 mutations, several authors have proposed that aggregation may be 
triggered by specific post-translational modifications (PTMs) or dimer dissociation. Here we describe 
capillary electrophoresis mass spectrometry (CE-MS) and nano-electrospray ionization-ion mobility 
mass spectrometry (IM-MS) for the analysis of SOD-1, as an alternative to the existing ESI-MS and 
LC-MS methods that do not allow dimer detection. Using the optimum methodologies to avoid metal 
release and to minimize dimer dissociation, both techniques allowed detecting monomeric and dime-
ric forms of bovine and human SOD-1 and several PTMs. IM spectrometry separates ions in the gas 
phase in function of their size-to-charge ratios in a similar way to charge-to-size based separations of 
ions in solution in CE. CE-MS and IM-MS yield three-way data (migration time-m/z-intensity and drift 
time-m/z-intensity, respectively), but while monomeric and dimeric SOD-1 solution forms comigrate in 
CE-MS, nano-ESI-IM-MS allowed separation of monomeric and dimeric gaseous ions with the same 
m/z values. This was crucial to obtain reliable information about monomer-to-dimer abundance ratios 
in blood samples from healthy control and ALS patients. A comparison between both groups of sam-
ples demonstrated that only IM-MS was able to confirm the presence of a higher relative abundance 
of Cu,Zn-monomer SOD-1 in patient samples. This novel analytical tool may be of great importance 
to elucidate the molecular mechanisms of aggregation related to PTMs or monomerization that may 
underlie ALS, and also other neurodegenerative diseases related to protein aggregation, such as 
Alzheimer’s, Parkinson’s, Huntington’s and prion diseases.
References:
1. Shimizu A, Nakanishi T, Miyazaki A. Mass Spectrom. Rev. 2006, 25, 686-712. 
2. Wilcox KC, Zhou, L, Jordon JK, Huang, Y, Yu Y, Redler RL, Chen X, Caplow, M, Dokholyan NV. J. Biol. Chem. 2009, 284, 13940-13947. 
3. Borges-Alvarez M, Benavente F, Barbosa J, Sanz-Nebot V. Electrophoresis 2012, 33,2561-2569.
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HYDROGEN-DEUTERIUM EXCHANGE FOR PROTEIN STRUCTURE ANALYSIS
Robert Tonge, Joomi Ahn, Michael Eggertson, Keith Fagden, Ying Qing Yu, James Langridge 
Waters Corporation, Manchester, UK 
Hydrogen/deuterium exchange mass spectrometry (HDX MS) has proven to be a useful analytical 
method for the study of protein dynamics and changes to protein conformation.  Typical uses include 
structural characterisation of recombinant proteins, mutation effects on protein structure and protein-
protein and protein-ligand interaction mapping. Improvements in LC-MS such as UPLC and the incor-
poration of high peak capacity ion mobility separations have made HDX MS increasingly feasible to 
researchers, yet data interpretation remains a major challenge. Conventionally, the HDX MS data are 
interpreted either manually or processed with semi-automated tools to determine the deuterium up-
take at peptide level. These are time-consuming processes due to the thousands of spectra involved 
for processing hundreds of peptides, multiple time-courses, replications in comparative analyses. In 
order to enhance the efficiency of data processing, a new HDX software tool, DynamX (1), is presen-
ted. 
All samples were analysed using the Waters SYNAPT G2 HDMS in combination with the nanoACQUI-
TY UPLC with HDX Technology. Analytical column was an ACQUITY UPLC  BEH C18 1.7 µm 1.0 x 
50 mm. The trap column was an ACQUITY VanGuard Pre-column, BEH C18 1.7 µm 2.1 x 5 mm. 
Online pepsin digestion was performed using a 2.1 x 30 mm immobilized pepsin column (Applied 
Biosystems). MSE data were collected for all analyses. Undeuterated analyses were processed using 
ProteinLynx Global Server (PLGS) 2.5 with IdentityE informatics. DynamX was used to measure the 
deuterium uptake of each peptide as a function of deuterium exposure time.  
Experimental examples showing conformational changes of calmodulin upon calcium binding, and 
Fab paratope mapping will be presented. The automated software generated a list of reproducible 
peptic peptides based on retention time, intensity, fragment ions, and mass accuracy. The amount of 
deuteration of the identified peptides was automatically determined and displayed in processed spec-
tra view. The deuterium uptake curves were automatically plotted in a function of time for comparative 
analysis using multiple batches of proteins. Finally the calculated results of relative deuteration and 
its difference were summarized in butterfly and difference charts for convenient data interpretation. 
In addition, DynamX was used to process the ion mobility data and successfully eliminated the inter-
ferences of co-eluting peptides separated by a mobility drift time.  This process automation greatly 
improves the speed and accuracy of HDX MS experiments and is a step towards extending the appli-
cation of this approach into new research areas. 
(1) Wei H, Ahn J, Yu YQ, Tymiak A, Engen JR, Chen G. Using hydrogen/deuterium exchange mass 
spectrometry to study conformational changes in granulocyte colony stimulating factor upon PEGyla-
tion. J Am Soc Mass Spectrom. 2012 Mar;23(3):498-504
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CYCLODEXTRIN- AND METHYL JASMONATE-MEDIATED RESVERATROL ACCUMULATION 
IN GRAPEVINE CELL CULTURES:AN OMICS APPROACH
Maria José Martinez-Esteso1 , Maria Teresa Vilella-Antón1, Susana Sellés-Marchart2, Lorena Almagro3, Jaime 
Morante-Carriel1, Juan Carlos Vera-Urbina1, Maria Angeles Pedreño-García3 and Roque Bru-Martínez1
1Plant Proteomics and Functional Genomics Group, Department of Agrochemistry and Biochemistry, Faculty of Science, 
University of Alicante, Alicante, Spain. 2Research Technical Facility, Proteomics and Genomics Unit, University of Alican-
te, Alicante, Spain. 3Plant Peroxidases Group. Department of Plant Physiology, Faculty of Biology, University of Murcia, 
Murcia, SPAIN 
Grapevine (Vitis vinifera) cell suspension cultures accumulate large extracellular amounts of the stilbenoid 
resveratrol along several days, in response to elicitation with methylated cyclodextrins (MBCD) and methyl 
jasmonate (MeJA) [1,2,3]. The aim of this study was to investigate changes in both the transcriptome and 
cellular proteome potentially related to resveratrol production and accumulation in response to MeJA, 
MBCD and MBCD+MeJA treatments. The GrapeGenAffymetrixGeneChip® (23,096 probesets corres-
ponding to 18,711 non-redundant grapevine transcripts [4]) and the quantitative proteomics gel-based 
DIGE technique were used to detect statistically significant changes in transcripts 24 hours, and proteins 
during an incubation time of up to 120 hours after elicitation, respectively. We focused on transcripts 
encoding metabolic enzymes from the primary metabolism precursors i.e. phosphoenol pyruvate and 
malonyl CoA to the final product, i.e. stilbenes. While CD or CD+MeJA induced accumulation of shi-
kimate, general pheylpropanoid, stilbenoid and malonylCoA pathways transcripts, MeJA induced only 
general phenylpropanoid and stilbenoid pathways. In the proteome kinetics experiment sampling four 
data points (6, 24, 72 and 120 hours) from each experimental condition, 212 de-regulated unique spots 
were detected. Protein identification based in nLC-MS/MS analysis and NCBInr database search revea-
led a large complexity in the abundance pattern of several proteins relevant to resveratrol synthesis and 
accumulation. Stilbene synthases (STS), found in 29 unique spots, encoded by up to 40 paralogs, were 
classified into 6 phylogenetic groups. Such groups showed specific abundance patterns in response to 
the different elicitor treatments. The comparison of STS protein and stilbene metabolite profiles lead to 
detect potential STS groups specifically involved in the response to MBCD alone or combined with MeJA 
elicitors that lead to resveratrol accumulation. Likewise, glutathione-S-transferases (GST) were found in 
a high number of spots. These belonged to two tau phylogenetic subgroups, one phi and one lambda 
class. Interestingly, the five GST whose abundance profiles correlated with profiles of STS and metabolites 
composed one of the two tau class clusters, thus pointing to a potential role in resveratrol trafficking within 
the cell and across plasma membrane. Other findings will be presented and discussed in relation to the 
effect of MBCD and MeJA elicitation.
References
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Defense Responses in Grapevine Cell Cultures. J. Agric. Food Chem. 54, 65-71.
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A NEW APPROACH FOR SYSTEMS BIOLOGY ANALYSIS OF HIGH-THROUGHPUT 
QUANTITATIVE PROTEOMICS EXPERIMENTS
Marco Trevisan-Herraz, Elena Bonzon-Kulichenko, Juan Carlos Silla-Castro, Emilio Camafeita, Inmaculada 
Jorge, Juan Antonio Lopez, Fernando García-Marqués, Jesús Vázquez
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
In a previous work we presented a statistical model for the analysis of quantitative proteomics ex-
periments using stable isotope labelling approaches. Currently, the tools to perform systems biology 
analyses on these experiments are limited. In our laboratory we have further developed our algorithm 
to facilitate this kind of studies.
A large number of high-throughput quantitative proteomics experiments have been analysed, using 
samples from yeast, human, pig, rat and mouse models. Quantified proteins were integrated into 
ontological categories and the distributions describing the intra- and inter-category variability were 
analysed. Unexpectedly, we observed that the distribution of proteins within categories was undistin-
guishable from the expected null hypothesis behaviour for all proteomes studied to date, with a very 
low proportion of outliers. 90-98% of the proteins behaved in this coordinated manner. In contrast, 
5-30% of categories were found to deviate in the treated samples compared to the null hypothesis. 
These category changes were not produced by individual protein deviations but were rather the result 
of a homogeneous increase or decrease of their protein components. To further study this behaviour, 
we have developed a novel algorithm to integrate quantitative protein information into ontological 
categories. With this algorithm we have been able to separate successfully the technical variance 
(intra-category protein variability) from the “category variance” (a novel concept that quantifies the glo-
bal effect of treatments on cell functionality). In contrast, when proteins were randomly classified into 
the same categories, in none of the cases the category variance was significantly different from zero, 
demonstrating that the coordinated behaviour was not a consequence of protein grouping.
This new threshold-free approach for systems biology analysis of quantitative proteomics experiments 
allows a straightforward and global interpretation of biological results in terms of ontological alterations 
as well as the identification of specific proteins that show a separated, non-coordinated behaviour.
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ON THE FEASIBILITY OF 2D HIGH pH / LOW pH LIQUID CHROMATOGRAPHY COUPLED TO 
MASS SPECTROMETRY IN LABEL-FREE INTENSITY-BASED QUANTIFICATION
Alex Campos1,2, and Eliandre de Oliveira1
1Proteomics Core Facility, Parc Científic de Barcelona, Barcelona, Spain, 2Integromics, Madrid, Spain
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has emerged as a 
powerful analytical method for systematically profiling biological samples. With the advent of a new 
generation of LC-MS/MS systems, label-free intensity-based methods for comparative proteomics 
analysis has gained great popularity in the past years. Despite the major advancements in this field, 
the proteomics community still face important challenges in terms of reproducibility and sensitivity of 
label-free proteomics analysis. The problem of variability may significantly impact comparative studies 
aimed to profile biological states or phenotypes. Often label-free intensity-based quantitative proteo-
mics is approached in an unfractionated fashion in order to achieve better reproducibility. 
To make confident inferences about biological differences in quantitative analysis, proteomics experi-
ments must be accurate and reliable. To this end, we implemented a series of performance metrics for 
benchmarking label-free intensity-based quantitative proteomics analysis of both fractionated (online 
high pH C18) and unfractionated samples.  As expected, the number of features, peptides and proteins 
detected was substantially increased following fractionation. Overall, we detected and consequently 
identified approximately 500,000 and 50,000 (figure 1) features across 8 samples after fractionation (8 
fractions). Despite yielding more identifications, there is a general notion that fractionation deteriorates 
technical reproducibility. Therefore, we thoroughly evaluated the reproducibility of fractionated and un-
fractionated approaches. Overall, this study demonstrates how the performance metrics can be used 
to benchmark the quality of proteomics data generated in proteomics studies.
Figure 1. 2D feature map. Each feature detected and identified is shown in the map m/z (x-axis), elution time apex (y-axis) and colored 
according to its summed abundance across samples. The feature size in the map is represented by the feature detection frequency across 
the samples
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ANTIBODY COLOCALIZATION MICROARRAY: A SCALABLE TECHNOLOGY FOR MULTI-
PLEX PROTEIN ANALYSIS IN COMPLEX SAMPLES
Mateu Pla-Roca1, Rym Leulmi2, Saule Tourekhanova2, Sebastien Bergeron2, Veronique Laforte2 and David 
Juncker2
1Nabioengineering laboratory, Institute for Bioengineering of Catalonia, Barcelona, Spain. 2Micro and Nanobioengineering 
laboratory, Mcgill University, Montreal, Canada 
DNA microarrays were rapidly scaled up from 256 to 6.5 million targets, and although antibody mi-
croarrays were proposed earlier, sensitive multiplex sandwich assays (MSA) (Figure 1.A) have only 
been scaled up to a few tens of targets. Cross-reactivity, arising because detection antibodies are 
mixed (usually known as “cocktail of detections”), is a known weakness of multiplex sandwich assays 
that is mitigated by lengthy optimization. In order to circumvent this limitation, here we propose a 
novel concept for multiplexing without mixing named antibody colocalization microarray (ACM) (Fi-
gure 1.B). In ACMs, both capture and detection antibodies are physically colocalized by spotting 
to the same two-dimensional coordinate. Following spotting of the capture antibodies, the chip is 
removed from the arrayer, incubated with the sample, placed back onto the arrayer and then spotted 
with the detection antibodies. ACM may be seen as an array of singleplex nano-sandwich assays, 
each requiring only 1 nL of dAb solutions. ACMs with up to 50 targets were produced, along with a 
binding curve for each protein (Figure 2).The ACM was validated by comparing it to ELISA and to 
a small-scale, conventional multiplex sandwich assay (MSA). Using ACMs, proteins in the serum of 
breast cancer patients and healthy controls were quantified, and six candidate biomarkers identified. 
Our results indicate that ACMs are sensitive, robust, and scalable (M. Pla-Roca et al. Molecular and 
Cellular Proteomics 2012). 
Figure 1. Schematic process flow for multiplexed sandwich as-
says (MSA) in microarray format, and the antibody colocalization 
microarray (ACM). In an ACM, the initial steps are identical to a 
MSA, with the difference that the first spotting is precisely re-
gistered and that a second round of spotting is used to deliver 
each dAb exactly on the spots with the matched cAb, physically 
colocalizing them. This strategy avoids mixing of reagents.
Figure 2. ACM layout and binding curves for 50 Ab pairs inclu-
ding. (A)  Fluorescent micrograph of a representative slide with 16 
replicate arrays incubated with two serum samples and corres-
ponding dilutions (left), and buffer solution with recombinant pro-
teins with seven dilutions and a negative control used to establish 
the standard curves (right). (B)  Detail of a single array. Standard 
binding curves of Ab pairs with lower (C) and higher (D) sensitivity 
that extend into the low pg/ml range.  Scale bar in (B): 2 mm.
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CONSERVATION OF PEPTIDE EXTRACTS FROM TRYPSIN DIGESTION OF PROTEINS IN A 
HOSPITAL BIOBANK FACILITY
Mateos J1, Pintor-Iglesias A, Fernández-Puente P1, Ruíz-Romero C1 and Blanco FJ*1
1 Rheumatology Division, Proteomics Unit - ProteoRed / ISCIII, INIBIC-Hospital Universitario A Coruña, A Coruña-SPAIN
Purpose: Protein fingerprinting and MSMS-based protein identification yields spare peptide extracts 
that, usually, are not conserved in the Proteomics Facilities due to lack of storage space. However, 
in most of the cases, a second analysis of the same sample is required some weeks or even months 
later by the user. If the original sample has not been properly conserved, that implies, for the user, to 
get enough amount of sample for a new analysis, which is time-consuming and, eventually, some pro-
blems in terms of reproducibility could arise. In the other hand, emerging Biobank Facilities, offer the 
solution for proper storage and conservation of samples in individually-coded collection tubes allowing 
automated pick-up of a specific sample without breaking the cold chain of the others. In this study we 
tested our Hospital Biobank as a facility for the proper storage for mid-term conservation of peptide 
extracts coming from samples with low and high protein complexity.
Methods: For PMF and MSMS analisis, purified proteins -Albumin, Holotransferrin and a-casein- 
were loaded in replicates in SDS-PAGE and subjected to standard in-gel trypsin digestion and peptide 
extraction. For LC-MALDI-TOF/TOF analysis, purified b-galactosidase and Human Serum Samples 
were in-solution-digested following standard procedures and desalted with C18 nu-tips. In both ca-
ses, peptides extracts were aliquoted in individually-coded Micronic ® tubes, dried in a speed-vac, 
bar-coded read and stored in a automated freezer in the Biobank facility. Samples were kept dried 
at -20 oC until the correspondent time-point of analysis, then reconstituted in the proper buffer and 
analyzed by either MALDI-TOF/TOF (Peptide fingerprinting and MSMS) or LC-MALDI-TOF/TOF fo-
llowing a highly reproducible pattern to assure the reproducibility of the results.  Protein identification 
was done with either Mascot or ProteinPilot® as search engines using constant parameters.
Results and Conclusion: Over a period of three months, we checked four time points, at Days 0, 7, 
30 and 90, although we plan to extend the study over a total period of one year.  We compared MS 
and MSMS protein score, number of identified peptides and coverage of the identified proteins. In the 
low complexity samples the number of peptides detected decrease with the time affecting especially 
the MS score. However, two out of the three proteins –Albumin and Holotransferrin- are identified 
both by PMF and MSMS at day 90. By LC-MSMS, b -galactosidase and the most abundant Serum 
proteins are identified with good scores at day 90, although we found a decrease in the total number 
of detected peptides as well. Our results encourage us to use the Biobank Facility in the future for 
storage of peptide extracts.
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PROTEOGENOMICS OF BACTERIA AND ARCHAEA: A ROMPER LA PIÑATA!
Jean Armengaud, Céline Bland, Guylaine Miotello, Joseph Christie-Oleza
CEA, DSV, iBEB, Lab Biochim System Perturb, Bagnols-sur-Cèze, France
High-quality genome annotation is today a crucial starting point for characterizing new microor-
ganisms. Proteogenomics consists in better annotating genomes with the help of proteomic data. 
High-throughput identification and characterization of proteins by extra-large shotgun tandem mass 
spectrometry approaches allow identifying new genes and characterizing the exact initiation of the 
translation. We applied such strategy on various microorganisms, such as Deinococcus deserti 
VCD115, a bacterium from the Thermus-Deinococcus phylum that was isolated from surface sands 
from Sahara, the archaeon Thermococcus gammatolerans, and the marine bacterium Ruegeria po-
meroyi. The D. deserti bacterium exhibits an extraordinary ability to withstand desiccation and ionizing 
radiations. We sequenced and annotated its genome by proteogenomics. We systematically investi-
gated the existence of remaining unannotated genes, defined translational start sites, and listed signal 
peptide processing events and post-translational modifications. Surprisingly, experimental evidences 
were obtained indicating that translation is sometimes initiated in Deinococcaceae from non-canonical 
codons such as ATC and CTG. Based on our proteomic results we found that predicting translation 
initiation codons is still difficult for most bacteria. Proteomic-based refinement of genome annotations 
may be helpful in such cases. We are developing specific methods to enrich the peptides corres-
ponding to the N-termini of proteins in the framework of a large program to better annotate various 
bacterial phyla. 
References:  Armengaud (2009) A perfect genome annotation is within reach with the proteomics and genomics alliance. Curr Opin Mi-
crobiol 12:292-300; Armengaud (2010) Proteogenomics and systems biology: quest for the ultimate missing parts. Expert Rev Proteomics 
7:65-77; Christie-Oleza et al. (2012) High-throughput proteogenomics of Ruegeria pomeroyi: seeding a better genomic annotation for the 
whole marine Roseobacter clade. BMC genomics 13:73; Christie-Oleza et al. (2012) Comparative proteogenomics of twelve Roseobacter 
exoproteomes reveals different adaptive strategies among these marine bacteria. Mol Cell Proteomics 11:M111.013110; Armengaud (2012) 
Microbiology and proteomics, getting the best of both worlds! Environ Microbiol: in press.
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THE HUMAN PROTEOME PROJECT INTERCONNECTED WITH LARGE SCALE BIOBANKING
György Marko-Varga
Div. Clinical Protein Science & Imaging, Biomedical Center, Dept. of Measurement Technology and Industrial Electrical 
Engineering, Lund University, Lund, Sweden
The recent developments and announcement from the Human Proteome Organization (HUPO), on the 
Human Proteome Project (HPP) is a major undertaking, in some ways similar to the Human Genome 
Project (HUGO) that was announced by Bill Clinton and Tony Blair in June 2000. The major difference 
is that each of the approximate number of 20,300 proteins encoded by the human genome will be 
mapped to specific locations on individual chromosomes. Protein annotations will be linked to the 
human genome and to specific diseases by applying both mass spectrometry assays and antibody 
based assays [1-3]. This program is expected to play a central role in these developments, as a resou-
rced facility where the basis of all the developments within HPP will be made publicly available [4]. Re-
cently the initiation of the Chromosome initiative of HUPO, (C-HPP), the first step Toward completion 
of a Genome-Wide characterization of the human proteome was published (http://pubs.acs.org/toc/
jprobs/current) with a total of 33 scientific papers. 
Biobanks are a major resource for scientists to access unique patient samples for medical research.
Many studies within clinical proteomics utilize stored samples contained in biobanks to measure spe-
cific end points. Today we have not yet achieved consensus on how to collect, manage, and build 
biobank archives in order to reach goals where these efforts are translated into value for the patient. 
Standardizations of quality control of samples being processed for storage as well as retrieval of 
stored samples are important goals in order to support the development of diagnostic tools such as 
biomarkers. Lack of available high quality sample collections with a wide range of disease cohorts has 
become a rate-limiting step for drug development, medical research and novel diagnostics. These de-
velopments will be of great value and importance to programs such as the Chromosome Human Pro-
tein Project (C-HPP) that will associate protein expression in healthy and disease states with genetic 
foci along of each of the human chromosomes. In this paper we review the technical and administra-
tive aspects of biobanking and present examples of preferred best practice and potential future use [5].
References
1 A Gene-centric Human Proteome Project. Mol Cell Prot 2010, 9, 427-429
2 Hancock W, Omenn G, LeGrain P, Paik Y-K., J Proteome Res 2011, 10, 210
3 Paik Y-K., et al., Nature Biotech, 30, 221-223, 2012
4 Fehniger TE, Marko-Varga G.J Proteome Res, 2011, 10, 3-4
5 Marko-Varga G, et al., J. Proteome Res., 2012, 11, 5124-34
HPP Session HPP1
66
NEXTPROT: THE HUMAN PROTEIN-CENTRIC KNOWLEDGE PLATFORM, STATUS AND FU-
TURE DEVELOPMENTS
Amos Bairoch
SIB- Swiss Institute of Bioinformatics and University of Geneva; CMU, Geneva, Switzerland.
In September 2008, the UniProt/Swiss-Prot group achieved a major milestone: the first complete 
manual annotation of the full set of human proteins (derived from about 20’000 genes). This corpus 
of data which is quite rich in information pertinent to modern biomolecular medical research clearly 
shows that there is a large gap in our knowledge of human proteins in terms of functional information 
as well as protein characterization (PTMs, protein/protein interactions, subcellular locations, etc.). This 
gap resides not only in the available experimental information, but also in the way this information has 
been stored, which is far from being sufficient to help researchers making sense of what all these 
human proteins do in our bodies! Therefore, in the framework of CALIPHO, an interdisciplinary group 
created jointly by the University of Geneva and the SIB, we are developing neXtProt, a new human-
centric protein knowledge resource, with the aim to help researchers answer pertinent questions. To 
achieve this goal we need to build up on a corpus of both curated knowledge - originating mainly 
from the UniProtKB/Swiss-Prot knowledgebase - and carefully selected and filtered high-throughput 
data pertinent to human proteins. Such a data gathering and grading effort are complemented by the 
development of tools that allow such data to be analyzed.
neXtProt (www.nextprot.org) is a work in progress. Currently we are involved in supporting the efforts 
of HUPO Human Proteome Project (HPP). In this context we are integrating into neXtProt data origi-
nating from proteomics experiments, including peptides and PTMs identification. To allow our users 
to make the best use of the information that is available in the platform we have developed exports 
options (PEFF, XML) as well as programmatic access (API).
There are many things we plan to add to neXtProt in the near future especially in term of supporting 
information pertinent to protein networks. In this context we plan to integrate information originating 
from STRING as well as other resources.
There is a very long road in front of us and the challenge of integration the mass of heterogeneous 
knowledge on human proteins is a distant perspective and we hope you will enjoy working with neXt-
Prot and will help us making it evolve by telling us of your specific needs.
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HUMAN PROTEOME PROJECT: CHARACTERIZATION OF THE PROTEINS ENCODED BY 
THE CHROMOSOME-16 PROTEIN CODING GENES
SI. Gharbi1, V. Segura2, JA. Medina-Aunon1, E. Guruceaga2, C. González-Tejedo1, MM Sánchez del Pino3, F. Canals4, M. 
Fuentes5, I. Casal6, S. Martínez-Bartolomé1, F. Elortza7, JM. Mato7, JM. Arizmendi8, J. Abian9, E. Oliveira10, C. Gil11, F. 
Vivanco12, F. Blanco13, FJ. Corrales2*and JP. Albar1*
1 ProteoRed-ISCIII, Centro Nacional de Biotecnología - CSIC, Madrid, Spain.
2 ProteoRed-ISCIII, Center for Applied Medical Research (CIMA), University of Navarra. Pamplona, Spain. 
3 ProteoRed-ISCIII, Biochemistry Department, University of Valencia, Valencia, Spain.
4ProteoRed-ISCIII, Proteomics Laboratory,Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital Research 
Institute, Barcelona, Spain.
5Centro de Investigación del Cáncer/IBMCC (USAL/CSIC), Departamento de Medicina and Servicio General de Citometría, 
University of Salamanca, IBSAL, 37007 Salamanca, Spain
6ProteoRed-ISCIII, Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain.
7 ProteoRed-ISCIII, Proteomics Platform, CIC bioGUNE, , Bizkaia Technology Park, Derio, Spain.
8 ProteoRed-ISCIII, University of the Basque Country, UPV/EHU, Spain
9 ProteoRed-ISCIII, CSIC/UAB Proteomics Laboratory, Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior 
de Investigaciones Científicas/ Bellaterra, Spain.
10 ProteoRed-ISCIII, Parc Cientifıc de Barcelona, Universitat de Barcelona, Barcelona, Spain
11 Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
12 Department of Immunology, IIS-Fundacion Jimenez Diaz, Madrid, Spain.
13 Osteoarticular and Aging Research Lab, Proteomics Unit, ProteoRed/ISCIII, Rheumatology Division, INIBIC-CHU A Coruña, 
Spain.
The Chromosome 16 Consortium is integrated in the global initiative Human Proteome Project that 
aims to map and annotate all proteins encoded by the genes on each human chromosome following 
a gene-centric strategy (C-HPP) to make progress in the understanding of human biology in health 
and disease (BD-CHPP). Overall, the B/D-HPP attempts to generate and disseminate the assays and 
resources to support the analysis of biological networks underlying biological processes and disease. 
The structure of the consortium involves 17 groups organized in five working sections, namely Protein 
Expresion and Peptide Standards, Selected Reaction Monitoring team, Protein Sequencing team, 
Bioinformatic Support team and Clinical healthcare and biobanking teams. 
A description of chromosome 16 based on knowledge repositories has been analysed; the chromo-
some contains 866 protein coding genes including 595 “known” and 271 “unknown” 0r “missing” 
gene products (log(e)>-5 GPMDB), participating in 116 OMIM diseases. T-Lymphocytes, epithelial 
cells and fibroblasts were selected for further studies as transcriptomic evidences suggest that most 
chromosome 16 protein coding genes are expressed in these cell lines. For analytical purposes, the 
866 proteins have been clustered in two groups according to the robustness of the evidences sup-
porting their MS observation, It is expected to set SRM assays for the top rank third of chromosome 
16 proteins in both protein groups.
The process is being developed on a multi-centric configuration, assuming the standards and inte-
gration procedures already available in ProteoRed-ISCIII, which are encompassed with HUPO-PSI 
initiatives. A biobanking initiative has been launched in collaboration with the Spanish National Bioban-
king Network to optimize methods for sample collection, management and storage under normalized 
conditions and to define QC standards.
As a proteomic pilot study, we are defining a comprehensive proteomic map based on high-resolution 
data dependent mass spectrometry to define the protein coverage of the Chr16. This study will permit 
to assist the development of MRM methods for the quantitative targeted strategy. We are dissecting 
the human T lymphoblast cell line (Jurkat T cells) using in a first instance a MUDPIT type approach, 
with in-solution digestion and off-line pre-fractionation by RP-HPLC-Basic. Then, to gain better insight 
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into integral membrane proteins, our analysis is combined with strong detergent protein extraction 
and 1D-gel-digestion. In all our workflows, data is acquired using a high resolution and accurate mass 
5600 TripleTOF LC/MS/MS system (AB SCIEX) on long HPLC runs (4 hrs). This global proteome is 
then fed into our in-house MIAPE-Extractor tool that compiles all the Mascot-searched data and ex-
tracts specific MIAPE information relative to Chr16. This logistic permits the integration of the versatile 
formats and workflows that can all converge into providing a fast and complete understanding of the 
proteome of the cell model of interest. We anticipate that this rapid screen will greatly complement our 
efforts in mapping the Chr16. 
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PROTEIN EXPRESSION PATTERNS ASSOCIATED WITH INTRINSIC 
AEROBIC EXERCISE CAPACITY
Leonardo P. Ribeiro1, Juliana B. T. Carnielli2, Vinicius K. Uliana1, Pedro Henrique Lemos1, Wellington Lunz1, 
Simone F. Pires3, Hélida M. de Andrade3, Suely G. Figueiredo1
1 Laboratório de Química de Proteínas, Departamento de Ciências Fisiológicas, Universidade Federal do Espírito Santo, 
Brazil,  2 Laboratório de Leishmanioses, Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Brazil, 
3 Laboratório de Leishmanioses, Departamento de Parasitologia, Universidade Federal de Minas Gerais, Brazil.
Exercise capacity is a complex attribute that involves different physiological systems under the influen-
ce of both genetic and environmental factors. Related to genetic influence, results have shown that 
more than 70% of aerobic exercise capacity is intrinsically determined. In this work, a comparative 
proteomic approach, two dimensional gel electrophoresis (2D) combined with MALDI-TOF/TOF tan-
dem mass spectrometry, was used to investigate possible molecular differences at the protein expres-
sion level between rats heart (left ventricle - LV) with distinct intrinsic exercise capacity. Low running 
performance (LRP) and high running performance (HRP) rats were categorized by a maximal exercise 
test protocol performed on a motor-driven treadmill, according to total distance performed (TDP). 
The running capacity of HRPs was 3.5 fold greater than LRPs. Protein expression profiling revealed 
29 statistically significant (p<0,05) differences between HRP and LRP, and 15 of these proteins were 
identified by MALDI-TOF/TOF (MS and MS/MS). Robust alterations were detected in components 
involved in antioxidant and stress response, miofibrillar and cytoskeletal proteins. Contractile proteins 
were found to have special expression modification: a-myosin heavy chain-6, myosin light chain-1 
and creatine kinase up regulation in LV of HRP rats on patterns in HCR. In contrast, LV of LRP rats 
exhibited increase in abundance of protein associated with stress response. These animals exhibited 
enhanced expression of the antioxidant enzyme (aldehyde dehydrogenase 2), and heat shock pro-
teins (a-crystallin B chain, heat shock protein b-2). In addition, the cytoskeletal proteins, desmin and 
a-actin, were upregulated in LCRs. In conclusion, our results suggest that the increased contractile 
proteins levels in HCRs rats may explain, in part, the improved exercise capacity. The increased stress 
protein expression in LCR suggests that the LV proteome of these animals are exposed to greater 
stress.
Supported by: CNPq, CAPES and FAPES.
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DESIGN OF SRM BASED MASS SPECTROMETRY METHODS FOR QUANTITATIVE 
ANALYSES OF PORCINE ACUTE PHASE PROTEINS
Anna Marco-Ramell1, Thomas F. Dyrlund2, Stine Lønnerup Bislev2, Lorenzo Fraile3,4, 
Kristian Wejse Sanggaard2, Jan J. Enghild2, Emøke Bendixen2 and Anna Bassols1
1Dept. Bioquímica, Universitat Autònoma de Barcelona (Spain), 2Dept. Molecular Biology, Aarhus Universitet (Denmark), 
3Centre de Recerca en Sanitat Animal (Spain), 4Universitat de Lleida (Spain)
It is mandatory, after protein identification, to validate candidate markers in a larger amount of sam-
ples for biomarker discovery. The most used methods for validation of new markers are enzymatic 
or immunoassay-based commercial kits. However, these kits are not always available for farm animal 
species. SRM, a targeted quantitative proteomic technique, may be used as an alternative to com-
mercial kits for the measurement and validation of target proteins.
Serum acute phase proteins (APPs) are widely recognized markers for inflammation, infection and 
welfare. In pigs the most important APPs include haptoglobin (Hp), C-reactive protein (CRP), the 
inter-a-inhibitor-heavy chain 4 (ITIH4, also called Pig major acute phase protein, or Pig-MAP), serum 
amyloid A (SAA) and apolipoprotein A-I (Apo A-I), but also other proteins are well known to mark the 
acute phase response, including fetuin A, albumin and transferrin.
We designed and optimized an SRM based method for the measurement of four APPs in porcine 
serum: Hp, ITIH4, Apo A-I and fetuin. The Skyline software (MacCoss Lab Software) was used to 
analyze the spectra of the targeted transitions corresponding to unique tryptic peptides of each APP. 
Serum samples were run on an AB SCIEX QTRAP® 5500 System.
Porcine serum samples with high APP levels were used for method optimization. Four proteotypic 
peptides were selected from Hp, ITIH4 and Apo A-I, and the 3 most intense transition signals from 
each of these were optimized, while for analysis of fetuin A,  only a single peptide with high transition 
signals was available.
After method optimization, the method was used to measure the acute phase response of 15 sows, 
which were subjected to moderate stress after moving them from a pen to individual boxes for in-
semination and gestation. Samples were run as triplicate technical repetitions. The SRM data were 
compared to previous analyses based on commercial ELISA and colorimetric kits.
Changes in protein concentrations were observed by both SRM based and commercial kits, and a 
general agreement between these methods was clearly observed. SRM analyses confirmed previous 
observations that positive APPs (Hp and ITIH4) levels are generally elevated while negative APPs (Apo 
A-I and fetuin A) are decreased for a period of 2-4 days after the exposure to stress. 
We conclude that SRM is an important alternative to commercial kits for the quantification of farm 
animal proteins.
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FROM LIPIDOMICS TO TARGETED LIPID ANALYSIS: DIFFERENT STRATEGIES TO EVALUA-
TE RELEVANT LIPID CONTENT OF HUMAN SERUM SAMPLES
Ferran Sanchez, Antonio Serna
AB SCIEX Barcelona, Spain
One common powerful mass spectrometry (MS) technique for direct analysis of global cellular lipido-
mes is the shotgun approach, which is basically infusion of the whole extract at one time using elec-
trospray ionization. The idea is to generate high throughput data in conjunction with global analysis of 
cellular lipids directly from biological extracts. Although this easy-to-use and, thus, powerful approach 
is well established, alternative workflows can bring important (additional) information related to the 
nature of lipids, e.g. isomeric/isobaric lipid species, within the diversity of concentrations. 
As electrospray ionization efficiency is depending on total amount of ions, infusion of concentrated 
solutions will highly be influenced by ion suppression. Hence, fastLC separation will avoid sensitivity 
issues of shotgun only approach and help to resolve complex lipid mixtures.
Last but not least, a reliable and straightforward way is usage of validated kit assay like AbsoluteIDQ™ 
p150 Kit (Biocrates, Innsbruck, Austria) to evaluate same kind of human plasma samples.
Within samples from human plasma distinct differences in the lipid classes and lipid species are found 
and evaluated using statistical and special lipid ID software for HRMS and HRMS/MS data and Bio-
crates’ AbsoluteIDQ software solution to handle specific triple quad kit assay data.
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PROTEOMIC CHARACTERIZATION OF THE ROLE OF SNAIL1 IN THE DIFFERENTIATION OF 
3T3-L1 FIBROBLASTS 
Alberto Peláez-Garcia1,  Rodrigo  Barderas1*, Marta Mendes1,  María López-Lucendo1, Roi Villar-Vázquez1 , 
Sofia Torres1, Rubén A. Bartolomé1, Antonio García de Herreros2,  J. Ignacio Casal1
1 Functional Proteomics Laboratory. Centro de Investigaciones Biológicas (CIB-CSIC). 28040 Madrid. Spain, 2 Programa 
de Investigación en Cáncer, IMIM-Hospital del Mar, Barcelona, * Current address: Department of Biochemistry & Molecular 
Biology I. Universidad Complutense de Madrid. 28040 Madrid. Spain
Snail1 is a transcriptional repressor required for a correct embryonic development. Snail1 is required 
for specific processes, such as gastrulation. In cancer, Snail1 promotes the epithelial to mesenchymal 
transition (EMT). In this work, we have analyzed the control of Snail1 in the differentiation to adipocytes 
of the 3T3-L1 cell line derived from murine embryo cells. By retroviral infection, we generated 3T3-L1 
cells over expressing Snail1 (3T3L1/Snail1) and stable control (3T3-L1/control) cells. We used cytoki-
ne antibody arrays and a SILAC quantitative approach to identify and characterize protein alterations 
induced by Snail1. Protein cell extracts were fractionated in 5 cellular fractions and separated by 10% 
SDS-PAGE. Gels with forward and reverse experiments were stained with Coomassie Blue and the 
whole lanes were horizontally cut into 18 slices prior to reduction, alkylation and digestion with trypsin. 
Tryptic peptides were scanned and fragmented with a linear ion trap-Orbitrap Velos (ThermoScientific). 
The Top-15 most intense ions were selected for collision induced dissociation (CID) fragmentation. We 
analyzed membrane, cytoplasmic and nuclear fractions for identifying a total of 6337 proteins, with 
4764 quantified proteins, and 875 proteins deregulated >1.7-fold by Snail1 overexpression.  
We performed in silico bioinformatics analysis using IPA, STRING and DAVID Functional Annotation 
with the differentially regulated proteins. The most significant altered functions were Cellular Move-
ment, Gene Expression and Protein Synthesis. Furthermore, we analyzed alterations in the cytokine/
chemokine profile in culture media by ectopic snail1 expression in 3T3-L1 by antibody microarrays 
using Ludesi software. After normalizing spot intensities and calculating ratios of expression, we ob-
served that Snail1 induced the differential expression of 14 out of 62 cytokines/chemokines.  Finally, 
we have validated the results by western blot, ELISA and RT-PCR using control and ectopic Snail1 
expression 3T3-L1 cells to verify the differential expression of the proteins and their role in adipogene-
sis. We identified among the top deregulated proteins a large number belonging to the eIF complex, 
mTOR signaling, and the splicesome. We found interesting up-regulated proteins associated to early 
differentiation of adipogenesis (C/EBPb) and down-regulated proteins implicated in the final stages of 
differentiation to adipocytes (Fatty acid-binding protein or Fatty acid synthase). On the other hand, we 
observed down-regulated in 3T3-L1/Snail1 important mediators of PPARg pathway.  
These results show that Snail1 ectopic expression is enough to inhibit the adipocyte differentiation 
signaling pathways (PPARg or mTOR signaling). This work has provided many novel proteins with 
potential roles in the regulation of differentiation to adipocytes of the 3T3-L1 cells for future studies.
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SHOTGUN PROTEOMIC ANALYSIS OF BANANA UNDER COLD STORAGE CONDITIONS
Heliofábia Virgínia de Vasconcelos Facundo, João Roberto Oliveira do Nascimento, Beatriz Rosana Cordenun-
si and Franco Maria Lajolo
Department of Food and Experimental Nutrition, University of São Paulo, Brazil. 
Storage fruit at low temperatures has been widely used to extend its postharvest life. In this study, a 
shotgun proteomics approach was conducted on banana cv. Nanicão from a control group stored at 
19 ºC compared with other group stored at 13 ºC for 15 days, and after that, transferred the tempe-
rature to 19 ºC for complete the maturation. Five pools of each group (control and cold) of ‘‘unripe’’ 
and ‘‘ripe’’ phase was prepared for analysis. The proteins were extracted with phenol and digested 
by trypsin. The resulting highly complex peptide mixtures were inject in an analytic column C18 and 
analyzed by RP-UPLC (nanoAcquity UPLC, Waters) coupled with nano-electrospray tandem mass 
spectrometry on a Q-Tof Premier API mass spectrometer. Databases searches for peptide identifica-
tion were done with Mascot and proteins were identified by searching musa_pep database. Scaffold 
was used to validate MS/MS based peptide and protein identifications which identified 71 proteins 
(< 0.5% false discovery rate). Twenty-three significant proteins by Anova (p < 0.05) were submitted 
to Principal Component Analysis. The first component separated the samples by stage of maturation 
and the second component separated the control and cold groups, but there was a major discrimi-
nation in the cold group from ripe fruits, being farther than the control group in the graphic. The pro-
teins superoxide dismutase [Cu-Zn], abscisic stress-ripening protein 3, putative horcolin, stromal 70 
kDa heat shock-related protein and a chloroplastic probable steroid-binding protein were correlated 
with the unripe control samples and a putative stress responsive protein and cytochrome c oxidase 
subunit 5B mitochondrial precursor were strongly correlated with the unripe cold samples. Other pro-
teins such as L-ascorbate peroxidase cytosolic and nascent polypeptide-associated complex subunit 
alpha-like protein were common for both groups. On the other hand, enolase, malate dehydrogena-
se, mitochondrial, metallothionein-like protein type 3, 1-aminocyclopropane-1-carboxylate oxidase, 
defensin-like protein 5, endochitinase, heat shock cognate 70 kDa protein and germin-like protein 
present a strong association with the ripe control samples while the cold group was characterized by 
the presence of thaumatin-like protein, isoflavone reductase homolog, granule-bound starch synthase 
1, chloroplastic / amyloplastic, and a putative lichenase dirigent protein. 
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STAIN-FREE TECHNOLOGY AS NOVEL NORMALIZATION TOOL IN WESTERN 
BLOT ANALYSIS
Anton Posch, Soile Tapio
Helmholtz Zentrum München, Institute of Radiation Biology, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
Proteomic technologies like two-dimensional electrophoresis (2-D PAGE) are valuable tools in semi-
quantitative protein profiling studies in order to identify specific expression patterns enabling a better 
understanding of molecular events. The de-regulated protein spots on 2-D maps are usually identified 
and characterized by mass spectrometry. In addition, the quantitative protein profiling data need to 
be confirmed by a second, independent method like Western-blotting. Western blots are used to 
specifically measure the relative quantities of proteins of interest in complex biological samples. Howe-
ver, quantitative measurements can be subject to error due to process inconsistencies like uneven 
protein transfer to the membrane. These non-sample related variations need to be compensated for 
by an approach known as normalization. Two approaches to data normalization are commonly em-
ployed: housekeeping protein (HKP) or total protein normalization (TPN). In this study we evaluated 
the performance of Stain-Free (SF) technology as a novel TPN tool for western blotting experiments in 
comparison to GAPDH as a representative of the HKP normalization strategy. The target protein (TP) 
used for this study was MCM7, a DNA licensing replication factor, which was shown previously to be 
down-regulated by 20% in irradiated lymphoblastoid cells (LCL). We studied the relative expression 
level of MCM7 with a multiplex western blotting approach based on fluorescently labeled secondary 
antibodies and found that Stain-Free technology appears to be more reliable, robust and more sensiti-
ve to small effects of protein regulation when compared to HKP normalization with GAPDH. Stain-Free 
technology offers the additional advantages of providing check points throughout the western blotting 
process by allowing rapid visualization of gel separation and protein transfer. 
77
5th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
P07PS1 Quantitative Proteomics
QUANTITATIVE PROTEOMICS (iTRAQ) AS A TOOL TO UNDERSTAND THE PREMATURE 
AGING PROCESS IN PROGERIA
Mateos J1, Landeira A1, Fernández-Puente P1, Arufe MC1,2 and Blanco FJ*1,3  
1 Rheumatology Division, Proteomics Unit-ProteoRed/ISCIII, INIBIC-Hospital Universitario A Coruña, 15006 A Coruña-
SPAIN 2 Department of Medicine, Area of Anatomy and Human Embryology,University of A Coruña-SPAIN 3 Rheumatology 
Division, Cellular Therapy Unit, INIBIC-Hospital Universitario A Coruña, 15006 A Coruña-SPAIN
                     
Purpose: Accumulation of a mutant form of the nuclear protein Lamin-A –called Progerin (PG) or 
Lamin AΔ50- is the causal agent of Hutchinson-Guilford Progeria Syndrome (HGPS) or Progeria, an 
accelerated aging disease. One of the main symptoms of this genetic disorder is a loss of sub-cuta-
neous fat due to a dramatic lipodystrophy. We stably induced the expression of human PG and GFP 
-Green Fluorescent Protein- as control in 3T3L1 cells using a lentiviral system in order to study the 
effect of Lamin A de-regulation in the differentiation capacity of this cell line, one of the most studied 
adipogenic models. 
Methods: Efficient gene delivery of PG and GFP in the lentivirus-transduced cell lines were checked 
by immunoblotting. Proliferation rate was studied using CellTiter 96® Aqueous Non-Radioactive Cell 
Proliferation Assay (Promega). Adipogenic capacity was checked by immuno-histochemistry - Oil 
red Staining-. Quantitative proteomics analysis iTRAQ (ABSciex) was done in a 4800 MALDI-TOF/
TOF system (ABSciex) using ProteinPilot software as search engine, String 9.0 software was used to 
establish altered pathways based on previously known protein interactions.
Results and conclusion: We found that over-expression PG by lentiviral gene delivery leads to a 
decrease in the proliferation rate (more than 50%) compared to the control. iTRAQ analysis showed 
181 proteins significantly (p<0.05) modulated in PG-expressing pre-adipocytes, Several GO Biological 
Processes were altered including Structure of Cytoskeleton (Vimentin, Ratio Control/PG=27.28) 
Energy Generation (ATP sinthase, Ratio Control/PG=0.34), Lipid Metabolism (Fatty Acid Syntha-
se Ratio Control/PG =0.55), Calcium Regulation (Caldesmon Ratio Control/PG =2.29) and Trans-
lation (Elongation factor 1-beta, Ratio Control/PG =0.34). Our results will be helpful for a better 
understanding of the aging process.
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EVALUATION OF DIFFERENT DIGESTION TECHNIQUES TO IMPROVE DIGESTION REPRO-
DUCIBILITY IN PROTEIN QUANTIFICATION
Cristina Chiva, Mireia Ortega, Eduard Sabidó
Proteomics Unit, Centre for Genomic Regulation (CRG) and Universitat Pompeu Fabra (UPF), Dr. Aiguader 88, 08003 
Barcelona, Spain
Protein quantitation by mass spectrometry is commonly based on the generation of proteolytic protein 
fragments (peptides) that are later used to infer the corresponding protein abundances. During protein 
digestion there are several sources of potential variation such as incomplete protein digestion, uns-
pecific cleavages, and different protease specificity1, which might affect the reproducibility of protein 
quantitation2.
In this study we evaluated the digestion efficiency of several in-solution and filter-aided digestion pro-
tocols3 and assessed their influence in protein quantitation by mass spectrometry. We evaluated the 
the percentage of peptides with missed cleavages and the reproducibility of the different techniques 
at the peptide and the protein level both among technical replicas and among different techniques.
Our results clearly show that digestion reproducibility and protein quantitation results change signi-
ficantly depending on the enzyme and the digestion technique used. These observations are of es-
pecial interest as they evidence potential important errors when estimating protein fold-changes and 
abundances in large-scale protein quantitation studies.
1 Peng M et al “Protease bias in absolute protein quantitation” Nat. Methods, 9, 524-5, 2012.
2 Glatter T et al “Large-Scale Quantitative Assessment of Different In-Solution Protein Digestion Protocols Reveals Superior Cleavage Efficien-
cy of Tandem Lys-C/Trypsin Proteolysis over Trypsin Digestion.” J.Proteome Res, 11, 5145-56, 2012.
3 Wisniewski JR et al “Universal sample preparation method for proteome analysis” Nat. Methods,, 6, 39-362, 2012.´
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BIOMARKERS OF TGFb PATHWAY IN GLIOMAS
Núria Colomé1, Gerard Folch2, Luna Martín1, Ma Ángeles Artaza3, Marta Monge1, Ricardo Gonzalo3,  
Joan Seoane2, Francesc Canals1
1Proteomics Laboratory, Vall Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), Barcelona 
Spain, 2Gene Expression and Cancer Laboratory, VHIO, UAB, Barcelona, Spain, 3Unit of High Technology (UAT), Vall He-
bron Research Institute (VHIR), UAB, Barcelona, Spain
Gliomas are the most frequently primary tumors in the brain. Transforming growth factor b (TGFb) 
pathway is related with a subgroup of them. Nowadays, TGFb is being evaluated as a therapeutic 
target. The definition of a protein signature of the TGFb activity in gliomas could help to select the po-
pulation that could benefit from an anti-TGFb therapy and monitor the treatment on the clinical assays.
With the objective of identifying biomarkers of the TGFb activity in gliomas, secreted proteins of pri-
mary cultured tumor cells (PCTCs), treated or not with TGFb, were analyzed by label free and Isotope 
Code Protein Labeling (ICPL) quantitative proteomic experiments. Several candidate secreted pro-
teins responding to TGFb were identified. In order to validate these candidate proteins selected reac-
tion monitoring (SRM) methods were developed. SRM methods were applied to cerebrospinal fluid 
(CSF) and plasma samples from glioma patients.
When CSF samples from glioma and other brain tumor patients were analyzed using the SRM methods 
developed, a clear correlation between the protein levels and the TGFb concentrations was observed. 
Plasma samples from glioma patients under alternated treatment phases with a TGFb inhibitor were 
also analyzed by the SRM method. The levels of some of the candidate proteins were found modula-
ted along the treatment.
Globally, this group of proteins constitutes a possible protein signature useful for diagnosis and moni-
toring of the treatment of the glioma patients with TGFb activity.
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PROTEOMIC CHARACTERIZATION OF THE SARCOPLASMIC AND MYOFIBRILLAR PRO-
TEINS IN LOCAL CHICKEN MUSCLE USING 2DE AND MASS SPECTROMETRY
Edita Bueno Soto1, Montserrat Carrascal1, José Larrasa2 and Joaquin Abian1
1 Laboratorio de Proteómica CSIC/UAB, Campus Universidad Autónoma de Barcelona, Facultad de Medicina, Edificio M, 
Bellaterra, CP: 08193, Cerdanyola del Vallès, Barcelona, 2 Laboratorios Larrasa. Polígono Industrial “El chaparral” 17 CP: 
06170 La Albuera, Badajoz
For a number of years, poultry selection has concentrated on growth velocity and muscle mass in 
meat lines. Proteomic methods are useful for the identification of proteins markers associated with 
meat quality traits in animal species. The information from proteome can be used to optimize the pro-
cessing method and meat technologies and to assist in selection of markers by geneticists in poultry. 
The aim of this study was to apply a proteomic approach for the characterization of local chicken legs. 
We optimized methods for extraction and evaluated the reproducibility. Three different fractions were 
analyzed: total protein, sarcoplasmic protein and myofibrillar protein. The profiles of different fractions 
were analyzed by 2D SDS-PAGE and the most relevant spots were identified by MALDI-TOF/TOF.
References
Zapata I, Reddish JM, Miller MA, Lilburn MS, Wick M “Comparative proteomic characterization of the sarcoplasmic proteins in the pectoralis 
major and supracoracoideus breast muscles in 2 chicken genotypes”. Poult Sci. 2012 Jul;91(7):1654-9
Zanetti E, Molette C, Chambon C, Pinguet J, Rémignon H, Cassandro M.” Using 2-DE for the differentiation of local chicken breeds” Pro-
teomics. 2011 Jul;11(13):2613-9. 
Dransfield E, Sosnicki AA “Relationship between muscle growth and poultry meat quality”. Poult Sci. 1999 May;78(5):743-6.
Joo ST, Kauffman RG, Kim BC, Park GB “The relationship of sarcoplasmic and myofibrillar protein solubility to colour and water-holding 
capacity in porcine longissimus muscle”. Meat Sci. 1999 Jul;52(3):291-7
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RICE PROTEOME UNDER SALT STRESS AT THE REPRODUCTIVE STAGE
Farinha, A.P.1, Gonçalves, N.1, Oliveira, M.M.1 and Negrão, S 1
1 ITQB (Instituto de Tecnologia Química e Biológica - Universidade Nova de Lisboa) and iBET (Instituto de Biologia Expe-
rimental e Tecnológica), Oeiras, Portugal
Salinity is one of the abiotic stresses with a highest impact on crop productivity, causing losses that 
can reach up to 50% of crop yield potential. Nearly half all irrigated land is affected by salinity with 
Portugal being no exception. It is known that rice pollen is particularly sensitive to abiotic stress at the 
early stages of development. Therefore we were interested in studying how salinity affects rice at the 
reproductive stage, focusing our analysis on the anthers, the male floral organ responsible for pollen 
formation. In fact, pollen development is controlled by complex mechanisms requiring coordinated 
gene expression between both somatic (from the anther’s wall) and gametophytic cells (the pollen 
itself). In our study, salinity was applied immediately after panicle initiation and the anther material was 
collected 1 day before anthesis. In order to get a deeper knowledge on the salt stress response and 
on the possible mechanisms involved in salt tolerance, we further compared the protein expression 
patterns between tolerant and sensitive genotypes. Two of these varieties are advanced breeding lines 
included in the Portuguese rice breeding program. 
A quantitative analysis of the rice anther proteome in response to salt stress was performed using 
two-dimensional difference in gel electrophoresis (2D-DIGE). Comparisons at proteome level were 
also established between two salt-tolerant rice genotypes and one salt-sensitive, together with phy-
siological and agronomic measurements. As anthers are quite challenging to isolate (under stereomi-
croscope), we had to first test different protein extraction protocols in order to get simultaneously the 
highest protein yield and the 2D protein profile with the best resolution. Here we present the results 
concerning the optimisation steps on protein extraction and separation by 2-D DIGE. The rice anther 
proteins differentially expressed under salt stress were already validated by statistical analyses and will 
be further identified by mass spectrometry. 
This work was supported by FCT-Portugal (PTDC/AGR-AAM/099234/2008).
82
P12PS1 Quantitative Proteomics
PROTEOMIC PROFILES OF Pisum sativum INNER AND OUTER CHLOROPLAST ENVELOPE 
MEMBRANES
Elain Gutierrez-Carbonell1, Daisuke Takahashi2, Giuseppe Lattanzio1, Katrin Philippar3, Matsuo Uemura4, 
Javier Abadía1, Ana Flor López-Millán1 
1Plant Stress Physiology Group, Plant Nutrition Department, Aula Dei Experimental Station, CSIC, Apdo. 13034, 50080 
Zaragoza, España, 2United Graduate School of Agricultural Sciences, Iwate University, Morioka 020-8550, Japan, 3Plant 
Biochemistry and Physiology, Department Biology I, Ludwig-Maximilians-Universität München, Großhadernerstr. 2-4, 
D-82152 Planegg/Martinsried, Germany, 4Cryobiosystem Research Center, Faculty of Agriculture, Iwate University, Japan
The chloroplast envelope comprises a pair of membranes surrounding the chloroplast which control 
the communication between the chloroplast and the rest of the cell, and therefore is essential for the 
proper functioning of this semiautonomous organelle. Translocation of nuclear encoded precursor 
proteins across the envelope is achieved by the joint action of Toc and Tic translocons located at the 
outer and inner envelope membranes, respectively. The envelope participates in the translocation of 
intermediates of various metabolic pathways and inorganic ions, and also contains unique biosynthe-
tic pathways for the synthesis of plastid membrane components, chlorophyll breakdown or synthesis 
of lipid-derived signaling molecules. Despite its importance, the proteomic characterization of this 
membrane system is challenging due to the difficulty of obtaining separate inner and outer membra-
ne fractions with high purity and the inherent problems involving the separation and solubilization of 
highly hydrophobic membrane proteins. Therefore, the aim of this work was first to obtain inner and 
outer membranes from the envelope of Pisum sativum and second to characterize their protein profile 
by Shotgun proteomics which allows analyses of membrane proteins. Four independent biological 
replicates for both membrane systems were obtained and analyzed in a nHPLC-MS system. MS/
MS spectra were processed using Proteome Discoverer software and identification was achieved by 
comparison with the NCBInr Green Plants database, using MASCOT as a search engine. Only pro-
teins with two or more matched peptide sequences were considered as positively identified. Using this 
criterion, 546 proteins were identified in the envelope. Comparisons between the protein profiles of the 
inner and outer envelope membranes allowed identification of 22 and 96 proteins, respectively, which 
were  assigned as specific for each membrane using ANOVA (p<0.05) and a relative abundance ≥85% 
as selection criteria. A preliminary analysis of these protein species reveals that the outer membrane 
is mainly involved in transport processes, whereas the inner membrane participates in chloroplast 
functionality, including proteins related to protein metabolism, photosynthesis and energy. 
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A QUANTITATIVE PROTEOMIC APPROACH FOR THE DISCOVERY OF CHARACTERISTIC 
BIOMARKERS IN OSTEOARTHRITIS CARTILAGE
Lucía Lourido, Valentina Calamia, Patricia Fernández-Puente, Jesús Mateos, Beatriz Rocha, Carolina Fernán-
dez, Francisco J. Blanco, Cristina Ruiz-Romero
Osteoarticular and Aging Research Laboratory, Proteomics Unit-Associated Node to ProteoRed-ISCIII, INIBIC-CHUAC, 
A Coruña, SPAIN.
PURPOSE: Osteoarthritis (OA) is characterized by the loss of structural components from the ex-
tracelullar matrix (ECM) of articular cartilage. The aim of this study was to perform a proteomics 
approach to identify and quantify those proteins released from normal (N) and OA human articular 
cartilage explants. Furthermore, we seeked to differentiate those proteomic signatures displayed from 
the wounded zones (WZ) from those corresponding to the area adjacent to the lesion, or unwounded 
zones (UZ), in the OA samples. These proteins released from cartilage might have a tissue-charac-
teristic biomarker value for early diagnosis and/or therapy monitoring. METHODS: Macroscopically 
articular cartilage was obtained from the dissection of normal and OA femoral heads. The cartilage 
from normal samples, and from WZ and UZ of the same OA piece, was cut into five 6mm2 explants. 
Then, these explants were washed in PBS and harvested in 96-well plates with 200µL of serum-free 
DMEM. The conditioned media from each condition were collected at days 1, 3, 6 and replaced with 
fresh medium. Media from each condition were quantified, concentrated and precipitated with ace-
tone. Finally, proteins were digested with trypsin and each peptide solution was labelled with different 
isobaric tags using the iTRAQ reagents. The labelled peptides of the different conditions were mixed, 
desalted and separated by HPLC. The resulting fractions were resolved by nanoLC-MS/MS and the 
relative quantification of the proteins was carried out with Protein Pilot 3.0 software. RESULTS: Pro-
tein concentrations were higher in the culture media from wounded zones than from unwounded 
zones of OA cartilage, due to the increased degradation that is taking place in the lesion. We first 
identified several ECM proteins that were differentially released between WZ and UZ in OA samples at 
two different times of culture. Most of them were increased in the wounded tissue, including collagens 
(I, II, VI and XV), proteoglycans (biglycan, lumican or perlecan) and proteins related with cell adhesion 
(tenascins, osteomodulin or vitronectin). In a second step, proteins released to the media up to day 
6 of culture were compared between three conditions (WZ, UZ and normal tissue). This analysis led 
to the identification of 199 proteins, 110 of them quantitatively altered between the conditions of the 
study. Interestingly, several proteins were differentially released already in the unwounded zone of OA 
cartilage compared to the normal samples (osteopontin, matrilin-3, cartilage link protein or transfor-
ming growth factor-beta-induced protein), and their amounts do not seem to be increased in the WZ. 
Finally, a small set of proteins, including thrombospondin-1 or type XVIII collagen, was more abundant 
in the media from N cartilage than from OA. CONCLUSIONS: We have identified a profile of proteins 
released from diseased cartilage in OA. Our work describes a panel of cartilage-characteristic proteins 
with potential biomarker value of the tissue degradation process that takes place in OA. This panel will 
be further explored in biological fluids (synovial fluid and serum) for the development of early diagnosis 
and/or therapy monitoring strategies.
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A NOVEL PLATFORM FOR THE ABSOLUTE QUANTIFICATION OF  PROTEINS BASED ON 
ISOTOPE PATTERN DECONVOLUTION AND MINIMALLY 13C-LABELLED PEPTIDES 
Ana González Antuña1, Sergio Cueto Díaz1, Pablo Rodríguez-González1, Jorge Ruiz Encinar1, Rüdiger Ohlen-
dorf2, André Henrion2 and Jose Ignacio García Alonso1
1Department of Physical and Analytical Chemistry. Faculty of Chemistry. University of Oviedo, Julián Clavería 8, 33006 
Oviedo, Spain, 2Department of Metrology in Chemistry, Physikalisch-Technische Bundesanstalt,Braunschweig, Germany
Enriched stable isotopes play a crucial role on the development of new MS-based techniques for pro-
tein quantification. First, using isotopic labelling, different methodologies have been developed to ex-
plore the dynamics of whole proteomes and provide relative comparisons of protein abundances bet-
ween samples (relative quantification). Secondly, Isotope Dilution Mass spectrometry (IDMS) has been 
employed to develop methods capable of providing the highest level of accuracy and precision in the 
determination of proteins (absolute quantification). Only using absolute quantification approaches we 
can ensure that the measurement of the protein mass fraction in a given sample is traceable to the 
International System of units (SI).
The use of isotopically labelled “proteotypic” peptides can be considered as the best alternative for 
the absolute quantification of proteins. However, the main metrological drawback of protein determi-
nations using labelled peptides is the initial certification of peptide standards (both natural abundance 
and isotopically labelled) on a mass basis. Additionally, the stability of the internal standard during 
enzymatic digestion and the accurate measurement of the molar ratio between natural and labelled 
peptides need to be addressed. Most of the current methodologies employed in this field make use 
of multiply labelled peptides to avoid spectral overlap and this can cause isotopic effects. Under those 
conditions, the ratio of intensities for the natural and labelled analogues is assumed to be the same as 
the ratio of moles. However, this assumption needs to be demonstrated for a large range of concen-
tration ratios between the natural abundance and labelled peptide. 
We propose here a novel platform for the absolute quantification of proteins which combines: a) the 
certification of the concentration of labelled peptides by reverse IDMS using certified natural abun-
dance peptide standards. In this case, the certification process for the natural abundance standards 
follows a proprietary procedure based on post-column 13C-IDMS after online chemical oxidation of the 
peptide to CO2; b) The use of minimally labelled peptides (only two 13C atoms) added to the sample 
before the enzymatic digestion of the protein and, c) the measurement of the molar ratio between 
natural and labelled peptides by Isotope Pattern Deconvolution from the experimental isotopic abun-
dances of the mixture obtained by MRM using the whole isotopic envelope. The performance of the 
procedure will be exemplified with the determination of the renal biomarker Cystatin C in human serum 
using a proteotyptic peptide labelled with two 13C atoms.
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CHARACTERIZATION OF PROTEOMIC PROFILES PREDICTIVE OF HEPATOTOXICITY 
ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS: A PILOT STUDY
Carolina de la Torre1, Luna Martín1, Núria Colomé1, Joan-Josep Bech1, Jaume Reventos2, 
Luisa Ibáñez Mora2, Francesc Canals1
1Laboratori de Proteòmica, Vall d’Hebron Institute of Oncology (VHIO, Barcelona), 2Institut de Recerca Hospital Universitari 
Vall d’Hebron, Barcelona,Universitat Autònoma de Barcelona
Nowadays, tuberculosis represents a major problem in public health both in non-developed and in 
developed countries. The increase of the incidence of tuberculosis during the last years has been 
related to an increase in complications derived from its treatment, as the appearance of resistance, 
therapeutic failure or hepatotoxicity. In particular, hepatotoxicity due to anti-tuberculous drugs is a 
relevant problem as it results in the modification of the treatment and in liver transplantation or death 
in the most extreme situations.
We have studied a large cohort of patients under treatment or profilaxis with antituberculous drugs, 
selecting from them a group (n=8) that developed hepatotoxicity, and a group of matched controls not 
developing hepatotoxicity (n=8). We have analyzed the plasma proteomic profiles of these patients, 
with the aim of identifying biomarkers which would be predictive of hepatotoxicity associated with anti-
tuberculous drugs. For each patient, plasma samples were collected at the beginning of the treatment 
(basal conditions), and at the moment of appearance of hepatotoxicity or the end of the treatment, 
respectively. The comparative analysis of these 32 samples was performed using 8-plex iTRAQ rea-
gents. Samples were first depleted of the 20 top abundant proteins in plasma using a Proteoprep-20 
affinity column (Sigma). After tryptic digestion and labeling, iTRAQ-labeled samples were combined in 
five sets of labeled samples, each one including an internal standard, consisting on a pool of the 32 
samples, labeled with iTRAQ-121. This workflow allowed thus the quantitative comparison of the 32 
samples. Each labeled peptide mixture was first fractionated by “off-gel” isoelectric focusing, and the 
resulting fractions were subsequently analyzed by LC-MSMS on an Orbitrap Velos system. Quantifi-
cation was based on the ratios between the intensity of each reporter ion and the internal standard. 
Approximately 350 proteins could be identified and quantified in each set, with an overlap of 194 
proteins on the five iTRAQ 8plex sets. The results obtained in this analysis led to the identification of 
some candidate biomarkers predictive of the development of hepatotoxicity.
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DECIPHERING THE CATABOLITE REPRESSION PHENOMENON BY QUANTITATIVE 
PROTEOMICS
Gómez Álvarez, Helena1; Voigt, Birgit2; Floriano Pardal, Belén3; Santero Santurino, Eduardo4
1(University Pablo de Olavide. Seville, SPAIN), 2 (University Ernst-Moritz-Arndt. Greifswald, GERMANY), 3(University Pablo 
de Olavide. Seville, SPAIN), 4(University Pablo de Olavide. Seville, SPAIN)
Sphingomonas macrogolitabida strain TFA is a Gram-negative bacterium which capacity to grow very 
efficiently in the aromatic compound tetralin (1,2,3,4-tetrahydronaphthalene) has already been well 
characterized and described in our laboratory. We are currently working on a more global understan-
ding of the overall cellular processes applying a Systems Biology approach. Therefore, our aim is to 
combine the knowledge yielded by our studies in Genomics, Transcriptomics, and Proteomics in order 
to describe the transcriptomic and metabolic networks that operates in this bacterium to improve its 
response to environmental signals.
Carbon Catabolite Repression (CCR) is a global regulatory phenomenon that results in the establis-
hment of a hierarchical use of the different carbon and energy sources. In TFA, tetralin metabolism is 
abolished in the presence of the better carbon source b-hydroxybutirate, which exerts carbon cata-
bolite repression on the tetralin genes. In order to understand the global changes that occurs in TFA 
when growing making use of this compound, we have applied two different proteomic techniques:
 On one hand, DIGE (Differential In Gel Electrophoresis) assays allowed us to identify specific proteins 
(labelled with fluorophores) that are over-expressed or repressed during CCR conditions at a specific 
time point during bacterial growth. This resulted in “static” global information of the TFA proteome in 
CCR conditions.
Secondly, we have detected newly synthesized or repressed proteins soon after the CCR stimulus 
was applied using radioactive labelling with 35S-methionine. Employing dual channel imaging and 
warping of two-dimensional protein gels1 we have visualized global changes on gene expression 
patterns over time during TFA growth on CCR-conditions. By using a false colouring plus the overlap 
of those images taken at different times, it became possible to follow the fate of each single protein 
and visualize whether its expression was reduced or increased; therefore yielding a more “dynamic” 
information about the changes on the TFA proteome in CCR conditions.
This last approach allowed us to identify groups of proteins responding in the same way in TFA. These 
proteins could be part of the same regulon and this information could be used to search for common 
DNA sequences within the intergenic regions of the corresponding genes. These DNA sequences 
could represent binding motifs for global regulatory proteins involved in CCR in TFA. Finally, the total 
data yielded by the Proteomics assays will help us to perform an in-silico metabolic reconstruction of 
Sphingomonas macrogolitabida strain TFA.
1 Bernhardt et al. Genome Res. 2003 Feb;13(2):224-37.
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CHARACTERIZATION OF PROTEIN CHANGES ON THE STATOCYST ENDOLYMPH FOR THE 
ASSESSMENT OF ACOUSTIC TRAUMA ON COMMON CUTTLEFISH (Sepia officinalis)
Marta Solé1, Marta Monge2, Michel André2, Francesc Canals2 and Carme Quero3,4
1Laboratory of Applied Bioacoustics, Technical University of Catalonia, Barcelona, Spain, 2Proteomics Laboratory, Vall He-
bron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain, 3Department of Biological 
Chemistry and Molecular Modelling, IQAC (CSIC), Barcelona, Spain.
Artificial sound sources are increasingly contributing to the general noise budget of the oceans distur-
bing the natural balance of the marine ecosystems. Study of the effects of the anthropogenic sound 
sources has become a crucial question to environmentally regulate human activities on the oceans. 
Despite its importance, little information is currently available about how cephalopods, and marine 
organisms in general, process and analyze sound.
In a previous work we have described how some cephalopod species subjected to low-frequency 
sounds suffer important morphological and ultrastructural acoustic trauma, not compatible with life. 
Exposure to low-frequency sounds resulted in permanent and substantial alterations of the sensory 
hair cells of the statocysts, the structures responsible for the animals’ sense of balance and position 
1, 2. 
With the aim of identifying changes in protein expression in the statocyst endolymph after low-fre-
quency sound exposition, endolymph from exposed and non-exposed individuals sacrificed at diffe-
rent times after sound exposure was analyzed using two-dimensional differential gel electrophoresis 
(2D-DIGE) and the most relevant spots were identified by mass spectrometry. Some differential pro-
teins with a significant change in abundance were identified, most of them being structural or stress-
related proteins. 
In summary, our experiments confirm that protein content of endolymph changes after been exposed 
to low frequency sounds. These changes can be expected to affect physiology and functioning of S. 
officinalis statocyst and alter the sensory information of this species. 
1 André, M., et al., Low frequency sounds induce massive acoustic trauma in cephalopods. Front. Ecol. Environ., 2011. 9: p. 489-493.
2 Solé, M., et al., Does exposure to noise from human activities compromise sensory information from cephalopod statocysts?. Deep-Sea 
Res.II 2012. http://dx.doi.org/ 10.1016/j.dsr2.2012.10.
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DETECTION OF POST-TRANSLATIONAL MODIFICATIONS IN HUMAN TRANSTHYRETIN 
ASSOCIATED WITH FAMILIAL AMYLOIDOTIC POLYNEUROPATHY BY A SRM MASS SPEC-
TROMETRY METHOD
Marta Vilà1, Núria Colomé2, Francesc Canals2,*, Antoni Planas1,*
1Laboratory of Biochemistry, Institut Químic de Sarrià, Universitat Ramon Llull, Barcelona, 2Proteomics Laboratory, Vall 
d’Hebron Institut of Oncology, Universitat Autònoma de Barcelona, Barcelona
Transthyretin (TTR) is an amyloidogenic tetrameric protein (55kDa) synthesized in liver and choroid 
plexus in brain. TTR is present in human plasma, transporting T4 hormone and retinol through the re-
tinol binding protein (RBP). TTR is associated with several amyloidosis namely familial amyloidotic po-
lyneuropathy (FAP), familial amyloidotic cardiomyopathy (FAC) and senile systemic amyloidosis (SSA), 
the first two classified as rare diseases1-2. Whereas FAP and FAC are caused by single point mutants, 
SSA is associated to the wild-type TTR. Variability of TTR is not only due to point mutations in the en-
coding gene but also to post-translational modifications (PTMs) at Cys10. Only around the 10-15% of 
the circulating TTR in plasma remains unmodified at this residue, finding as the most common PTMs 
the S-sulfocysteinylation, S-glycinylcysteinylation, S-cystinylation and S-gluthationcysteinylation3. It is 
thought that PTMs at Cys10 may play an important biological role in the onset and pathological pro-
cess of the amyloidoses related to TTR. 
The objective of our study is to establish the most significant Cys10 PTMs present in TTR human 
serum samples of patients with TTR-related amyloidosis carrying the most common V30M mutation 
and to establish a relationship between those PTMs and the clinical profile of the patients. We here 
will report the development of the methodology for detection and quantification of PTMs in serum 
samples. It involves a first enrichment step by TTR-immunoprecipitation using a polyclonal antibody, 
followed by protease digestion of the protein, and finally, the design of a Selected Reaction Monitoring 
(SRM) method to detect and quantify those PTMs (Fig.1). The enrichment step is shown to be highly 
efficient and reproducible. Different proteases were tested for TTR digestion to release the peptide of 
interest for quantification. Using properly designed labelled peptide standards, an SRM method has 
been developed for PTMs quantification. 
  
  Fig.1 PTMs detection by an SRM method in 
  TTR from human serum samples
1 Saraiva, M.J.M., 2002. Expert Reviews in Molecular Medicine, 4(12), p.1–11.
2 Westermark, P. et al., 1990. PNAS, 87(7), p.2843.
3 Poulsen et al., 2012. Methods,56(2):284-92
This work is supported in part by a “Research Grant for Rare Diseases” from La Fundació Marató de TV3
89
5th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
P19PS2  PTMs
COMPREHENSIVE CHARACTERIZATION OF THE PEPTIDOME AND PHOSPHOPEPTIDOME 
DISPLAYED BY THE HUMAN LEUKOCYTE ANTIGEN (HLA)-B*40:02 
Miguel Marcilla, Adán Alpízar, Manuel Lombardía and Juan Pablo Albar
Proteomics Unit. Centro Nacional de Biotecnología (CSIC). Madrid
HLA class I molecules bind peptides derived from proteolytic degradation of endogenous proteins 
and present them to cytotoxic T lymphocytes, allowing the immune system to detect transformed or 
virally infected cells. The peptide pool presented by a particular HLA allotype consists on up to 10000 
different peptides which share specific structural motives that determine its binding to the class I mo-
lecule. Posttranslational modifications are known to be present in some class I ligands. In this regard, 
phosphorylated peptides have raised much interest as potential targets for cancer immunotherapy 
since aberrant protein phosphorylation is a hallmark of tumor cells.
Using HLA-B*40:02 as a model molecule and combining affinity purification and high resolution mass 
spectrometry we have identified more than 2000 different ligands (FDR < 5%). Sequence analysis 
of this set of ligands revealed two strong anchor motives: Acidic residues at peptide position 2 and 
methionine, phenylalanine or aliphatic residues at the peptide C term. After IMAC and TiO2 enrich-
ment, about 100 phosphorylated ligands were identified. To avoid false identifications every peptide 
sequence of this subset was further confirmed by comparing its experimental MS/MS spectrum with 
that obtained upon fragmentation of the corresponding synthetic phosphopeptide.
We suggest that high throughput identification of HLA class I bound ligands combined with phos-
phopeptide enrichment may be a useful approach to identify targets for T cell based immunotherapy.
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DEPOLARIZATION DEPENDENT SPATIAL LOCALIZATION OF PROTEINS 
IN NERVE TERMINALS
M. Ibáñez-Vea, S. Shah, A. Edwards, L. Jakobsen, M.R. Larsen
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230, Odense 
M, Denmark
Phosphorylation is among the most widespread post-translational modifications in nature, and re-
gulates a great variety of biological processes. On depolarized nerve terminals, phosphorylation and 
dephosphorylation play a great role on the release of neurotransmitters by exocytosis and the recy-
cling of the synaptic vesicles involved on this process (endocytosis). Depolarization of the neuron 
membrane produces a collapse on the membrane potential leading to an influx of calcium ions into 
the nerve terminals. The calcium influx leads to extensive activation of phosphatases (e.i. calcineurin) 
and protein kinases (e.i. PKC and calcium/calmodulin dependent kinases) which control exocytosis 
and endocytosis and localization of proteins. Especially the localization of proteins is of great impor-
tance in nerve terminals as the specialized processes are relying on proteins being transported from 
the cytoplasm to the membranes or the opposite way to participate in various protein complexes. 
Phosphorylation could be important as a regulator of protein localization in nerve terminals.
The aim of this study is to identify proteins that travel between the cytoplasm and membrane upon 
chemical depolarization of nerve terminals and determine the influence of phosphorylation on localiza-
tion of proteins in nerve terminals. This is a preliminary study to observe the transfer of proteins bet-
ween the cytoplasm and membrane of the main proteins involved on the release of neurotransmitters 
from nerve terminals.  
Nerve terminals are isolated from rat brains as synaptosomes, keeping most of their functions intact. 
After chemical depolarization using KCl, proteins were separated into membrane and cytoplasmic 
fractions using sodium carbonate combined with ultracentrifugation. The changes in the protein levels 
and protein phosphorylation after stimulation on the membrane and the cytoplasmic fractions were 
assessed using isobaric tags for relative and absolute quantification (iTRAQ). Mono-phosphopeptides, 
multi-phosphopeptides and glycopeptides were analysed with accurate liquid chromatography cou-
pled with tandem mass spectrometry (nano LC-MS/MS) after enrichment and fractionation using the 
TiSH procedure (TiO2 SIMAC-HILIC). 
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CHARACTERIZATION OF S. SHIBATAE AND S. ACIDOCALDARIUS DNA-DIRECTED RNA 
POLYMERASE METHYLATION BY CID AND ETD
Azkargorta M1, Wojtas MN2, Abrescia NG2,3, Elortza F1
1Proteomics Platform, CIC bioGUNE, CIBERehd, ProteoRed, 48160 Derio, Spain, 2Structural Biology Unit, CIC bioGUNE, 
CIBERehd, 48160 Derio, Spain, 3IKERBASQUE, Basque Foundation for Science, 48011 Bilbao, Spain
Lysine methylation is a thoroughly analyzed post translational modification (PTM) whereby a hydrogen 
atom is replaced by a methyl group. This modification process is closely linked to regulation of trans-
cription, protein stability, elongation, and protein interaction, among others.
Although methylation has been profusely analyzed in eukaryotes, little is known about this process in 
archaea. Lysine methylation is known to increase the pKa of the side chain, changing the hydrophobi-
city and solubility of the protein. Therefore, it may play an important role in the heat stability of proteins 
from hyperthermophilic crenarchaea. A recent MS-based analysis identified several methylated lysines 
in Sulfolobus solfataricus RNA polymerase, pinpointing that methylation occurs in crenarchaea.
Collision-induced dissociation (CID) is one of the most commonly used dissociation methods for cha-
racterizing peptides. CID, however, may fail to identify large, highly charged, modified peptides. Elec-
tron-transfer dissociation (ETD) has been shown to generate more complete series of ions, thereby 
leading to more extensive sequence information, and is of special interest for the analysis of PTMs. 
The use of ETD in conjunction with CID has been shown to be a very valuable approach because of 
their differential dissociation nature.
In this work we characterize the methylation pattern of the DNA-directed RNA polymerase from Sul-
folobus acidocaldarius and Sulfolobus shibatae. Protein was both¬¬ in-gel and in-solution digested 
prior to analysis, and peptides were analyzed by both CID and ETD in an LTQ Orbitrap XL ETD mass 
spectrometer.
Our findings extend previous proteomic studies on this enzyme and indeed reveal that DNA-directed 
RNA polymerase is extensively methylated in both organisms.
P21PS2  PTMs
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N-GLYCOSYLATION ANALYSIS OF TRASTUZUMAB BIOSIMILAR CANDIDATES BY LIQUID 
CHROMATOGRAPHY AND MASS SPECTROMETRY STRATEGIES
MªCarmen Durán1,2, Ivan Sánchez de Melo3, Miguel Curto3, Paola Grassi4, Francisco Ochoa3, Anne Dell4, 
Francisco J. García-Cózar1,2
1 Research Unit, Hospital Puerto Real, Cádiz,  2 Biomedicine, Biotechnology and Public Health Department, Cádiz Univer-
sity, 3 Curaxys Biopharmaceuticals, Cádiz, Spain,  4 Biopolymer Mass Spectrometry group, Imperial College, London UK
The biotechnological production of protein-based therapeutics is one of the fastest growing sectors 
of the pharmaceutical industry1. Biosimilars, also known as follow-on biologics, constitute subsequent 
“copies” of innovator biopharmaceutical products made by a different sponsor following patent and 
exclusivity expiry on the innovator product. Differences in impurities and/or breakdown products can 
have serious health implications and therefore it´s of high importance to deliver biosimilars with the 
same or the nearest structural properties than the patented product.
Trastuzumab (Herceptin), a commercially available monoclonal antibody (IgG1) employed to block the 
ErbB2 overexpression in breast cancer, it´s comprised of a tetramer of two heavy and two light chains 
with one N-glycosylation in each heavy chain. Several factors, such as growing conditions or cell types 
can determine the final structure of the glycans, significantly affecting the properties of the generated 
antibodies. Therefore, the production of antibodies with the appropriate N-Glycosylation is a critical 
step and one of the most time consuming parts of the developing process for those companies ac-
tually producing Herceptin biosimilars (or any other glycosylated drug). 
In the present study, we describe two different but complementary strategies to characterize the N-gl-
ycosylation of Trastuzumab biosimilars currently in process. Both methodologies include a first step of 
enzymatic N-glycan releasing from the protein and a second step of glycan characterization. In the first 
case, N-glycans are fluorescently labeled with 2-aminobenzamide (2-AB) and separated by Normal 
phase HPLC (NP-HPLC). Different sugars will elute at different times and can be detected and identi-
fied employing specific sugar standards. In the second approach, released glycans are permethylated 
and analysed by MALDI-TOF/TOF, being able to determine the structure because of the differential 
sugar masses. Herein, the N-glycosylation structures of two different Trastuzumab biosimilars will be 
compared, and both approaches, HPLC and MALDI analysis, will be described. 
1 Nicolaides NC et al. Advances in targeted therapeutic targets. Expert Opinion Drug Discov. 2010;5(11):1123-40 
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COMPARATIVE PROTEOMIC ANALYSIS OF MILTEFOSINE-SENSITIVE 
AND MILTEFOSINE-RESISTANT Leishmania chagasi CLINICAL ISOLATES
Juliana B. T. Carnielli1, Simone F. Pires2, Hélida M. de Andrade2, Reynaldo Dietze1, Suely G. Figueiredo3, 
Elenice M. Lemos1
1 Laboratório de Leishmanioses, Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Brazil, 2 Labo-
ratório de Leishmanioses, Departamento de Parasitologia, Universidade Federal de Minas Gerais, Brazil, 3 Laboratório de 
Química de Proteínas, Departamento de Ciências Fisiológicas, Universidade Federal do Espírito Santo, Brazil. 
Visceral leishmaniasis is a serious disease caused by protozoan parasites called Leishmania. The 
treatment for this disease is difficult, as it requires prolonged and painful applications of toxic drugs 
that are poorly tolerated. Therefore, one of the most significant advances in the leishmaniasis therapy 
was the identification of an effective and safe oral drug, the miltefosine. However, different sensitivities 
to miltefosine by Leishmania have been observed in clinically relevant species and the biological me-
chanism whereby Leishmania clinical isolates acquire drug resistance is poorly understood. In this con-
text, comparative two-dimensional gel electrophoresis and mass spectrometry methodologies were 
applied to highlight and identify proteins that are differentially expressed between miltefosine-sensitive 
and miltefosine-resistant L. chagasi clinical isolates. It is described here a high-resolution proteome 
for L. chagasi promastigotes comprising an average of 459 spots (fig 1A), which corresponds to 5,7% 
of gene products predicted for Leishmania spp. Following comparison of the whole proteome profiles 
between sensitive and resistant strains, 67 differentially expressed spots were detected. Eighteen 
spots were found to be specific of a sensitive group and only one of a resistant group, while 48 spots 
changed in intensity between these groups. MALDI/TOF-TOF mass spectrometry allowed the iden-
tification of 48 spots (71,6%), corresponding to 39 distinct proteins of which seven are hypothetical 
proteins. Among the proteins identified, the comparative proteomics screen highlighted the peroxido-
xin, a serine/threonine protein phosphatase, a calpain-like cysteine peptidase and a 4-3-3 protein-like 
protein that have been reported to play a role in the drug-induced programmed cell death in parasites 
(fig 1B), suggesting that resistance mechanisms to miltefosine are possibly associated with a lesser 
susceptibility to apoptosis. Our findings demonstrate that proteomic screen has great potential to 
identify protein differences between closely related parasite strains and can be used to distinguish 
parasite phenotypes of clinical relevance. Supported by: CNPq, CAPES and FAPES.
Figure 1. Comparative proteomics analysis between sensitive and resistant Leishmania chagasi clinical isolates. (A) Represen-
tative 2D gels comparing L. chagasi miltefosine-sensitive and miltefosine-resistant strains. Gel obtained after separation of 800 µg of soluble 
protein in IPG strip covering pH range 4-7. (B) Insets (I-IV) corresponding to zoomed gel areas with spots showing difference in protein 
expression between the miltefosine-sensitive and miltefosine-resistant group. S, miltefosine-sensitive group; R, miltefosine-resistant group.
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IDENTIFICATION OF Leishmania infantum VIRULENCE 
FACTORS BY PROTEOMIC APPROACH
Simone da Fonseca Pires1, Luiz Carlos Fialho Júnior1, Carolina Carvalho2, Wagner Luiz Tafuri2, Maria Norma 
Melo1, Alexander D. Chapeaurouge3, Jonas Perales3, Hélida Monteiro de Andrade1
1 Departamento de Parasitologia da Universidade Federal de Minas Gerais
2 Departamento de Patologia da Universidade Federal de Minas Gerais
3 Fundação Oswaldo Cruz, Instituto Oswaldo cruz, Rio de Janeiro, Brasil
Leishmania infantum chagasi is the visceral leishmaniasis (VL) agent in Brazil, a zoonotic disease with 
high morbidity and mortality with the dogs being the main reservoir. VL canine is a severe disease 
which the symptoms are present in less than 50% of infected dogs. Clinical variability suggests that 
parasite factors are involved in virulence. We used two L. infantum chagasi strains: MHOM/BR/1972/
BH46 (BH46) and MCAN/BR/2000/BH400 (BH400) with high and low virulence, respectively. We 
realized in vitro and in vivo virulence characterization these strains by infecting macrophages and 
hamsters, respectively. These assays had shown a statistically significant bigger parasitism in cells 
and animals infected with BH400 than BH46 strain. Furthermore, we used proteomic approach to 
identify proteins that may be involved in virulence difference.  The protein extracts were obtained 
from promastigotes forms and fractionated by electrophoresis two dimensional DIGE (Differential Gel 
Electrophoresis ) using 18 cm pH 4-7 strips and 12% SDS-PAGE. The gel images were analyzed by 
DeCyder® software (GE Healthcare, USA). The analysis showed 13 spots with higher expression in 
BH400 than in BH46. No overexpressed spots were identified in BH46 when compared to BH400. 
The differential expressed spots were identified by Mass Spectrometry (MALDI/ToF-ToF) (Bruker Dal-
tonics, Billerica, USA). Among them are a and b-tubulins, heat shock protein 83-1, paraflagellar rod 
protein 2C, putative cysteine peptidase, enolase, putative adenosine kinase, translation elongation 
factor 1-b, putative NADP-dependent alcohol dehydrogenase, putative proteasome activator protein 
pa26, kinetoplastid membrane protein-11, glutaredoxin-like protein and conserved hypothetical pro-
tein. Some the identified proteins are described as virulence factor in literature and their role in virulen-
ce phenotype will be evaluated by transgenic parasites.  The virulence factor studies may contribute 
to the discovery of new targets with therapeutic potential against leishmaniasis and in parasite-host 
interaction. 
Financial support: FAPEMIG, CAPES and CNPq
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A STRUCTURE-BASED STRATEGY FOR EPITOPE DISCOVERY IN BURKHOLDERIA 
PSEUDOMALLEI OPPA ANTIGEN
Patricia Lassaux1,7, Claudio Peri3,7, Mario Ferrer-Navarro4, Louise J. Gourlay1, Alessandro Gori3, 
Oscar Conchillo-Solé4, Darawan Rinchai5, Ganjana Lertmemongkolchai5, Renato Longhi3, 
Xavier Daura4,6, Giorgio Colombo3 and Martino Bolognesi1,2
1 Department of Biosciences, University of Milan, Milan 20133, Italy, 2 Consiglio Nazionale delle Ricerche, Institute of Bio-
physics University of Milan, Milan 20133, Italy, 3 Consiglio Nazionale delle Ricerche, Institute for Chemistry of Molecular 
Recognition, Department of Computational Biology, Milan 20131, Italy, 4 Institute of Biotechnology and Biomedicine, Uni-
versitat Autònoma de Barcelona, Bellaterra 08193, Spain, 5 Center for Research and Development of Medical Diagnostic 
Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand, 6 Catalan 
Institution for Research and Advanced Studies, Barcelona 08010, Spain, 7 These authors contributed equally to this work
We present an approach integrating mass spectrometry, structural and computational biology with im-
munological tests to identify epitopes in the OppA antigen from the Gram-negative pathogen Burkhol-
deria pseudomallei, the etiological agent of melioidosis. The crystal structure of OppABp, reported 
here at 2.1 A° resolution, was the basis for a computational analysis that identified three potential 
epitopes. In parallel, antigen proteolysis and immunocapturing allowed us to identify by mass spec-
trometry three additional peptides. All six potential epitopes were synthesized as free peptides and 
tested for their immunoreactivity against sera from healthy seronegative, healthy seropositive, and 
recovered melioidosis patients. Three synthetic peptides allowed the different patient groups to be 
distinguished, underlining the potential of this approach. Extension of the computational analysis, in-
cluding energy-based decomposition methods, allowed rationalizing results of the predictive analyses 
and the immunocapture epitope mapping. Our results illustrate a structure-based epitope discovery 
process, whose application may expand our perspectives in the diagnostic and vaccine design fields.
Reference: Lassaux P, Peri C, Ferrer-Navarro M, et al. A Structure-based strategy for epitope discovery in Burkholderia pseudomallei OppA 
antigen. Structure (2013), 21, 1-9.
Acknowledgments: This work was supported by CARIPLO ‘‘From Genome to Antigen: a multidisciplinary approach towards the development 
of an effective vaccine against Burkholderia pseudomallei, the Etiological Agent of Melioidosis’’ (contract number 2009-3577)
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ORNITHODOROS MOUBATA SOFT TICK SALIVA PROTEOME: A COMPARISON 
BETWEEN FEMALE AND MALE SALIVA
Verónica Díaz-Martín, Raúl Manzano-Román, Eduardo de la Torre-Escudero, Luz Valero*, Ana Oleaga, Ricardo 
Pérez-Sánchez
Instituto de Recursos Naturales y Agrobiología (IRNASA, CSIC), Salamanca, Spain. *Sección de Proteómica, Universidad 
de Valencia, Spain
Ticks are ectoparasites that feed on the blood of their hosts. To do this, ticks suppress the host hae-
mostatic and immune systems by using anti-haemostatic, anti-inflammatory and immunomodulatory 
proteins that are synthesized in the tick salivary glands and inoculated with tick saliva into the host 
during the feeding process. The host immunosuppression caused by ticks can further facilitate the 
transmission of tick-borne pathogens. Therefore, these salivary proteins could be adequate antigenic 
targets for development of anti-tick vaccines that would have the dual effect of blocking the tick fee-
ding and the pathogen transmission.
The objective of the present work was to identify the salivary proteins of Ornithodoros moubata, an 
African argasid tick that transmits Human relapsing fever and African swine fever. With this aim, we 
have used pilocarpine to induce salivation of O. moubata adult ticks and collected saliva samples from 
females and males separately. Saliva has been analyzed for protein identification in several ways: (i) 
samples of crude native saliva have been subjected to LC-MS/MS and database searching (EST_acari 
and NCBInr_metazoa); (ii) to make it possible the identification of the low abundant proteins, additional 
samples of saliva of both sexes have been equalized (ProteoMiner, BIO-RAD) and then subjected to 
LC-MS/MS and database searching; and (iii), female and male crude native saliva samples have been 
resolved by monodimensional SDS-PAGE and the stained gel bands sliced and analyzed by LC-MS/
MS.
Here, we report the array of more than 200 proteins identified in the saliva of O. moubata showing: (i) 
the broad and complex composition of the saliva of this tick, in good agreement with the complexity of 
the argasid and ixodid sialomes described previously; (ii) a remarkable difference in the saliva proteo-
mes of females and males, since hardly 6% of the proteins identified appeared to be shared by both 
sexes; and (iii) the presence in the salivary fluid of a wide range of proteins known to be housekeeping/
intracellular, which lack classical secretion signals and could have been secreted in unconventional 
ways, including exosome secretion.
This is the first description of the proteome of the saliva of an argasid tick, and besides providing inter-
esting information, it also opens new questions such as what the biological meaning of the observed 
differences in the saliva composition between females and males could be.
This work has been financed by projects AGL2010-18164 from the Spanish Ministry of Science and Innovation, and CSI062A11-2 from the 
Regional Government of Castilla y León (Spain).
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PROTEOMIC IDENTIFICATION OF VASCULAR SURFACE PROTEINS ISOLATED FROM THE 
LIVER OF MICE INFECTED WITH SCHISTOSOMA BOVIS
Eduardo de la Torre-Escudero, Verónica Díaz-Martín, Luz Valero*, Raúl Manzano-Román, Ricardo Pérez-Sán-
chez, Ana Oleaga.
 
Instituto de Recursos Naturales y Agrobiología (IRNASA, CSIC), Salamanca, Spain. *Sección de Proteómica, Universidad 
de Valencia, Spain. 
Schistosomiasis is a parasitic disease affecting man and domestic and wild animals that represents 
an important health and veterinary problem in many tropical and subtropical areas of the world. Schis-
tosoma bovis is an intravascular parasite that lives within the venous portal mesenteric system of 
ruminants. Schistosome cercariae infect their vertebrate hosts through the skin. Then, they enter the 
blood circulation, performing an intra-organic migration along which they mature and reach their final 
localization, where they transform into adults and live for years. Eggs laid by S. bovis adult females 
in the mesenteric veins pass through the intestinal wall and then exit the host through the faeces, or 
they are swept into the liver and trapped in the sinusoids, where they induce granulomatous lesions.
The purpose of this work was to analyze the changes induced by S. bovis eggs and adult worms in 
the proteome expressed by infected mice on the endothelial cell surface of blood vessels of the liver. 
With this aim, we have utilized a methodology that allows the purification, identification and relative 
quantification of endothelial cell surface proteins after their selective in vivo biotin labeling. Trypsin 
digestion of the biotinylated proteins and subsequent liquid chromatography and tandem mass spec-
trometry analysis (LC-MS/MS) resulted in the identification of a total 167 non redundant proteins. Of 
these proteins, 47 were identified only in the liver of non-infected mice; 64 only in infected with S. bovis 
mice and 56 in both groups of mice. The efficiency of vascular biotinylation after in vivo perfusion was 
assessed in liver samples taken from the mice infected and non-infected with S. bovis by immunohis-
tochemistry of paraffin sections and by western blotting with streptavidin-HRP.
Here we report the identified proteins classified according to their function and cellular location, and 
the differences between S. bovis-infected and non-infected mice in their vascular proteomes of the 
liver. This work provides the first data on the vascular surface proteome of the liver after S. bovis in-
fection. 
This work has been financed by project AGL2010-18163 from the Spanish Ministry of Science and 
Innovation.
98
PS3 Disease Proteomics P28
PROTEOME MAPPING OF THE LUNG ENDOTHELIAL CELL SURFACE IN SCHISTOSOMA 
BOVIS-INFECTED HAMSTERS
Eduardo de la Torre-Escudero, Verónica Díaz-Martín, Luz Valero*, Raúl Manzano-Román, Ricardo Pérez-Sán-
chez, Ana Oleaga
Instituto de Recursos Naturales y Agrobiología (IRNASA, CSIC), Salamanca, Spain. *Sección de Proteómica, Universidad 
de Valencia, Spain.
Schistosoma bovis is a blood-dwelling fluke worm affecting ruminants that lives for years inside its 
hosts vasculature, in direct contact with the vascular endothelium and exposed to the blood compo-
nents. As do other species of Schistosoma, S. bovis penetrates into the host body through the host 
skin until reaching a skin capillary vessel. After that, it migrates through the blood stream towards the 
lungs, where it stays several days as schistosomulum larva, and later to the portal vein and the mesen-
teric vessels where it finally develops into the adult stage. Since this parasite is adapted to such an in-
travascular habitat, it is expected him to modulate the endothelial cell function to favor its own survival.
The objective of this work was to investigate the proteome of the lung vascular endothelial cell surface 
expressed as a result of the presence of schistosmulae larvae. To accomplish this, we have subjected 
the lungs of S. bovis-infected and non-infected hamsters to vascular perfusion with a biotin ester 
reactant. In this way, the proteins from the endothelial cell surface showing free amino groups would 
become biotinylated allowing their efficient purification by streptavidin affinity chromatography. Trypsin 
digestion of the biotinylated proteins and subsequent liquid chromatography and tandem mass spec-
trometry analysis (LC-MS/MS) resulted in the identification of 185 and 143 non-redundant proteins in 
infected and non infected hamsters, respectively. The efficiency of vascular biotinylation after this in 
vivo perfusion procedure was assessed by immunohistochemistry in paraffin sections of lung, and by 
western blotting with streptavidin-HRP.
Here we report the identified proteins classified according to their function and cellular location, and 
the differences between S. bovis-infected and non-infected hamsters of their lung vascular proteomes 
were analyzed. This work provides the first data on the vascular surface proteome of the lung after 10 
days S. bovis infection.
This work has been financed by project AGL2010-18163 from the Spanish Ministry of Science and 
Innovation.
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EXAMINING DIFFRENTIAL PROTEIN EXPRESSION IN COLORECTAL CANCER USING MASS 
SPECTROMETRY-BASED PROTEOMICS APPROACH
Dus K1,2, Ostasiewicz P1,2, Zielinska DF1, Gnad F1,Wozniak M2, Ziółkowski P2,  Wisniewski JR1 and Mann M1.
1 Department of Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry, Martinsried, Germany, 2 
Department of Pathology, Wrocław Medical University, Wrocław, Poland. 
AIM. The need of new markers for evaluation of colorectal cancer is continuously raised by different 
authors. Recent mass spectrometry- based proteomics studies provide not only the identification 
and quantification of highly abundant proteins but also systematic insights into organization of cancer 
cells- changes in cellular signaling pathways, alterations in the cell-surface proteome or biomarkers 
abundance.
In this study we analyze proteomes of normal mucosal tissue, adenocarcinoma, and its nodal metas-
tasis from laser microdissected patient matched archival FFPE clinical samples to identify the proteins 
that are key players in the development and progression of the colorectal cancer. 
Material and methods. The workflow involved lysis of cancerous and noncancerous tissue from 8 
patients in SDS-containing buffer. Detergent removal and consecutive digestion of the proteins with 
trypsin were prepared according filter aided sample preparation protocole modified for fomaline fixed 
paraffine embedded tissue samples (FFPE-FASP). Resulting peptides were fractionated by pipette-tip 
based strong anion exchange into 6 fractions and analyzed by LC-MS/MS on a linear ion trap Orbitrap 
mass spectrometer. The upregulation of 10 potential biomarkers in colorectal adenocarcinoma sam-
ples was confirmed by immunohistochemistry.
Results. Analysis of the data using the MaxQuant software version 1.2.2.8 resulted in the identifi-
cation of > 8100 proteins from normal mucosal tissue, adenocarcinoma, and its nodal metastasis, 
among which more than 7500 are common for three stages. We found >1800 proteins significantly 
changed between normal colonic mucosa and cancer tissue, while there was observed minimal pro-
teomic remodeling between primary cancer and metastases. Moreover, we reported that general 
transcription factors, nuclear transporters and chromatin activators are upregulated in the cancer 
samples, whereas the integral plasma membrane channel and transporter proteins were found down-
regulated in the same sample.  
Conclusions. Present work enables systemic insights into the organization of the colorectal cancer 
cells and an estimation of the abundances of known biomarkers. Furthermore, the data obtained in 
our study allows to identifying a number of proteins that weren’t known before to be significantly ove-
rexpressed in colorectal cancer. 
Mass spectrometry-based clinical proteomics may be essential for the further identification and valida-
tion of new protein biomarkers that have shown vast promise for the early colorectal cancer detection 
and  prediction.
´ ´ ´ ´
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2D-DIGE ANALYSIS OF FLUORESCENTLY LABELED SURFACE PROTEINS OF Xanthomo-
nas citri CELLS INTERACTING WITH CITRUS-HOST
Carnielli, C.M.1; Novo-Mansur, M.T.M1.
1Department of Genetics and Evolution, UFSCar, SP, Brazil
The causative agents of citrus canker are bacteria from the genus Xanthomonas, of which Xantho-
monas citri subsp. citri (XAC) is more virulent and attacks a greater number of hosts than other citrus 
canker pathogens. The genome of this bacterium has been totally sequenced. In this work it was 
performed a differential proteomic analysis of XAC proteins exposed in the cellular surface using fluo-
rescent dyes. The bacteria were grown in vitro (Nutrient Broth medium) or in vivo (citrus-host leaves) 
conditions. Intact cells were labeled with CyDyes (GE Healthcare), washed to eliminate non-incorpo-
rated dyes, and finally disrupted. The protein extracts were analyzed by Two-Dimensional Difference 
Gel Electrophoresis (2D-DIGE) and a statistical analysis (ANOVA) was performed using DeCyder 7.0 
software (GE Healthcare). Approximately 100 spots showed significant (p<0.05) differential expression 
and most of them were digested using trypsin and analyzed by mass spectrometry (ESI-QUAD-TOF) 
(LNBio, CNPEM-ABTLus, Campinas-SP, Brazil). The Mascot tool was employed to compare the re-
sults with annotated proteins of the respective NCBI genome database. Among the forty-six proteins 
identified, twenty-two were induced in the in vivo condition, including receptors, other known outer 
membrane proteins and several conserved hypothetical proteins. We concluded that surface proteins 
are involved in the pathogen response in citrus canker and could be important targets to drugs.
Keywords: citrus canker, Xanthomonas citri subsp. citri., pathogenicity, differential proteomic analysis, 2D-DIGE.
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PROTEOMICS APPROACH TO STUDY EARLY BIOCHEMICAL EVENTS IN CARNATION 
(DIANTHUS CARYOPHYLLUS L.)-FUSARIUM OXYSPORUM F. SP. DIANTHI INTERACTION
Harold Ardila1, Raquel González Fernández2, Blanca Ligia Higuera1, Sixta Tulia Martínez1, Jesús Jorrin Novo2
1Laboratorio Investigación Actividades Metabólicas Vegetales, Departamento de Química,  Universidad Nacional de Co-
lombia, sede Bogotá,  2Laboratorio de Bioquímica y Proteómica Vegetal y Agroforestal, Departamento de Bioquímica y 
Biología Molecular, Universidad de Córdoba. España
Vascular wilting caused by Fusarium oxysporum f. sp. dianthi race 2 is the worldwide most important 
disease affecting carnation (Dianthus caryophyllus L). Several strategies have been used to control this 
pathogen, but none has provided full protection. At present, no markers have been developed for re-
sistant cultivar selection in breading programs, because of the poorly biochemical and molecular infor-
mation about resistance to this pathogen. In order to know on this plant-pathogen interaction in terms 
of plant responses, a comparative proteomics approach has been used. In a preliminary experiment, 
we evaluated the differential protein accumulation during 6, 24 and 96 hours post-infection (hpi) with 
the pathogen, in two cultivars differing in resistance, using 1D electrophoresis. The protein extraction 
from stems and roots of carnation were carried by using protein precipitation protocols (TCA/acetone/
phenol). After gel analysis using Quantity-one software (Bio-Rad) bands of interest were subjected to 
MS (MALDI-TOF-TOF) analysis after tryptic digestion of the contained proteins. In a second step, 2-DE 
analysis of extracts from roots and stems, at 6 and 96 hpi respectively, was performed, with gel ima-
ges analyzed with the PDQuest software (Bio-Rad). Out of the 798 consistent spots detected and well 
resolved, 187 were variable among cultivars, tissue or treatments. Protein identification after MALDI/
TOF/TOF analysis were done by searching at the NCBInr database using MASCOT (MatrixScience) as 
search engine, and limiting the taxonomic category to plants (Viridiplantae). We got confident matches 
for 25 out 78 selected spots (30% success).  This low rate of identification is mainly due to the lack of 
reported sequences for carnation in public databases. Even so, we have identified some constitutive 
proteins associated with the resistant phenotype, such as a class III peroxidase and a NB-ARC re-
sistance protein (Nucleotide Binding domain shared by Apaf-1, certain R gene products, and CED-4 
fused to C-terminal leucine-rich repeats). Likewise, a differential protein accumulation associated to 
carbohydrate metabolism reorganization was found in the resistant cultivar during pathogen infection 
at the root level. The next step will be focused to develop a specific database for identifying those non-
identified remaining proteins which are differentially accumulated in the resistant cultivar, and the use 
of 2-DE complementary shot-gun approaches to deep in the carnation proteome coverage. 
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SUBCELLULAR FRACTIONATION AS A STRATEGY TO IDENTIFY KEY PROTEINS RELATED 
WITH ONCOGENESIS
S. Susana Novoa-Herrán1, Myriam Sánchez-Gómez1, Patricia Cuervo2, Leopold Ilag3
1 Grupo de Investigación en Hormonas, Departamento de Química, Universidad Nacional de Colombia, Bogotá, Colombia, 
2Laboratório de Pesquisa em Leishmaniose, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brasil, 3Department of 
Analytical Chemistry, Stockholm University, Arrhenius Laboratory of Natural Sciences, Stockholm, Sweden
It is becoming clear that the phenotypes that are characteristic of cancer cells are the result of nu-
merous and heterogeneous mutations that affect many signalling pathways and a vast array of key 
cytoplasmic proteins.  Increasing research is now devoted to the identification of the crucial oncogenic 
signalling molecules that contribute to the process of tumorogenesis. Proteomics has emerged as a 
promising tool for unraveling signalling proteins that are associated with oncogenesis, and in particu-
lar, to allow comparative studies between different types and states of cancer. An important body of 
knowledge has shown the similarities between the proliferative and invasive properties of trophoblastic 
and cancer cells. The aim of the present study was to compare the cytoplasmic sub-proteome of 
the human trophoblast HTR8/SVneo cell line with that of the malignant choriocarcinoma JEG-3 cell 
line in order to get insight into the molecular mechanisms responsible of oncogenesis.  We obtai-
ned the cytoplasmic sub-proteomes free of membrane proteins by differential detergent fractionation 
(DDF), their enrichment and quality were evaluated by Western Blot, using antibodies against IGF-IIR 
membrane receptor, FAK, ERK and p53 as cytoplasmic signal transducers. The proteomes were 
resolved by 2D electrophoresis and analyzed on three different groups: unique protein spots from 
JEG-3 sub-proteome, unique protein spots from HTR8/SVneo sub-proteome and differential protein 
spots present in both samples. Selected protein spots were identified, initially by MALDI MS/MS, and 
afterwards by HPLC-ESI-MS/MS, and analyzed using the DAVID 6.7 and STRING 9.0 softwares. 
Initially, 4 spots in each group were analyzed by  MALDI TOF/TOF, identifying 6 common proteins, 4 
proteins expressed only by JEG-3 cells and 7 proteins expressed only by HTR8/SVneo cells. All of 
them presented annotation to intracellular part and 35.7% mutagenesis site annotation, which repre-
sent a suitable strategy to study cytoplasm proteins related to oncogenesis.  Later, with the aim to 
find possible oncogenic proteins, a deeper study was developed on the unique protein spots obtained 
for JEG-3 sub-proteome, identifying 54 unique proteins by HPLC ESI-Q/TOF. Of these, 79.2% were 
protein binding, 50.9% had catalytic activity annotation, 13.2% oxidoreductase activity and 5.7% 
peroxiredoxin activity. In addition, proteins linked with b-alanine, cysteine and methionine metabolism, 
proteasome, glycolisis/gluconeogenesis, and expressed on response to ERK signaling pathway were 
detected. Furthermore, 22.6% had mutagenesis site annotation as Programmed cell death protein 6, 
Peroxiredoxin-2 and 6, Proliferation-associated protein 2G4 and Thioredoxin, among others.  From 
these results, it is possible to deduce a rise in metabolic, antioxidant and protease activities on cho-
riocarcinoma cells compared to trophoblast cells, as a tumorogenesis strategy. In conclusion, these 
analytical approach allowed to resolve and compare proteomes to find key cytoplasmic proteins pos-
sibly involved in altered networks and oncogenesis.
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DIFFERENTIAL PROTEOMIC ANALYSIS OF THE HUMAN PLATELET RELEASATE FO-
LLOWING ACTIVATION WITH DIFFERENT AGONISTS
Paula Vélez, Isaac Rosa and Ángel García 
Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Com-
postela, and Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS). Santiago de Compostela. Spain.
Platelets are cytoplasmic fragments without nuclei whose main function is to keep primary hemostasis 
by forming thrombi after an injury of the endothelium. Undesired activation and formation of arterial 
thrombi are implicated in many diseases, such as myocardial infarction and stroke [1]. Once activated, 
platelets release a high number of proteins and other biomolecules, which is known as releasate. The-
re are clear indications that proteins secreted by platelets are found in the atherosclerotic plaque con-
tributing to its pathogenesis [2]. In recent years there have been several groups focusing on the study 
of the releasate, analyzing the effect of different agonists and antiplatelet agents such as aspirin [2,3].
In our study we tested the hypothesis that the platelet releasate varies depending on the platelet 
stimulus used to activate them. We compared the releasate of thrombin-stimulated platelets versus 
collagen-stimulated. Proteome analysis was based on 2D-DIGE and MALDI-TOF MS or LC-MS/MS. 
We run four technical replicates per group. We detected 1742 spots per gel, 131 of which appeared 
differentially regulated between both conditions. Spots were filtered based on two parameters: fold 
change ≥ 2 and p < 0.05. We identified 72 different regulated spots, most of which corresponded to 
a, b and g chains of fibrinogen overexpressed in the releasate of collagen-activated platelets, which 
was found to be due to the ability of thrombin to transform fibrinogen into fibrin. We identified another 
25 unique proteins (13 overexpressed in collagen, 11 in thrombin and one in both conditions). The 
identified proteins were secreted in a similar proportion by both secretory pathways (classical and 
non-classical), and 7 of them had not been reported previously in platelet releasate studies. Tho-
se include nucleosome assembly protein 1-like 1 (NP1L1), glutathione peroxidase 1 (GPX1), myosin 
regulatory light polypeptide 9 (MYL9), caspase-3 (CASP3), ML12B, and cardiotrophin-like cytokine 
factor 1 (CLCF1). The latter is a cytokine with B-cell stimulating capability. Validation studies were by 
western blotting. The interest of the present study was to determine which proteins are secreted diffe-
rentially depending on the platelet receptor that is activated. This could have pathological implications; 
an important example is our study published in 2011, which shows a higher activation state of GPVI 
signaling (collagen receptor) in platelets from patients with acute myocardial infarction [4].
We are actually carrying out a study to compare releasates of collagen-activated platelets in presence 
/ absence of inhibitors of secondary mediators (as the ADP inhibitor apyrase and the thromboxane 
inhibitor indomethacin) and integrilin (to inhibit aggregation by aIIbb3). In this way we can study the 
effect of these drugs on the platelet releasate and identify proteins altered between both conditions, 
which would be interesting from a pharmacological point of view.
[1] Parguiña AF, Rosa I, García A. J Prot. 2012; 76:275-286.
[2] Coppinger JA et al. Blood. 2004; 103:2096–2104. 
[3] Coppinger JA et al. Blood. 2007; 109: 4786-4792.
[4] Parguiña AF et al. Arterioscler Thromb Vasc Biol. 2011; 31:2957-64.
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MODIFICATION OF THE PROTEIN PROFILE OF BLADDER TUMOURS INDUCED BY THE 
INHIBITION OF NITRIC OXIDE PRODUCTION
Langle Y1, Belgorosky D1, Monge M2, Colomé N2, Rojas Bilbao E1, Marino L1, Malagrino H1, Pasik L1, Casabé A1, 
Reventos J3,Canals F2 & Eiján AM1
1 Ángel H. Roffo Institute of Oncology, CABA, Argentina, 2Vall Hebron Institute of Oncology, VHIO, Universitat Autònoma 
de Barcelona, Barcelona, Spain, 3Research Unit in Biomedicine and Translational and Pediatric Oncology, Vall d’Hebron 
Institut de Recerca, Universitat Autònoma de Barcelona, Spain
Bladder cancer (BC) is the second cause of death from male urogenital tract tumours. It is classified 
as non invasive (NMI) or muscle invasive, when it reaches the detrusor muscle. NMI tumours represent 
80% of diagnosed BC and the transurethral resection can be useful to eliminate the tumour when the-
re is only one injury and the surrounding tissue is histologically normal. However, recurrences appear 
in 50% of patients, and 30% of them present a more invasive pattern, requiring more aggressive the-
rapies. The identification of new players involved in tumour progression can provide new therapeutic 
targets. 
Nitric oxide (NO) is a free radical produced by NO synthase (NOS). We previously described that 50% 
of human BC express the inducible isoform iNOS. We determined that 80% of iNOS+ patients show 
tumoral recurrence in the first year after the treatment while only 20% of iNOS- patients show recu-
rrence during that time. We also demonstrated that mouse MB49 BC growth is reduced with L-NAME 
(inhibitor of NO production) therapy. These results led us to propose that modulation of NO production 
in iNOS+ tumour could be a useful therapeutic strategy.
The aim of this work was to evaluate mouse MB49 BC protein expression and the modification of its 
protein profile upon L-NAME treatment. 
MB49 bladder tumours derived from mice treated or not with L-NAME were compared by 2D-DIGE 
technology. A total of 52 proteins were identified as differentially expressed. L-NAME induces the 
over-expression of Ras suppressor protein1 (fold change 1.66; p<0.04) and reduces the expression 
of Vimentin (fold change 1.81, p<0.01), Hemoglobin (fold change 3.0, p<0,001) and S100-A9 (fold 
change 5.6, p<0,008). We analyzed by western blot the MAPK proliferation network to validate over-
expression of Ras suppressor protein1. Both the cell line and MB49 derived tumours show up-regula-
tion of pERK which is reduced in MB49+L-NAME. The reduction in Vimentin expression upon L-NAME 
treatment was validated by immunohistochemistry (IHC). Hemoglobin under-expression was validated 
by in vivo tumoral angiogenesis assays which demonstrated that blood vessel density (p<0.05) was 
reduced in mice treated with L-NAME. S100-A9 is a protein involved in immunosupression, rela-
ted with appearance of myeloid suppressor cells. Down-regulation of its expression after L-NAME 
treatment was validated by IHC. We analysed 31 human BC samples and we observed S100-A9 
expression in 87% of the samples, located in the tumoral cells and/or in the myeloid cells. 
In conclusion, L-NAME inhibits BC growth by the inhibition of proliferation, angiogenesis and epithelial 
mesenquimal transition pathways. Given the large decrease in S100-A9 expression and its relevance 
in human BC, we propose to study in more detail its role in tumour progression. Taken together, these 
results suggest us that the inhibition of NO production would be a good therapeutic target in those 
patients with tumours expressing iNOS. 
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DIFFERENTIAL PROTEOMIC CHARACTERIZATION OF SEVERAL FAMILIES 
FROM BRACHYSPIRA HYODYSENTERIAE AND BRACHYSPIRA PILOSICOLI
Vanessa Casas1, Montserrat Carrascal1, S. Vadillo3, José Larrasa2 and Joaquín Abián1
1 Laboratorio de Proteómica CSIC/UAB, Campus Universidad Autónoma de Barcelona, Facultad de Medicina, Edificio M, 
Bellaterra, CP: 08193, Cerdanyola del Vallès, Barcelona, 2 Laboratorios Larrasa, Polígono Industrial “El Chaparral” 17, CP: 
06170, La Albuera, Badajoz, 3 Dpto. Sanidad Animal, Facultad de Veterinaria, Universidad de Extremadura.
Pathogenic spirochetes that inhabit the large intestine have an intimate association with the colonic 
mucosa. In the case of the agent of swine dysentery, Brachyspira hyodysenteriae, the spirochetes lo-
calize within colonic crypts, penetrate the protective mucus barrier and invade the epithelium and the 
lamina propia. In contrast, the weakly B-hemolytic intestinal spirochete Brachispira pilosicoli (the agent 
of intestinal spirochetosis) attaches by one cell end to the colonic epithelium but it also may localize 
within the colonic crypts and invade beyond the epithelium.
By analogy with other pathogenic organisms, it is probable that proteins expressed on the surface 
of B. hyodysenteriae and B. pilosicoli play an important role in colonization and disease expression. 
This interaction may be direct (for example by mediating attachment to host cells) or indirect (for 
example by being the targets for the host immune response). It is interesting to note that relatively 
few Brachyspira outer membrane proteins have been characterized. To date only eleven proteins are 
available in Uniprot at evidence level for Brachyspira. All of them have been identified in Brachyspira 
hyodysenteriae.
The aim of this study is the characterization of the sufarce proteins of Brachyspira Hyodysenteriae and 
Brachyspira Pilosicoli. 
To isolate the proteins located in the outer membrane of Brachyspira, a short incubation with trypsin 
was carried out adding the enzyme directly to the bacteria. After this incubation the supernatant pro-
tein were digested for 7 hours. Control samples were running in parallel to discard secreted proteins. 
Digested samples were analyzed by LC-µESI-MS/MS (Orbitrap).
Using this methodology more than 500 new proteins were identified, most of them located on mem-
brane. 
Bibliography
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2D-DIGE STUDY IN SEMINAL PLASMA FROM DIFFERENT INFERTILE GROUPS WITH A 
CHARACTERISTIC PROFILE OF SPERM DNA FRAGMENTATION 
Fernandez-Encinas, A.1; García-Peiró, A.1,2; Ribas-Maynou, J.1; Abad, C.3; Amengual, MJ.4; Navarro, J.1 and 
Benet, J.1
1 Departament de Biologia Cel·lular, Fisiologia i Immunologia. Universitat Autònoma de Barcelona. 08193 Bellaterra, Spain, 
2 Centro de Infertilidad Masculina y Análisis de Barcelona (CIMAB). Edifici Eureka, PBM5. Parc de Recerca de la UAB 
(PRUAB). Campus de la UAB. 08193 Bellaterra, Spain, 3Servei d’Urologia. Corporació Sanitària Parc Taulí. Sabadell. Insti-
tut Universitari Parc Taulí – UAB. 08208 Sabadell, Spain, 4UDIAT, Centre Diagnòstic. Corporació Sanitària
Seminogram is the method of routine analysis in the laboratory of andrology. It gives a descriptive eva-
luation of semen, but these parameters are not always sufficient for accurate diagnosis, treatment or 
to explain the molecular basis of male infertility; in this sense, the identification and characterization of 
protein biomarkers are required. Human seminal plasma is loaded with proteins that are essential both 
for the sperm and for the fertilization process. For these reasons, two-dimensional gel electrophoresis 
(2D DIGE) was performed on seminal plasma from 24 males. The samples were selected according to 
three characteristics: the pathology, the rate of sperm with completely degraded DNA relative to total 
sperm with fragmented DNA (DDS) measured by Sperm Chromatin Dispersion (SCD) and the charac-
teristic profile of Sperm DNA Fragmentation (SDF) measured by alkaline and neutral Comet assay. The 
selected patients were: six fertile donors (FD), six asthenoteratozoospermic (ATZ) patients, six asthe-
noteratozoospermic patients with varicocele (ATZ-VAR) and six patients of recurrent miscarriage with 
normal seminogram (RM). After silver staining, the differential expression proteins were analyzed by 
Nonlinear Dynamics Progenesis SameSpots analysis software. A total of 72 spots showed statistically 
significant differential protein expression (p<0.05) with a fold>2. Forty-three (60%) were differentially 
expressed in FD group compared to the other groups, 16 (22%) in ATZ patients, 9 (12.5%) in ATZ-VAR 
patients and 4 (5.5%) in patients with MR. These results could allow distinguishing between fertile and 
infertile individuals and also between fertile individuals and RM although these groups have both nor-
mal seminogram. ATZ and ATZ-VAR patients have similar seminogram but only six spots had similar 
protein expression and were different from the other groups suggesting that asthenoteratozoospermia 
might be caused by different molecular mechanisms.  Thirty spots of interest were identified by mass 
spectrometry to verify these findings.
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EFFECT OF PROTEIN SOLID SUPPORT AND EXPRESSION PLATFORM ON BIOMARKER 
DISCOVERY AND VALIDATION 
Roi Villar-Vázquez1, Rodrigo Barderas1, Ingrid Babel1, Alberto Peláez-García1, Marta Mendes1, Juan Ignacio 
Imbaud2, Sofía Torres1, Rubén A. Bartolomé1, J. Ignacio Casal1 
1 Centro de Investigaciones Biológicas – CSIC, (Madrid, Spain), 2. ProAlt, Protein Alternatives SL. (Tres Cantos, Spain) 
Colorectal Cancer is one of the deadliest cancers in developed countries; its early diagnosis would 
improve survival rates. Detection of antibodies directed to Tumor Associated Antigens (TAAs) through 
ELISA provide a reliable alternative to Fecal Occult Blood Testing (FOBT), colonoscopy or CEA analy-
sis, characterized by lower costs and higher specificity. In previous studies we have reported the 
diagnostic value of 6 TAA’s identified in ProtoArray v4.0, and 6 TAAs in phage display arrays.
By testing ProtoArray version 4.1, characterized by a different and thinner nitrocellulose support, we 
identified 3 new TAAs: GTF2B, HCK and EDIL3. To compare their diagnostic performance to pre-
viously identified TAAs, we expressed full-length human TAA’s in E.coli or Sf9 cells and tested their 
diagnostic value by indirect ELISA using 153 patients’ sera. In order to assess the effect of the recom-
binant expression platform on TAA discrimination power, we compared the performance of selected 
TAA’s expressed in both E.coli and Sf9 cells using smaller patient cohorts. The validation cohort was 
distributed through colorectal cancer patients, healthy individuals and patients suffering from other 
cancers. Differences among groups were detected through one-way parametric analysis. Predicti-
ve ability was determined by logistic regression and ROC curves. TAA redundancy was examined 
through Principal Component Analysis. 
In total, we expressed and purified to homogeneity 13 human recombinant TAAs, and amplified 6 
phages displaying human peptide TAAs. By adding Edil3, HCK and p53 to previous panel composed 
of GTF2i, SREBF2, MST1/STK4, SRC and multiplexed PIM1, MAPKAPK3 and FGFR4, we have im-
proved the diagnostic panel previously described. With an AUC=0.94 and 86% specificity at a 90% 
fixed sensitivity (Fig1), we achieved an optimal value for cancer screening. Adding GTF2B to GRN, 
GTF2i, MST1/STK4 and SULF1, we were able to discriminate late stages C and D from early stages 
A and B with an AUC of 0.90 and 87% sensitivity for a fixed 90% specificity. 
Regarding comparison of protein expression systems, we found generally lower false positive rates 
when using Sf9 produced proteins, leading to higher specificities, although serum dilution and quantity 
of protein adsorbed needs to  be optimized case by case. 
By using different protein array technology as well as different expression platforms we have improved 
diagnostic performance and added prognostic abilities to previously described panel.
 Figure 1: Combined ROC 
 Curve for described diagnostic algorithm.
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ANALYSIS OF CONIDIAL GERMINATION OF Colletotrichum acutatum
Mohamed Rabie El-Akhal1, Thomas Colby2, Eva Liñeiro1, Jesús M. Cantoral1, Anne Harzen2, Jürgen Schmidt2 
and Francisco Javier Fernández-Acero1
1Microbiology Laboratory, Faculty of Marine and Environmental Sciences, University of Cádiz, Pol. Río San Pedro s/n, 
Puerto Real, Cádiz, Spain, 2Max Planck Institute for Plant Breeding Research, Mass Spectrometry Group, 
Carl-von-Linné-Weg, Cologne, Germany
One of the main problems in the actual agriculture is the appearance of fungal plant diseases that 
produces critical losses in the fields. Colletotrichum acutatum is an important phytopathogenic fungus 
causing anthracnose in commercially important fruit crops, especially in strawberry. The fungus uses a 
set of infection strategies to complete its infection cycle and avoid the activity of commercially available 
fungicides. IN this sense, conidia produced by the fungus are survival structures which play a key role 
in host infection and fungal propagation. Despite its relevance to the fungal life cycle, conidial biology 
has not been extensively investigated. 
We had developed a proteomic approach to provide the first description of the conidial proteome 
during germination process in C. acutatum. We had compared the proteomic profile of ungermina-
ted and germinated conidia by using a two-dimensional electrophoresis combined with MALDI-TOF/
TOF mass spectrometry. We have identified 365 proteins in 354 spots, which represent 245 unique 
proteins. We had identified some proteins with key functions in pathogenesis, while the role of most 
of them remains undilucidated.
All identified proteins have been classified according to their molecular function and their involvement 
in biological processes, including cellular energy production, oxidative metabolism, stress, fatty acid 
synthesis, protein synthesis and folding. This report constitutes the first comprehensive study of pro-
tein expression during the early stage of the C. acutatum conidial germination. It advances our un-
derstanding of the molecular mechanisms involved in the conidial germination process, and provides a 
useful basis for the further characterization of proteins involved in fungal biology and fungus life cycles.
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PROTEOMIC ANALYSIS (2D-DIGE and MS/MS) OF SERA AND LYMPHOYD ORGANS FROM 
COLLAGEN-INDUCED ARTHRITIC MICE 
Antonio Rosal-Vela1, Jorge Postigo2, Sonia García-Rodríguez1, María Victoria Longobardo3, Antonio Lario3, 
Ramón Merino4, Jesús Merino2, Mercedes Zubiaur1, Jaime Sancho1.
1 Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN), CSIC, Armilla (Granada), 2 Facultad de Medicina, Uni-
versidad de Cantabria, Santander, 3 Servicio de Proteómica, IPBLN, CSIC, Armilla (Granada), 4 Instituto de Biomedicina y 
Biotecnología de Cantabria, CSIC, Santander 
Introduction. Collagen-induced arthritis (CIA) in C57BL/6 (B6 WT) mice closely resembles human 
rheumatoid arthritis (RA) in terms of its disease course, histological findings and response to drugs 
treatment. We have recently reported that CD38 deficient mice (CD38ko) develop an attenuated form 
of CIA as compared with WT mice (Postigo et al., Mice Deficient in CD38 Develop an Attenuated Form 
of Collagen Type II-Induced Arthritis, PlosOne , 2012). 
Objetive. In this work we have performed a proteomic approach to identify CD38-dependent chan-
ges in protein abundance in CIA+ mice. To this end, proteomic analysis using 2D DIGE in serum and 
lymphoid organs such spleen and lymph nodes to differentiate between WT and CD38ko mice in CIA 
model.
Materials and Methods. Blood serum samples from WT and CD38 KO mice, which have immunized 
with chicken collagen type II, were treated with ProteoMiner beads to equalize protein concentrations 
and subjected to 2D-DIGE and MS-MALDI-TOF analysis.  Differential protein expression was validated 
by ELISA, or Western-blotting. Spleen and lymph nodes samples were disaggregated using MicroRo-
tofor Lysis kit (Bio-Rad) and subjected to 2D-DIGE and MS/MS analysis. First dimension were run on 
Protein IEF Cell and 2nd dimension on Criterion Dodeca Cell (BioRad). Gels were scanned with the 
Amersham Typhoon Imager 9410. Two variables were determined: affectation (affected vs unaffected) 
and mouse type (WT vs CD38ko) for two-way ANOVA analysis using DeCyder 7.0 software (GE). The 
EDA module 1.0 was used for multivariate analysis.
Results. Using multivariate analyses, 25 differentially expressed spleen proteins were able to discri-
minate between WT and CD38ko mice, while in lymph nodes 8 differentially expressed proteins could 
be used to differentiate whether mice were affected or not affected. In serum some proteins such as 
serum amyloid A, transthyretin, IgG, ficolin, complement C4b were overexpressed in affected WT 
as compared with affected CD38ko mice, while in the latter proteins related to apolipoproteins were 
found to be overexpressed; ELISA or Western Blot validated some of these differences. 
Conclusions. Multivariate analyses showed that there were some proteins differentially expressed 
in spleen and lymph nodes that could be used to distinguish whether mice were WT or CD38ko, or 
whether mice were affected or not, respectively. In contrast, multivariate analysis of serum proteins 
was not powerful enough to discriminate between these variables. However, most of the down-regu-
lated proteins identified in the sera of collagen-immunized CD38 KO mice are involved in inflammatory 
processes.  Some of them could be indicative of the relatively milder pathological process found in 
CIA+ CD38 KO than in WT mice. 
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SUBPROTEOME ANALYSIS REVEALS REMARKABLE DIFFERENCES IN PERIPLASMIC 
PROFILES OF Xanthomonas spp. DIFFERING IN VIRULENCE AND CITRUS-HOST RANGE
Zandonadi, F.S.1; Carnielli, C. M.1; Artier, J.2; Novo-Mansur, M.T.M1
1Laboratório de Bioquímica e Biologia Molecular de Microrganismos, Departamento de Genética e Evolução, UFSCar, São 
Carlos, SP, Brazil, 2Oklahoma State University, Stillwater, OK, USA.
Citrus canker is a disease caused by Xanthomonas spp, a Gram-negative bacterium, and its con-
trol could have an important impact in the economy of Brazil and other citrus producers around the 
world. The aim of this work was to perform differential proteomic analysis of the periplasmic protein 
profiles from the types A, B and C of Xanthomonas spp, which had their genome previously sequen-
ced. Whereas Xanthomonas citri subsp. citri (XAC) is the most virulent and infects all types of citrus, 
Xanthomonas fuscans subsp. aurantifolii (Xau-B) is less virulent and Xanthomonas fuscans subsp. 
aurantifolii (Xau-C) has a unique citrus-host. The bacteria were grown in XAM-1, which is known to 
be a pathogenicity-inducing medium for XAC, and in a non-inducing pathogenicity medium (Nutrient 
Broth, NB). Periplasmic proteins were separated by two- dimensional electrophoresis (2D-PAGE) and 
the gels were stained using Coomassie Brilliant Blue R-250 and documented. A comparative analysis 
of the protein profiles between XAC and Xau-B, and between XAC and Xau-C, grown in the same 
culture medium, was performed using ImageMaster Platinum software (GE Healthcare). Spots that 
showed a significant differential expression by statistical analysis (ANOVA, p <0.05) were isolated from 
gels and identified by ESI-QUAD-TOF mass spectrometry (LNBio, CNPEM-ABTLus, Campinas-SP, 
Brazil), using the respective databases. Differential expression for superoxide dismutase was confir-
med by Western blot. The results showed that XAC, Xau-B, and Xau-C have remarkable differences 
between the periplasm protein profiles in both conditions of growth, even though most genes related 
to the differential proteins are present in the genome of all of them. This work showed that the subpro-
teomic analysis of the periplasm is an important tool to differentiate the species of Xanthomonas spp 
(supported by FAPESP and Fundecitrus, Brazil).
Keywords: Citrus canker, Xanthomonas citri subsp. citri, Xanthomonas fuscans subsp. aurantifolii 
type B; Xanthomonas fuscans subsp. aurantifolii type C; pathogenicity; differential proteomic analysis, 
two-dimensional electrophoresis.
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SUBPROTEOME ANALYSIS IN Xanthomonas citri subsp citri PERIPLASM FOR HETEROLO-
GOUS EXPRESSION OF GENE PRODUCTS INVOLVED WITH PHYTOPATHOGENICITY
Goto, L.S.1; Artier, J2; Zandonadi, F.S.1; Alexandrino, A.V.1; Novo, M.T.M.1
1Laboratório de Bioquímica e Biologia Molecular de Microrganismos, Departamento de Genética e Evolução, UFSCar, São 
Carlos, SP, Brazil, 2Oklahoma State University, Stillwater, OK, USA
Citrus canker is an economically important disease that affects all citrus growing areas. There is no 
effective control or cure for such disease. The citrus canker causative agents are bacteria from the 
genus Xanthomonas. The most virulent strain is X. citri subsp. citri (XAC) which infects all types of 
citrus. Differential proteomic analysis of periplasmatic proteins from XAC was performed by compa-
rison of protein profiles after growth in pathogenicity- inducing medium (XAM1) or non-inducing me-
dium (Nutrient Broth) analyzed by two dimensional electrophoresis (2D-PAGE). Several spots showed 
significant differences on expression levels between the two conditions, which were digested with 
trypsin and analyzed by ESI-QUAD-TOF mass spectrometry (LNBio, CNPEM-ABTLus, Campinas-SP, 
Brazil). Data mining was performed based on annotations from XAC genome databases. Among XAC 
proteins identified as higher expressed in XAM1, two were classified as “Proteins involved with Patho-
genicity, Virulence, and Adaptation” (Genome annotation), namely superoxide dismutase (SOD, code 
XAC2386) and phosphoglucomutase (PGM, XAC3579). Such genes and proteins could be interesting 
targets for inhibition studies, as molecular markers in the development of canker control tools and for 
future functional studies, including gene knockouts. Furthermore, functional and structural studies on 
the proteins could provide additional knowledge about citrus canker infective process. For cloning 
purposes, oligonucleotides were designed to amplify both structural genes from XAC genomic DNA 
and engender recombinant expression systems. Molecular cloning and protein production were suc-
cessfully accomplished in E. coli. Both plasmidial clones were confirmed by complete DNA sequen-
cing and provide soluble homogeneous purified proteins.
Native SOD expression profiles were analyzed in pathogenicity- inducing medium or non-inducing 
medium by Western blot, confirming the SOD differential expression in XAC. Recombinant PGM is 
being used aiming production of antibodies.
Work is in progress and initial structural studies on both SOD and PGM are being conducted. Other 
differently expressed genes in Xanthomonas shall be cloned and their product studied. Defining pro-
tein targets in comparative proteomics and using recombinant expression for the study of such targets 
provided a valuable approach on understanding and hopefully helping on controlling the citrus canker.
(Supported by FAPESP, CAPES, Fundecitrus)
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CHROMOSOME 16 CONSORTIUM: CURRENT DEVELOPMENTS ON THE CHARACTERIZA-
TION OF THE PROTEINS ENCODED BY THE CHROMOSOME 16”
Fernando Corrales7; Juan Pablo Albar1; Joaquín Abián2; Francecs Canals3; Eliandre de Oliveira4; Jesus Mari 
Arizmendi5; Felix Elortza6; Francisco J. Blanco8; Manuel Fuentes9; Manuel Sánchez del Pino10; Silvia Barceló11; 
Ignacio Casal12; Fernando Vivanco13; Concha Gil14; Adolfo López de Munain15; Cristóbal Belda16; Manuel M. 
Morente17
1Centro Nacional de Biotecnologia, Madrid, Spain, 2Laboratorio de Proteómica CSIC-UAM, Barcelona, Spain, 3Hospital 
Universitario Vall d´hebron, Barcelona, Spain, 4Parque Científico de Bracelona, Barcelona, Spain, 5Universidad del Pais 
Vasco, Vizcaya, Spain, 6Centro de Investigacion cooperativa en Biociencias, Vizcaya, Spain, 7Centro de Investigación Mé-
dica Aplicada, Pamplona, Spain; 8Centro Hospitalario Universitario A Coruña, A Coruña, Spain, 9Centro de Investigación 
del Cáncer de Salamanca, Salamanca, Spain, 10Universidad de Valencia, Valencia, Spain, 11Instituto Aragonés de Ciencias 
de la Salud, Aragón, Spain, 12Centro de Investigaciones Biológicas, Madrid, Spain, 13Fundación Jiménez Díaz, Madrid, 
Spain, 14Parque Científico de Madrid, Madrid, Spain, 15Ciber Ned, San Sebastián, Spain, 16Hospital Universitario de La Paz, 
Madrid, Spain, 17Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
The Chromosome 16 Consortium is integrated in the global initiative Human Proteome Project that 
aims to develop an entire map of the proteins encoded following a chromosome-centric strategy (C-
HPP) to make progress in the understanding of human biology in health and disease (BD-CHPP). After 
several preliminary meetings, the kick-off workshop was held in Madrid on April 2012. The structure 
of the consortium involves 17 groups organized in four working sections, namely SRM and protein 
sequencing, antibody and peptide standard, clinical healthcare and biobanking and bioinformatics. 
During this meeting the general objectives, working plan and timeline of the project were defined.
A description of chromosome 16 based on knowledge repositories was presented; the chromosome 
contains 870 protein coding genes including 599 “known” and 271 “missing” gene products, partici-
pating in 110 OMIM diseases. Lymphocytes B, epithelial cells and fibroblasts were selected for further 
studies as transcriptomic evidences suggest that most chromosome 16 protein coding genes are 
expressed in these cell lines. For analytical purposes, the 870 proteins have been clustered in two 
groups according to the robustness of the evidences supporting their MS observation, using a cut-off 
log(e) value of -15 (562 proteins with log(e)<-15 and 300 with log(e)>-15). It is expected to set SRM 
assays for the top rank third of chromosome 16 proteins in both protein groups.
The process will be developed on a multicentric configuration, assuming the standards and integration 
procedures already available in ProteoRed-ISCIII, which are encompassed with HUPO initiatives. A 
biobanking initiative has been launched in collaboration with the Spanish National Biobanking Network 
to optimize methods for sample collection, management and storage under normalized conditions, 
and to define QC standards.
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CHROMOSOME 16. TRANSCRIPTOMIC AND SG PROTEOMIC PROFILING OF LYMPHOCY-
TE T JURKAT CELLS, MCF-7 EPITHELIAL CELLS AND CCD18 FIBROBLASTS
Elizabet Guruceaga1, Victor Segura1, Alberto Medina2, Salvador Martínez de Bartolomé2, C. González-Tejero2, 
Armando Moreno1, Manuel Sánchez del Pino3, Francecs Canals4, Manuel Fuentes5, Ignacio Casal6, Felix Elort-
za7, Jesus Mari Arizmendi8, Joaquín Abián9, Eliandre de Oliveira10, Concha Gil11, Fernando Vivanco12, Francisco 
J Blanco13, Jose María Mato7, Juan Pablo Albar2 and Fernando Corrales1
1Centro de Investigación Médica Aplicada, Pamplona, Spain, 2Centro Nacional de Biotecnologia, Madrid, Spain, 3Univer-
sidad de Valencia, Valencia, Spain, 4Hospital Universitario Vall d´hebron, Barcelona, Spain, 5Centro de Investigación del 
Cáncer de Salamanca, Salamanca, Spain, 5Universidad de Salamanca, Salamanca, Spain, 6Centro de Investigaciones 
Biológicas, Madrid, Spain, 7Centro de Investigacion cooperativa en Biociencias, Vizcaya, Spain, 8Universidad del Pais Vas-
co, Vizcaya, Spain, 9Laboratorio de Proteómica CSIC-UAM, Barcelona, Spain, 10Parque Científico de Bracelona, Barcelo-
na, Spain, 11Parque Científico de Madrid, Madrid, Spain, 12Fundación Jiménez Díaz, Madrid, Spain,13Centro Hospitalario 
Universitario A Coruña, A Coruña, Spain
To uncover the chromosome 16 associated proteome and to take advantage of the generated 
knowledge to make progress in human biology in health and disease, a consortium of 15 groups was 
organized in four working groups: SRM and protein sequencing, antibody and peptide standard, clini-
cal healthcare and biobanking and bioinformatics. According to a preliminary in silico study integrating 
knowledge from Ensembl, UniProtKB and GPMDB, Jurkat T lymphocyte cells, MCF-7 epitelial cells 
and CCD18 fibroblast are theoretically expected to express more than 70% chromosome 16 protein 
coding genes. To define in detail the molecular profile of the abovementioned cell lines, Affymetrix 
microarray based analyses and SG proteomics profiling were performed. a total of 19340 genes were 
expressed in at least one of the three cell lines, 82% were common, 1% were specifically detected 
in MCF7 cells, 2.6% in CCD18 and 0.9% in Jurkat cells. Up to 1533 genes from Chr16 were not de-
tected, most of these being non-protein coding genes. However, 84.6 % (736) of the Chr16 protein 
coding genes were detected among a total number of 18465 protein coding genes homogenously 
distributed across chromosomes with roughly 75% coverage in all cases with the only exception of 
chromosome Y. Assuming a FDR below 1% at the protein level, 9488 proteins were identified, 6092, 
5547 and 7197 in MCF7, CCD18 and Jurkat cells respectively, 40% commonly found in the three cell 
lines. The distribution of identified proteins across chromosomes is very dissimilar with chromosome 
coverage that was about 30%, in clear contrast with the transcriptomic results that showed coverage. 
Among the identified proteins, 388 are encoded by Chr16 genes, 155 were common to the three cell 
lines while 44 were only found in MCF7, 24 in CCD18 and 71 in Jurkat cells. Noteworthy, 9 of the 
identified proteins are among the group of missing proteins. The identified proteins represent a 44.6% 
coverage of Chr16 protein coding genes and correspond in all cell lines to proteins encoded by high 
expression genes with some exceptions, as might be expected.
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PROFILING THE CHROMOSOME 16 BY HIGH-RESOLUTION 
DATA-DEPENDENT MASS SPECTROMETRY
González-Tejedo C1*, Gharbi SI1*, Martínez G1, Navajas R2, Martínez-Bartolomé S2, Medina-Aunon JA1, 
Alpízar A, Paradela A2,  Marcilla M1, Corrales FJ3 and Albar JP1,2
1Proteomics Laboratory, Centro Nacional de Biotecnología - CSIC, Madrid, Spain, 2ProteoRed-ISCIII, Centro Nacional 
de Biotecnología - CSIC, Madrid, Spain, 3ProteoRed-ISCIII, CIMA, University of Navarra, Pamplona, Spain, *This authors 
contributed equally to this abstract
The Spanish Chromosome 16 Consortium forms part of the global initiative Chromosome-based Hu-
man Proteome Project (C-HPP), which aims to map the gene-coded proteins on each human chro-
mosome to complement our understanding of the human biology in health and disease (B/D-HPP). 
The project is based on a multicenter configuration, adopting the general rules established for the 
HPP.
To characterize the proteome of chromosome 16 (Chr16), we are defining a comprehensive proteomic 
map based on high-resolution data dependent mass spectrometry. This study will permit to assist the 
development of MRM methods for quantitative targeted analyses.
An initial in silico study showed that lymphoid tissues expressed at least 75% of the total (n=870) 
protein coding genes of Chr16. We are dissecting the human T lymphoblast cell line (Jurkat T cells) 
using in a first instance a MUDPIT type approach, with in-solution digestion and off-line pre-fractio-
nation by basic-RP-HPLC. Then, to gain better insight into integral membrane proteins, our analysis 
is combined with strong detergent protein extraction and 1D-gel-digestion. In all our workflows, data 
is acquired using a 5600 TripleTOF LC-MS/MS system (AB SCIEX) on long HPLC runs. Data genera-
ted from these experiments is analyzed using our in-house ProteoRed MIAPE-Extractor tool, http://
www.proteored.org/miape, which not only allows data calculations, data set comparisons and general 
analyses in an efficient way; but also extracts specific MIAPE information relative to Chr16.
The different proteomic approaches conducted and their biological replicates have led to the iden-
tification of more than 12,000 proteins in Jurkat T cells, assuming a FDR below 1% at protein level. 
Among the identified proteins, 447 are encoded by Chr16 genes, reaching near 50% coverage of 
Chr16 protein coding genes. Optimization of sample preparation to better extract membrane pro-
teins, fractionation procedures to enrich low abundance proteins and definition of additional cell lines 
and environmental conditions are key aspects to take into account to extend our Chr16 proteome 
coverage.
Finally, we show that these ongoing shotgun experiments are providing important hints to establish 
and optimize S/MRM methods for all proteins coded by Chr16 genes.
P44PS3 Disease Proteomics
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UNRAVELING SEROLOGIC RESPONSE TO THE CANDIDA ALBICANS CELL SURFACE-AS-
SOCIATED IMMUNOME DURING YEAST-TO-HYPHA TRANSITION IN INVASIVE 
CANDIDIASIS PATIENTS
Aida Pitarch, César Nombela, Concha Gil
Department of Microbiology II, Faculty of Pharmacy, Complutense University of Madrid and IRYCIS, Madrid, Spain 
Invasive candidiasis (IC) is a leading infectious cause of disease and death in cancer, post-surgical and 
intensive care patients because its early diagnosis is extremely difficult, resulting in delayed therapy 
and ensuing fatal outcomes. Better diagnostic biomarkers for invasive candidiasis (IC) are therefore 
needed to tailor and individualize therapeutic decision making and minimize its high morbidity and 
mortality. We investigated whether profiling of IgG antibody response to the Candida albicans cell 
surface-associated immunome during yeast-to-hypha transition (an important virulence factor) in IC 
might uncover molecular fingerprints of invasive infection and C. albicans morphogenesis. To address 
this goal, we performed 2-DE followed by Western blotting with human sera, mass spectrometry and 
bioinformatic analyses to examine serum IgG antibody-reactivity patterns to C. albicans yeast and 
hyphal cell surface-associated proteins (Y-CSPs and H-CSPs, respectively) in IC and non-IC patients 
as well as capture ELISAs to validate immunoproteomics-based results. A total of 28 immunogenic 
CSPs were differentially detected in yeast and hyphal forms by serum IgG antibodies from IC patients. 
Unsupervised clustering methods revealed two IgG antibody-reactivity signatures that segregated IC 
specimens hybridized with Y-CSPs and H-CSPs into two distinct groups. Pairwise correlation map-
ping across serum samples further highlighted that distinct biologic changes underlay commensal-
to-pathogen and yeast-to-hypha transitions. These 28-IgG antibody-reactivity profiles could also ac-
curately discriminate IC from non-IC patients. Supervised classification analyses with leave-one-out 
cross-validation identified a 3-IgG antibody-reactivity signature as the best diagnostic predictor of IC. 
By using capture ELISAs, we validated its discriminatory power in an independent group of IC and 
non-IC patients. Our findings provide a molecular signature of IC that may early and accurately discri-
minate IC from non-IC patients. These further offer new insights into pathogenic processes triggered 
during dimorphic transition and IC pathogenesis.
This work was supported by Spanish Network for the Research in Infectious Diseases (REIPI 
RD06/0008/1027); the Interministry Commission of Science and Technology (BIO-2009-07654) and 
the Community of Madrid (S2010/BMD-2414 PROMPT-CM), Spain.
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MOLECULAR PROFILING OF SEROLOGIC RESPONSE TO CANDIDA ALBICANS SOLUBLE 
PROTEINS IN NON-NEUTROPENIC PATIENTS WITH INVASIVE CANDIDIASIS
Aida Pitarch, César Nombela, Concha Gil
Department of Microbiology II, Faculty of Pharmacy, Complutense University of Madrid and IRYCIS, Madrid, Spain
Early diagnosis of invasive candidiasis (IC) in non-neutropenic patients is crucial for a successful cli-
nical outcome in such patients. However, it still remains a challenging task for physicians. In order to 
identify and validate useful serological biomarkers for early IC detection in this group of patients, sero-
logical proteome analysis and computational biology tools were applied to profile serum IgG-antibody 
reactivity to Candida albicans soluble proteins in non-neutropenic patients with and without IC. A total 
of 18 immunogenic C. albicans soluble proteins were differentially recognized by serum IgG antibodies 
from non-neutropenic IC patients as compared to controls. Unsupervised two-way hierarchical cluste-
ring and principal-component analyses of these 18-IgG antibody-reactivity patterns discriminated IC 
patients from controls reliably and independently of baseline characteristics of the study population. 
Selected biomarker candidates were then expressed in a heterologous system and validated using 
established prototype immunoassays in an independent non-neutropenic patient cohort. Receiver-
operating-characteristic curve analyses highlighted that this panel of selected biomarkers showed 
a good ability to discriminate IC from non-IC patients. Multivariate logistic-regression models further 
revealed a positive association between the IC risk and this panel that was unbiased by traditional cli-
nical IC-risk factors and other patients-related variables. We conclude that if confirmed in prospective 
cohort studies, this subset of clinical biomarkers may be valuable for early and accurate diagnosis of 
IC in non-neutropenic patients. In addition, this panel may also be useful in complement blood cultures 
for early IC detection in these high-risk patients because these selected serological biomarkers were 
identified in the absence of candidemia. Our findings further uncover new biologic perspectives into 
antibody response to IC.
This work was supported by Spanish Network for the Research in Infectious Diseases (REIPI 
RD06/0008/1027); the Interministry Commission of Science and Technology (BIO-2009-07654) and 
the Community of Madrid (S2010/BMD-2414 PROMPT-CM), Spain.
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PROTEIN PROFILES DERIVED FROM DIET AND EXERCISE: CAN WE TAKE THEM 
AS MOLECULAR SIGNATURES OF VASCULAR WELLNESS? 
Mª Carmen Durán1,2, Rocio Toro3, Jose A. Alonso2, Digna Corrales3, Eduardo Segura3, 
Francisco J. García-Cozar1,2, Alipio Mangas3. 
1 Dpto. Biomedicina, Biotecnología y Salud Pública, Universidad de Cádiz, 2 Unidad Investigación Hospital Universitario 
Puerto Real, 3 Dpto. Medicina. Hospital Universitario Puerta del Mar, Cádiz 
Diet and exercise constitute two of the main pillars in preventing and treating cardiovascular diseases. 
Despite of this assumption, the molecular mechanisms ultimately responsible behind the assigned 
beneficial effects remain unclear. The aim of the present study was to detect protein changes reflecting 
an improved physical condition in response to diet/exercise and to identify those proteins that could 
participate in maintaining vascular wellness. 
In the present study, 44 rugby players (all healthy, with not cardiovascular risk) enrolled in a 6 month 
diet intervention program, following either a hyperproteic diet with low glucemic index (PD), or a stan-
dard Mediterranean diet (MD) in parallel to their training season. Blood and urine samples were collec-
ted on day 0 and 6 months later. Plasma was obtained by centrifugation and both, plasma and urine 
were aliquoted and stored at -80C. Anthropometrical data and exercise intensity were also recorded. 
Only 26 rugby players completed the study: 10 following PM, 12 following the MD and 4 players that 
didn´t follow any specific diet. 
Protein profiles in both plasma and urine were analysed using a Surface-Enhanced Laser Desorption 
and Ionization Time of Flight (SELDI-TOF) mass spectrometer. Strong anion exchange (Q10) affini-
ty array was selected for the study, allowing the detection of a high number of protein peaks. For 
protein identification, a complementary approach using same anion exchange chromatography (Q1) 
was employed, and fractions were separated by SDS-PAGE gels for protein identification by mass 
spectrometry.
Anthropometrical data didn´t show significant differences between diets or exercise intensity. Never-
theless, independently of diet, a low body mass gain was seen, related with increase of muscle and 
body fat decreasing, with a general better outcome for those following the MD.  
SELDI data confirmed the lack of statistical significant differences between diets or due to exercise 
intensity. However, individuals were clearly clustered when comparing protein profiles regarding body 
changes, distinguishing 2 groups: players gaining or losing weight, with those maintaining weight 
(<1.5 kg difference) distributed in both groups. Protein peaks with p-values <0.05 showed six main 
behaviors regarding weight changes. Interestingly, individuals maintaining weight behaved in a particu-
lar manner versus gain/loss of weight. A tentative identification of such proteins have been made using 
TagIdent tool with some of the proteins being involved in glucose/fat metabolism, appetite regulation 
or hearth functioning. Further confirmation of the identity by using liquid chromatography and MALDI-
TOF/TOF is in progress.  
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HLA-DR-ASSOCIATED HUMAN THYMUS PEPTIDOME IS MAINLY COMPOSED OF HIGH-
AFFINITY PEPTIDES 
RUNNING TITLE: HLA-DR PEPTIDE REPERTOIRE IN HUMAN THYMUS
Javier A. Collado1,*, Iñaki Alvarez1,*, M. Teresa Ciudad1, Gabriel Espinosa1, Francesc Canals2, 
Ricardo Pujol-Borrell3, Montserrat Carrascal4, Joaquín Abian4 and Dolores Jaraquemada1
1Immunology Unit, Institut de Biotecnologia i de Biomedicina (IBB), Departament de Biologia Cel·lular, Fisiologia i Immu-
nologia (BCFI), Universitat Autònoma de Barcelona (UAB), Campus de Bellaterra, 08193 Barcelona, Spain, 2Vall d’Hebron 
Institute of Oncology (VHIO) and 3Immunology Department, BCFI, UAB, Hospital Universitari Vall d’Hebron, Barcelona, 
Spain and 4CSIC/UAB Proteomics Laboratory, IIBB-CSIC, IDIBAPS, Facultat de Medicina, UAB, Campus de Bellaterra, 
08193 Barcelona, Spain, * These authors contributed equally to this work
Major histocompatibility complex class II (MHC-II) molecules associate to and display antigenic pep-
tides on the surface of antigen-presenting cells (APC). In thymus, self-peptides associate to MHC-II 
molecules expressed by defined populations of APCs, specialized in different steps of T cell selection. 
Cortical epithelial cells show a distinct processing machinery that may allow the generation of unique 
peptides for positive selection. Medullary epithelial cells transcribe genes that are restricted to periphe-
ral tissue, presumably generating proteins and making their peptides available for negative selection. 
Dendritic cells can present material from the thymus environment and from the periphery. Very few 
data are however available on the peptides being presented by MHC molecules in the thymus. Here 
we report the application of mass spectrometry to analyze and identify MHC-II-associated peptides in 
five fresh human thymus samples. The data show a diverse self peptide repertoire, mostly constituted 
by predicted MHC-II high binders. 
These data constitute a first direct assessment to HLA-II bound peptidoma and provides an insight 
into how it is generated and how it drives T cell repertoire formation. 
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COMPARATIVE PROTEOMIC ANALYSIS OF SECRETED PROTEINS AND EXTRACELLULAR 
VESICLES FROM CANDIDA ALBICANS ECM33∆ MUTANT AND SC5314 WILD TYPE STRAIN
A. Gil-Bona, L. Monteoliva, C. Gil.
Dpto. Microbiología II, Universidad Complutense, Madrid, Spain
Candida albicans is a dimorphic fungus member of the human microbiota that causes a range of 
opportunistic infections from superficial to systemic. C. albicans Ecm33p is a glycosylphosphatidyli-
nositol-linked cell wall protein that is important for cell wall integrity and critical for normal virulence 
in the mouse model of hematogenously disseminated candidiasis.1,2 The ecm33Δ mutant (RML2U) 
presents an altered cell wall and aberrant morphology. Furthermore, it was shown that vaccination of 
BALB/c mice with this mutant protected them from a subsequent lethal infection with the virulent stra-
in SC5314 in a systemic candidiasis model. As the cell wall proteins of the mutant strain are involved in 
host immune response a comparative study between mutant and parental strain surfomes was carried 
out revealing a completely different protein profile: ecm33Δ presented a larger number of proteins that 
the wild type what could elicit the high protective ability shown3. Interestingly, proteins involved in cell 
wall organization and biogenesis are the only ones that are less abundant in the mutant. This might be 
due to the relevance of Ecm33p function for the anchoring of covalently cell wall proteins. To validate 
this hypothesis we are currently doing a comparative analysis of C. albicans wild type and mutant se-
cretome. Cells grown in minimal medium to exponential phase were harvested by centrifugation and 
the resulting supernatants were concentrated and analyzed by LC-mass spectrometric.
On the other hand, in recent years extracellular vesicles have been describe as a general mechanism 
in the molecular traffic across the cell wall to the extracellular space in  fungi, being important contri-
butors in the pathogenic process4. Transmission electron microscopy (TEM) of C. albicans cultures 
revealed the presence of intact vesicles that could be important in the transport of proteins related with 
virulence and host immune response. In this work, we also purified extracellular vesicles from ecm33Δ 
mutant and wild type cultures by ultracentrifugation of supernatants. The subproteome of these vesi-
cles is analyzed by MS after their purification.
1 Martinez-Lopez, R., et al.,  2004. Microbiology 150:3341-3354. 
2 Martinez-Lopez, R., et al., 2006. Eukaryotic cell, 2006: 140–147.
3 Martinez-Lopez, R., et al., 2008. Proteomics, 8: 2651-64.
4 Albuquerque, PC., et al., 2008. Cell Microbiol 8: 1695-710.
120
COMPREHENSIVE CHARACTERIZATION OF THE PEPTIDOME AND PHOSPHOPEPTIDOME 
DISPLAYED BY THE HUMAN LEUKOCYTE ANTIGEN (HLA)-B*40:02 
Miguel Marcilla, Adán Alpízar, Manuel Lombardía and Juan Pablo Albar
Proteomics Unit. Centro Nacional de Biotecnología (CSIC). Madrid
HLA class I molecules bind peptides derived from proteolytic degradation of endogenous proteins 
and present them to cytotoxic T lymphocytes, allowing the immune system to detect transformed or 
virally infected cells. The peptide pool presented by a particular HLA allotype consists on up to 10000 
different peptides which share specific structural motives that determine its binding to the class I mo-
lecule. Posttranslational modifications are known to be present in some class I ligands. In this regard, 
phosphorylated peptides have raised much interest as potential targets for cancer immunotherapy 
since aberrant protein phosphorylation is a hallmark of tumor cells.
Using HLA-B*40:02 as a model molecule and combining affinity purification and high resolution mass 
spectrometry we have identified more than 2000 different ligands (FDR < 5%). Sequence analysis 
of this set of ligands revealed two strong anchor motives: Acidic residues at peptide position 2 and 
methionine, phenylalanine or aliphatic residues at the peptide C term. After IMAC and TiO2 enrich-
ment, about 100 phosphorylated ligands were identified. To avoid false identifications every peptide 
sequence of this subset was further confirmed by comparing its experimental MS/MS spectrum with 
that obtained upon fragmentation of the corresponding synthetic phosphopeptide.
We suggest that high throughput identification of HLA class I bound ligands combined with phos-
phopeptide enrichment may be a useful approach to identify targets for T cell based immunotherapy.
P50PS3 Disease Proteomics
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SELF-ASSEMBLED PROTEIN ARRAYS FROM AN ORNITHODOROS MOUBATA 
SALIVARY GLAND EXPRESSION LIBRARY AND ITS APPLICATION TO STUDY 
THE TICK-HOST INTERPLAY
Verónica Díaz-Martín, Raúl Manzano-Román, Manuel Fuentes*, Ana Oleaga, Eduardo de la Torre, Ricardo 
Pérez-Sánchez
Instituto de Recursos Naturales y Agrobiología (IRNASA-CSIC), Salamanca,Spain. *Centro de Investigación del Cáncer 
(USAL-CSIC), Salamanca, Spain.
Protein interactions play a critical role in the regulation of many biological events and their study in a 
high-throughput format has become a key area of proteomic research. Nucleid Acid Programmable 
Protein Arrays (NAPPA) technology allows the construction of protein arrays from cDNA expression 
libraries in high-throughput cell-free systems to study protein interaction and functions. 
Tick saliva contains anti-haemostatic, anti-inflammatory, and immunosuppressive proteins that coun-
teract the host haemostatic, immune, and inflammatory responses allowing the ingestion of host 
blood and facilitating host infection by the tick-borne pathogens. Identification of such proteins and 
their functions could help in the selection of antigenic targets for the development of anti-tick and 
transmission-blocking vaccines. With that aim, we have prepared a cDNA expression library from 
the salivary glands of Ornithodoros moubata, which is a vector of Human relapsing fever and African 
swine fever, and subsequently produced a self-assembled protein microarray using 480 randomly 
selected clones from that library. The reproducibility of the array, its representativeness of the tick 
salivary protein repertoire, and the functionality of the in situ expressed proteins have been checked, 
demonstrating that it is a suitable tool for the identification and functional characterization of soft tick 
salivary molecules that interact with host proteins.
The array was screened for P-selectin ligands and several clones in the array were shown to bind to 
human recombinant P-selectin. One of them was a likely secreted tick phospholipase A2, which may 
represent a potential new ligand for P-selectin. As these salivary molecules are likely involved in blood 
meal acquisition through the modulation of the host immune and haemostatic responses, this new 
high-throughput tool could open new avenues for development of new therapeutic agents and control 
strategies against ticks and tick-borne pathogens.
Financial support: Spanish Ministry of Science and Innovation (project AGL2010-18164), Instituto de Salud Carlos III of Spain (ISCIII, project 
FIS PI081884) and Regional Government of Castilla y León (projects CSI062A11-2 and JCYL-SAN10).
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HIGH RESOLUTION HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY MAPS 
CONTACT SURFACES OF VEGF AND A NOVEL RECOMBINANT MONOCLONAL ANTIBODY 
FRAGMENT 
1Marina Gay, 2Andrey Dyachenko, 1Claudio Diema, 1Mar Vilanova, 2Michael Goldflam, 3Humberto Lamdan, 
2Ernest Giralt, 3Gabriel Padrón, 1Marta Vilaseca
1Mass Spectrometry Core Facility, Institute for Research in Biomedicine, IRB Barcelona, 2Institute for Research in Biomedi-
cine, IRB Barcelona, Barcelona, Spain, 3Centro Ingeniería Genética y Biotecnología, CIGB, La Habana, Cuba
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific angiogenic and vasculogenic 
mitogen. VEGF also plays a role in pathogenic vascularization which is associated with various clinical 
disorders, including cancer and rheumatoid arthritis.
A novel recombinant monoclonal antibody has been designed as a VEGF antagonist, preventing its 
interaction with its receptors and therefore acting as a potential drug for cancer treatment. The anti-
body fragment recognizes the VEGF dimer exclusively but its binding site to VEGF is not yet known. 
Mapping the antigen epitope is a key step in defining antibody specificity, predicting cross-reactivity, 
in assay development, rational vaccine design, and in understanding the fundamental aspects of 
protein-protein interactions.
Amide hydrogen/deuterium exchange (HDX) coupled with proteolysis and high resolution MS has be-
come a powerful method to study protein dynamics, protein-ligand interactions, and protein-protein 
interactions. In general, when performing antigen-antibody experiments by HDX-MS, regions of the 
antigen with different deuterium content in the presence or absence of the antibody are defined as 
the epitope.
In this study, we have designed two complementary labeling strategies to get insight into the VEGF 
interaction sites with the antibody fragment. Strategy 1 performs the deuterium labeling of VEGF and 
Mab separately, before inducing their interaction. The complex is then incubated in aqueous buffer, 
therefore interchanging all deuterium except those in the binding regions and in other protected re-
gions due to the tridimensional structure of the complex. Strategy 2 induces the complex first and than 
performs deuteration. In this case, non labeled regions would indicate VEGF-Mab sites of interaction 
and other protected regions, including the surface contact regions between monomers. Deuterated 
and non-deuterated control experiments of VEGF were also performed in the absence of the antibo-
dy. Here we performed a semi simultaneous reduction and digestion after H/D exchange and under 
quench conditions (0 ºC, pH 2.5). On-line desalting was then carried with an in-house double valve 
system, servicing a trapping and analytical column for sample resolution. All system was maintained 
at 0 ºC and column eluent was coupled to an LTQ-FT Ultra mass spectrometer. Data processing was 
done with HDX Sierra Analytics software. Percentage of deuteration for each region of the protein 
was calculated by comparing the results of the HDX experiments and putative regions of interaction 
VEGF-Mab were determined.
It is the first time that VEGF has been studied by HDX-MS and that this methodology has been applied 
to determine the epitope of VEGF against a monoclonal antibody fragment.
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COMPLEMENTARY ACTION OF CASPASES 3 AND 7 IN THE BREAKDOWN OF BOVINE AND 
PORCINE MYOFIBRILAR MUSCLE PROTEINS
Rosa A. Rodríguez-Frómeta1, Jesús Rodríguez-Díaz1, Enrique Sentandreu, Ahmed Ouali2, 
and Miguel A. Sentandreu1* 
1 Instituto de Agroquímica y Tecnología de Alimentos (CSIC). Avenida Agustín Escardino, 7. 46980 Paterna (Valencia), 
Spain, 2 UR370, QuaPA, INRA de Clermont Ferrand Theix, St. Genès Champanelle, France.
The conversion of muscle into meat is a complex process in which numerous biochemical reactions 
are involved. Among them, the hydrolysis of structural proteins by the action of endogenous muscle 
enzymes is in direct relation to the development of meat tenderness. Recent investigations have de-
monstrated the onset of apoptosis in post-mortem muscle cells and how this can influence the final 
quality of meat. Programmed cell death or apoptosis is mediated by the action of caspases, a parti-
cular group of enzymes that are in charge of cell dismantling. 
In this work, we report the selective and complementary action of effectors caspases 3 and 7 on the 
hydrolysis of myofibrilar muscle proteins. Thus, bovine and porcine muscle protein extracts were in-
cubated in the presence of recombinant purified caspases 3 or 7 for a period of 48 h. Changes in the 
protein profiles after incubation were monitored by SDS-PAGE. Identification of both intact proteins 
and peptide fragments generated by the proteolytic action of caspases was carried out by in-gel tryp-
sin digestion of bands, followed by peptide analysis on a LC-ESI-Ion Trap MS equipment and further 
identification using the mascot search engine. 
Between the main observed actions of caspases, it is worth highlighting the selective action on myosin 
heavy chain, which was effectively degraded by caspase 7 but not by caspase 3. However, the main 
hallmark of caspase-mediated proteolysis was the generation of a polypeptide of around 30 kDa, 
generated from both bovine and porcine muscle extracts in the presence of either caspase 3 or 7. 
Proteomic analysis revealed that this characteristic fragment was the product of actin degradation in 
all cases. On the other hand, a protein band of around 22 kDa was observed to be highly hydrolysed 
by caspase 3 in both bovine and porcine muscle extracts, which was not the case for caspase 7. 
The present work represents an important advance in exploring the potential consequences that 
apoptosis can have in post-mortem muscle in relation to caspases proteolytic action, selective degra-
dation of the muscle protein structure, development of meat tenderness and final meat quality. 
Acknowledgements 
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A CANDIDA ALBICANS PEPTIDEATLAS
Vital Vialas1,2, Zhi Sun3, Eric W. Deutsch3, Ruedi Aebersold4,5,6, Robert L. Moritz3, Concha Gil1,2
1 Dept. Microbiología II.Universidad Complutense de Madrid, Madrid, Spain, 2 IRYCIS: Instituto Ramón y Cajal de Investi-
gación Sanitaria, Madrid, Spain, 3 Institute for Systems Biology, Seattle, WA, USA, 4 Institute of Molecular Systems Biology, 
ETH Zurich, Zurich, Switzerland,  5 Faculty of Science, University of Zurich, Zurich, Switzerland, 6 Competence Center for 
Systems Physiology and Metabolic Disease, ETH Zurich,  Switzerland
Candida albicans is an organism of great clinical importance since, despite asymptomatically coloni-
zing mucoses of 30 to 50% of the population 1, it may cause opportunistic infections in specific cases 
such as weakened host immune defenses, a common circumstance in cancer and AIDS patients as 
well as in post-chirurgical and lC units stays. However, this clinical relevance is not reflected in the 
number of large-scale publicly available proteomics resources which is currently still very limited. We 
announce here the creation of a C. albicans PeptideAtlas 2 comprising 21938 distinct peptides at a 
0.24 % false discovery rate (FDR) that account for 2562 canonical proteins at a 1.2% FDR distributed 
across 16 experiments, attaining a coverage of 41.17% of the 6223 C. albicans open reading frame 
sequences in the database used for the searches. This C. albicans PeptideAtlas will provide a number 
of useful features, like comprehensive protein and peptide-centered data exploration tools, and it will 
stand as a valuable resource to assist SRM experiments aiding in the selection of candidate proteo-
typic peptides. 
To construct the C. albicans PeptideAtlas, a target fasta database was first built using sequences from 
the Candida Genome Database and appending them with cRAP contaminants and corresponding 
reversed decoy sequences. MS raw data were processed with the Trans-Proteomic Pipeline (TPP)3, 
a suite of software tools for processing shotgun proteomics datasets.  Briefly, X! Tandem with the k-
score algorithm identifies the highest scoring peptide for each spectrum, PeptideProphet calculates 
probabilities of correct identification for each spectrum, iProphet combines evidence from multiple 
identifications of the same peptide across spectra, experiments and charge and modification states, 
ProteinProphet performs statistical validation at protein level. Finally MAYU estimates FDR at the di-
fferent levels.
The PeptideAtlas build also provides the cumulative number of peptide and proteins across the experi-
ments, information on protein to genome location mappings and the peptides empirical and predicted 
proteotypic scores ESS and PSS.
Additionally, and due to the particularly rich number of identifications in experiments aimed at de-
tection of phosphorylated proteins, we have created a similarly processed version of the C. albicans 
PeptideAtlas including in this case PTMprophet results that provide, alongside each modified residue, 
the probability that the post-translational modification is truly detected at that site.
The current version of the C. albicans PeptideAtlas will be available at:
https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/buildDetails?atlas_build_id=323
and the C. albicans PeptideAtlas version including PTM results at:
https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/buildDetails?atlas_build_id=324
1 Cheng SG, Joosten LA, Kullberg BJ, Netea MG.  2012. Interplay between Candida albicans and the mammalian innate host defense. Infect. 
Immun. 80:1304-13
2 Deutsch E.W., Lam H., Aebersold R., PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows, 2008, 
EMBO Reports, 9, 429
3 Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, Tasman N, Sun Z, Nilsson E, Pratt B, Prazen B, Eng JK, Martin DB, Nesvizhskii 
AI, Aebersold R. 2010. A guided tour of the Trans-Proteomic Pipeline. Proteomics. 10:1150-1159
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DEVELOPMENT OF A SEMANTIC WIKI-BASED LIMS FOR PROTEOMICS LABORATORIES 
THAT SUPPORT EXPERIMENT AND SAMPLE TRACKING
Mancuso F. M.1,2; Hermoso Pulido A.2; Roma G.2; Molina H.3; Lowy E.2; Sabido E.1
1 Proteomics Unit, Centre for Genomic Regulation (CRG) and UPF, Dr. Aiguader 88, 08003 Barcelona, Spain, 
2 Bioinformatics Unit, Centre for Genomic Regulation (CRG) and UPF, Dr. Aiguader 88, 08003 Barcelona, Spain, 
3 Rockefeller University, New York, NY
In the last years, the unprecedented throughput, the experimental complexity, and the rapid changes 
in the proteomics field led to an exponential increase on experimental data.  It is crucial for researchers 
to store and track all these data, their derived processed files, and their associated experimental me-
tadata, and to retrieve them anytime. For these reasons, a dedicated laboratory information manage-
ment system (LIMS) that reflects the particularities of the proteomics experiments is highly required to 
facilitate the aforementioned data handling, and to accommodate the quality assurance requirements 
demanded for data publication.
ProteoWiki is a Semantic MediaWiki implementation to streamline generation, management, and 
analysis of proteomics data. In this system, users can enter information about their samples and the 
analyses to be performed by using a semantic-enabled form built on top of a wiki page. After sub-
mitting an on-line request, a workflow is created, and different experimental tasks are assigned to the 
lab operators. Users and operators, according to their profile and granted permissions, can track the 
state of the requests and the associated experiments at any time. The final output is the generation of 
a report that summarizes all the steps and parameters in analyzing proteomics samples, while keeping 
track of the original files.
User management, sample tracking, task assignment and lab scheduling, are all automated proces-
ses in ProteoWiki, thus highly improving laboratory efficiency, increasing throughput and ensuring data 
traceability for the final user. 
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SMART HYDROGEL PARTICLES TO DEPLETE PLASMA SAMPLES
Gerard Such-Sanmartín* 1, Estela Ventura Espejo, Ole N. Jensen 1
1 Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense 
M, Denmark
Plasma proteomics represents a challenge due to the extreme dynamic range of plasma, with high 
abundant proteins such as albumin accounting for more than 50 % of total protein content. Typica-
lly, depletion or fractionation steps are required prior LC-MS/MS analysis to have access to the low 
abundant sub-proteome.
N-isopropylacrylamide-based hydrogel particles have raised a high interest based on their dynamic 
characteristics, with a size and structure sensitive to external stimulus such as temperature or chan-
ges of pH. Mainly focused in drug release applications, in proteomics these have been employed as 
a cut-off filter with a pore size small enough to trap only the low MW proteins (Luchini et al, 2008).
Here, we report the use of pH-sensitive N-isopropylacrylamide hydrogel particles copolymerised with 
acid acrylic to effectively deplete albumin from human plasma samples. Once particles are incubated 
with the sample, most of proteins are effectively harvested within minutes into the acrylamide mesh. 
However, at concentrations higher than a fixed threshold, albumin gets irreversibly trapped inside par-
ticles. Within the elution step, the rest of the proteins are released from particles to be further analysed. 
Here, standard proteomic bottom-up analysis of the depleted mixtures has demonstrated the utility 
of this approach.
127
5th Congress of the Spanish 
Proteomics Society. 
Time to Imagine
P57PS6 Emerging Technologies
DIFFERENTIAL ANALYSIS OF THE PROTEOME OF Saccharomyces bayanus var. uvarum 
INDUCED BY TEMPERATURE, AND ITS INFLUENCE IN WINE QUALITY
Eugenia Muñoz-Bernal, María Esther Rodríguez, María Bernal, Jesús Manuel Cantoral, Francisco Javier Fer-
nández-Acero
Laboratory of Microbiology, Faculty of Marine and Environmental Sciences, Andalusian Center for Wine and Grapevine 
Research. University of Cádiz, Puerto Real, Cádiz, Spain
Nowadays, due to the increasing competitiveness in the international wine market, it is necessary 
a process of continuous improvement in the winemaking facilities and processes. These advances 
include, between others, the introduction of new varieties of white and red grapes to improve the 
fermentation process. However, to gain specificity and distinction in wines is essential to develop a 
broad knowledge of microbiological fermentation. Moreover, it is also necessary the development of 
criteria to select the most appropriate fermentation yeast and to study its fermentative behavior during 
the process. 
Our group has been developing several studies to analyze the diversity of yeasts involved in the wine 
making process that are of responsible of wine taste and complexity. During one of these projects, we 
isolated Saccharomyces bayanus var. uvarum from autochthonous microbiome of red wines in “Ribe-
ra del Duero” (Spain) winery during several vintage samplings. This strain has shown a great oenologi-
cal interest, due to posses the ability to grown at low temperatures fermenting the must. It provides to 
the obtained wine of high-valuable sets of aromatic compounds, increasing its organoleptic qualities. 
To detect the proteins involved in this process, we prepared two different wine fermentations of 
synthetic must, at two different temperatures, 13 °C and 25 °C. After protein extraction, we develop 
two different analyses, qualitative and quantitative, both in collaboration with “Cambridge Centre for 
Proteomics” (University of Cambridge). For the study of the qualitative analysis was used Coomassie 
staining and MALDI TOF/TOF mass spectrometry, with the identification of 71 differential spots. The 
quantitative study was conducted using 2DE-DIGE, being 51 the number of identified spot (up or 
down-regulated). The relevance of this identification in the winemaking process and wine quality is 
now under molecular analysis. 
The main aim of the present project is to detect those differential proteins at two different temperatu-
res, 13 °C and 25 °C and study its influence in winemaking process. By determining these proteins we 
will develop new strategies to improve the winemaking process, i.e. as markers for select yeast with 
better qualities, or those proteins involved in the wine bouquet. As far as we know, there is not pre-
vious report about proteomic approaches of S. bayanus var. uvarum, that seems to direct the initials 
steps of must fermentation where the aromatic profile is forming.
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EFFECT OF MATRIX DEPOSITION TECHNIQUES IN THE ACHIEVED LATERAL RESOLUTION 
IN MALDI IMAGING MASS SPECTROMETRY (MALDI-IMS)
Ibon Iloro1, Maren Ortiz-Zarragoitia2, Urtzi Izagirre2, Javier Calvo3 and Felix Elortza1
1 Proteomics Platform, ProteoRed-ISCIII. CIC bioGUNE, CIBERehd, Technological Park of Bizkaia, 48160, Derio, Spain, 
2 CBET Research Group, Research Centre for Experimental Marine Biology and Biotechnology, UPV/EHU-PiE, Plentzia 
(Spain), 3Mass Spectrometry Platform, CIC BiomaGUNE, Technological Park of Donostia, 20009, Donostia, Spain
MALDI-MS imaging has recently emerged as a powerful technique for analyzing the spatial distribution 
of peptides and small proteins within biological tissues. Obtained signals can be correlated with un-
derlying tissue architecture without any geometrical distortion, enabling the so-called Molecular Histo-
logy. This technique offers several advantages over other imaging methods like autoradiography, such 
as the high specificity of MS detection, minimal sample preparation, and applicability to a wide variety 
of analytes. One drawback, on the other hand, is that the matrix spray stage is a critical step determi-
ning the final quality of the obtained images. Recently, many advances in the practice of imaging mass 
spectrometry have taken place, like automated matrix sprayers, making the technique more sensitive 
and robust. In this work we have compared images obtained from different mussel gastrointestinal tis-
sue preparations sprayed in manual (standard TLC sprayer) and automated form (Bruker´s ImagePrep 
automated sprayer) using standard sinapinic acid (SA) matrix. Although the overall quality of obtained 
spectra with both techniques is similar, preparations in manual matrix spray, achieve only lateral reso-
lutions of up to 100 µm, whereas the automated spray procedure can achieve resolutions of up to 50 
µm, near the current technical restrictions in resolution of our MALDI spectrometer, at around 30 µm.
P58PS6 Emerging Technologies
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PLASMA BIOMARKERS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 
IDENTIFIED BY SPECTRAL COUNT
Isabel Serra 1, Mª José Fidalgo 2,  Oriol Bachs 3, Carolina Armengol 4,1, Josep Maria Estanyol 2
1 Liver Oncology Group, Hepatology Unit, Health Sciences Research Institute Germans Trias i Pujol (IGTP), Badalona, 
Spain, 2Proteomics Unit, CCITUB,  University of Barcelona, Spain, 3 Departament de Biologia Cel·lular, Immunologia i 
Neurociències, University of Barcelona, Spain, 4 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas 
y Digestivas (CIBERehd)
Biomarker discovery in human disease is a highlight to improve early diagnosis and predict response 
to treatment and prognosis. Mass spectrometry is a high throughput proteomic methodology that 
has been proved as a useful tool for biomarker identification. Hepatocellular carcinoma (HCC) is the 
main cause of death in cirrhotic patients. In spite of surveillance programs in cirrhotic patients, only 
about 40% of the HCC are diagnosed at early tumor stages when cure is still feasible. Therefore, the 
identification of biomarkers in cirrhotic patients is needed to use them as complementary tools for 
surveillance.
Plasma samples were depleted of abundant interfering proteins (ProteoPrep-20 kit, Sigma-Aldrich), 
fractionated by SDS-PAGE electrophoresis and enzymatically digested. The resulting peptides were 
analyzed by liquid chromatography coupled with mass spectrometry using SEQUEST as search engi-
ne and Trans-Proteomic Pipeline (v4.6.1) to generate probabilities for protein identifications. Quantita-
tive analysis was done using Spectral Count algorithms.
RESULTS: Here we have analyzed the variability of 17 selected cirrhotic patients, 10 of them with 
HCC, to adequate this methodology to identify possible biomarkers and the ability to be coupled 
to high throughput analysis by mass spectrometry. In relation to the protocol, we observed that the 
few number of reutilization of enrichment columns is a critical point to eliminate high abundant pro-
teins properly. However, we found a good correlation (75-97%) of protein profiles among the different 
samples that have a similar number of total spectra (spectra media: 446337 +/- 71663). Moreover, 
sixteen of the 17 samples share more than 85% of the proteins identified. Using spectral count, pu-
tative diagnostic markers were identified by comparing the plasma proteome of cirrhotic patients with 
HCC versus those without HCC (p value <0.01, number of peptides >1, 80% protein probability).  In 
conclusion, we have been able to identify putative diagnostic biomarkers of HCC by performing a high 
throughput proteomic analysis of plasma samples.
P59Poster
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PROTEORED MULTICENTER EXPERIMENT FOR LONG-TERM QUALITY CONTROL 
EVALUATION OF PROTEOMICS CORE FACILITIES 
A Campos1,2, R Díaz1, MA Odena1, S Martínez-Bartolomé3, F Canals4, O Gallardo5, MIF López-Lucendo6, 
I Casal 6, C Chiva7, E Borràs7, C Pasquarello8, MA Mugica9, F Elortza9, N Ibarrola10, JP Albar3, E. Oliveira1, the 
ProteoRed-ISCIII Consortium11
1 Proteomics Core Facility, Barcelona Science Park, Barcelona, Spain, 2 Integromics, Madrid, Spain, 3 Spanish Nacional 
Centre for Biotechnology-CSIC, Madrid, Spain, 4 Proteomics Laboratory, Vall d’Hebron Institute of Oncology(VHIO), 
Barcelona, Spain, 5 Proteomics Laboratory IIBB,CSIC/UAB, 6 Functional Proteomics laboratory, CIB/CSIC, Madrid, Spain, 
7 Proteomics Unit, Centre for Genomic Regulation CRG/UPF, Barcelona, Spain, 8 Proteomics Core Facility, Centre Medical 
Universitaire (CMU), Genève, Switzerland, 9 Proteomics Platform, CICbioGUNE, Derio, Spain, 10 Proteomics Unit, Center 
for Cancer Research CIC, CSIC/USAL, Salamanca, Spain, 11 ProteoRed-ISCIII Consortium. Spanish Networked Proteo-
mics Platform
Quality control (QC) is becoming increasingly important in proteomic experiments in order to gua-
rantee the quality of research results. Deployment of QC metrics helps in monitoring stability, overall 
performance and reproducibility of analytical techniques. In an attempt to dispel some of the notions 
that LC-MS-based proteomics is poorly reproducible, the proteomics community has demonstrated 
increasingly concerns about the quality of proteomics data made publicly available. Here we describe 
the ProteoRed Multicenter Experiment for Quality Control (PMEQC), a longitudinal QC multicenter stu-
dy involving 12 institutions, to assess the repeatability of LC-MS/MS proteomics data within a specific 
site, the reproducibility across multiple sites and across multiple platforms. Our experimental design 
also provided a unique opportunity to assess the repeatability of protein sample preparation within a 
specific site. 
The main study was divided into 2 sub studies (Study A and B) that evaluate separately inter- and in-
tra-laboratory variability. Each participant received two sample vials of trypsin-digested yeast proteins 
(Study A) and the same undigested protein sample (Study B).  All participants were requested to follow 
a strict LC-MS/MS guideline for sample injection amounts and LC gradient. To enable inter-laboratory 
comparisons, data analysis was centralized and performed under standard procedures using a com-
mon workflow that includes well-known software tools for proteomics analysis such as msconvert.
exe, X!Tandem, PeptideProphet, OpenMS and R programming language. 
Here, we summarize the key findings of the PMEQC project and provide technical insights to better 
understand and pinpoint the main sources of variability and other issues faced by proteomics core 
facilities. Our study reveals that the overall performance regarding reproducibility, sensitivity, dynamic 
range, among other metrics, is directly related to laboratory staff expertise, and less dependent on 
instrumentation. Furthermore, the present study provides a rich data set of metrics against which 
other laboratories can benchmark their performance. 
P60Poster
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RELATIVE QUANTITATION OF TMT-LABELED PROTEOMES – FOCUS ON QUANTITATIVE 
PRECISION AND ACCURACY
S. Baumgarten, R. Viner, M. Scigelova, M. Zeller, M. Oppermann, T. Moehring and V. Zabrouskov
Introduction. Isobaric tagging methods involving ‘differential’ isotope labeling using chemical tags 
are very popular and universally applicable approaches measuring relative amounts of proteins across 
two or more different samples. The main focus of the presented work was on assessing the percenta-
ge of quantifiable peptides, the quantitative precision, and the quantitative accuracy for a TMT sixplex-
labeled complex proteome sample.
Methods. A  digest of 9 proteins in equimolar amounts, which was aliquoted into six identical frac-
tions labeled each with one of the TMT sixplex reagents, and mixed to obtain the final ratio 10 : 1 : 10 
: 2 : 10 : 1.5, was added to the background of a TMT sixplex-labeled E. coli lysate digest.  
Peptides were analyzed using nano-LC coupled to the Orbitrap Elite. Two different acquisition methods 
were evaluated. 
Proteome Discoverer 1.3 was used for protein identification and quantification. 
Quantitative precision was expressed as protein ratio variability. Quantitative accuracy was presented 
as a deviation of a measured ratio value from the expected value. 
Results. The percentage of peptides whose fragmentation spectra contained all six reporter ions 
(quantifiable peptides) exceeded 90% for any sample load tested.
The variability was lower than 10% for approximately 90% of the quantified proteins at a 500 ng sam-
ple load, but only for about 70% at a 20 ng sample load.
The Orbitrap detection at resolution settings 15,000 corresponds to effective resolution >27,000 for 
m/z 126-130. Consequently, a very tight mass tolerance (+/- 10 ppm) could be used effectively filtering 
most reporter ion interferences.
For higher ratios (theoretical ratio 10:1) the median peptide ratio increased from 5.64 (Top10 method) 
to 7.97 (MS3 method). 
Conclusions. An improved mass spectrometer design resulted in a high percentage of quantifiable 
peptides.
The quantitative precision is signal intensity-dependent.
Very high resolution effectively eliminated isobaric interferences in the reporter ion region.
The impact of peptide precursor co-isolation issue on quantitative accuracy was minimized with MS3-
based acquisition method.
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IODOACETYL TANDEM MASS TAGS FOR CYSTEINE PEPTIDE MODIFICATION, 
ENRICHMENT AND QUANTITATION
Sigrid Baumgarten1, Madalina Oppermann1,Ryan Bomgarden2; Rosa Viner3; Karsten Kuhn4; Ian Pike4; John C. 
Rogers 2
1Thermo Fisher Scientific, Stockholm, Sweden; 2Thermo  Fisher Scientific, Rockford, USA; 3ThermoFisher Scientific, San 
Jose, USA; 4Proteome Sciences, Frankfurt Am Main, Germany 
Introduction. Thermo Scientific Tandem Mass Tag® (TMT®) Reagents enable concurrent identifica-
tion and multiplexed quantitation of proteins in different samples using tandem mass spectrometry. 
Here, we report the development of an irreversible, cysteine-reactive TMT reagent containing an io-
doacetyl reactive group (IodoTMT™). Due to the irreversible labeling of the IodoTMT reagent, it can be 
used for quantifying cysteine modifications such as S-nitrosylation, oxidation and di-sulfide bridges. 
Methods. Cell lysates and purified proteins were denatured in 6M Urea/50 mM Hepes buffer, pH 
8.0 and reduced with TCEP at 50°C for 60 min for total cysteine alkylation experiments. Samples 
were then labeled with excess IodoTMT, mixed and desalted prior to enzymatic digestion. For cystei-
ne S-nitrosylation quantitation, samples were treated with nitrosylation donor agents (e.g. GSH-NO) 
and alkylated with MMTS to block unmodified sulfhydryls.   After desalting, S-nitrosyl groups were 
then selectively reduced using ascorbate to generate free sulfhydryls for Iodo TMT reagent labeling. 
IodoTMT-labeled peptides were enriched using an immobilized anti-TMT antibody resin and analyzed 
using a Thermo Scientific LTQ™ Orbitrap XL or a Thermo Scientific Orbitrap Elite mass spectrometer. 
Data analysis was performed with Thermo Scientific Proteome 
Discoverer™ 1.3 software. 
Results. We have developed and used an IodoTMT reagent to irreversibly label sulfhydryls of cystei-
ne-containing peptides for multiplex quantitation by LC-MS. IodoTMT reagents showed efficient and 
specific labeling of peptide cysteine residues with reactivity similar to iodoacetamide. We used the 
IodoTMT reagent as a probe for labeling S-nitrosylated cysteines in a modified S-nitro switch assay. 
IodoTMT reagents successfully labeled S-nitrosylated cysteines after selective reduction using as-
corbate. In addition, we discovered that addition of 1mM copper sulfate to the switch reaction buffer 
inhibited IodoTMT reagent labeling. Finally, we characterized an anti-TMT antibody developed against 
the reporter region of the TMT reagent for Western blot detection of IodoTMT-labeled proteins and 
immuno-enrichment of IodoTMT-labeled proteins and peptides. Overall, using the combination of Io-
doTMT labeling with anti-TMT enrichment has several advantages over previously described cysteine-
reactive workflows including: 1) more specific labeling of sulfhydryl groups; 2) a choice of six-plex 
isobaric multiplexing or two-plex isotopic quantitation using the same chemistry; 3) isobaric tagging 
for more efficient MS data analysis; and 4) a simpler workflow using antibody-based capture for labe-
led peptide enrichment. 
P62Poster
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A HIGH RESOLUTION/ACCURATE MASS TARGETED APPROACH FOR KINASE INHIBITION 
SCREENING USING A QUADRUPOLE ORBITRAP MASS SPECTROMETER
Ryan D. Bomgarden1, Scott Peterman2, Rosa I. Viner 2, Chris L. Etienne1, John C. Rogers1, Sigrid Baumgarten3
Thermo Fisher Scientific; Rockford, 1; Thermo Fisher Scientific, San Jose, 2 USA; Les Ulis, Paris3
Introduction. Development of novel protein kinase inhibitors remains a strong focus of the phar-
maceutical industry. Performing multiplexed protein kinase detection/quantification presents many 
challenges. Recently, probe-based assays were introduced to increase kinase enrichment as well as 
provide a selective screening approach for kinase inhibitor analysis using tandem mass spectrometry. 
Here, we present a high resolution/accurate mass targeted approach for kinase inhibitor screening in 
A549 cells within a high-throughput workflow. 
Methods. A549 cell lysates were treated with staurosporine(0-10 uM).  Each sample was reacted with 
desthiobiotin ATP or ADP probes and then processed according to the manufacturing instructions to 
enrich labeled kinase active-site peptides. All mass spec experiments were performed on QExacti-
ve (Thermo Scientific, Bremen). Initial kinase identification and quantification was performed in data 
dependent acquisition mode followed by database searching and spectral library creation. Targeted 
quantification/verification was performed by narrow mass range multiplex SIM. Orthogonal experi-
ments were performed by Western Blots. 
Results. Desthiobiotin-ATP and -ADP are two nucleotide derivatives that have been shown to selec-
tively label kinase active sites.  Using these probes to enrich kinase active-site peptides, we identified 
126 kinases from A549 cell extracts using high resolution, accurate mass (HR/AM) spectrometry. 
Targeted SIM multiplexing enables shorter acquisition cycle times and is fully compatible with LC 
constraints of targeted proteomics experiments. We also assessed specificity of kinase inhibitors - 
staurosporine by determining IC50 values for kinase active-site peptides after drug treatment. The 
results for the staurosporine treated A549 cell line showed over 70% kinases demonstrated strong 
inhibition by the drug as expected.  In addition, we validated kinase inhibitor targets using a parallel 
Western blot workflow.
Conclusion. Kinase inhibition measured using targeted HR/AM spectrometry had strong correlation 
with Western blot data, previously published results, and enabled global profiling of kinase inhibitor 
target and off-targets.  
P63Poster
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PROTEOMICS A NOVEL TOOL FOR ANIMAL SCIENCE: ADVANTAGES AND DRAWBACK
André Martinho de Almeida
Instituto de Investigação Científica Tropical, CVZ-FMV, Av. Univ. Técnica, 1300-477 Lisboa, Portugal
Proteomics being the science that studies the proteome i.e. protein expression in a given tissue, fluid 
or organism has obtained several successes in numerous fields of application that include, for ins-
tance biomedicine, vaccine development or the study of processing of foods. Animal science, animal 
production and the processing and transformation of foods of animal origin is a key economic activity 
in the European Union and in the rest of the world and essential for the livelihood of numerous citi-
zens. Animal products are essentially proteinaceous products and therefore the study of the protein 
changes in animal products obtained as a consequence of management and production/processing 
practices is of enormous importance to this area of activity. Albeit its usefulness, quite a limited num-
ber of studies have been performed using proteomics based approaches. In this presentation we will 
examine the major areas of applications of proteomics in the context of animal science, presenting 
study cases of specific successful application cases. We will also present concise considerations on 
the major drawbacks that have hindered a wider use of proteomics in the field of animal sciences. 
We will finally make proposals on how such limitations may be overcome leading to a larger use of 
proteomics in animal science.
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THE PROTEOMIC TOOLBOX: 2-DE GELS AND MORE
Ingrid Miller
University of Veterinary Medicine Vienna, Vienna, Austria
Gel-based proteomics usually relies on two-dimensional electrophoresis, classically consisting of a 
first-dimensional charge-based separation (isoelectric focusing) followed by SDS-PAGE according to 
size, all under denaturing and reducing conditions. Protein spots are detected, spot volumes quan-
tified, and potentially interesting candidates identified by mass spectrometric methods. High-quality 
analyses today also comprise pathway analysis and verification of the findings, e.g. by immunoblotting 
or targeted proteomics (SRM/MRMs) 1. 
However, we should not forget that the panel of electrophoretic methods is much broader, including 
also separations under native or non-reducing conditions or combination of other separation criteria. 
This may allow the study of protein complexes or interactions, as well as application of other, specific 
detection methods, for instance zymography 2.
Verification of 2-DE results is not just a nuisance asked for by reviewers, but - with high-quality anti-
bodies - an important tool to learn more about the detected spots and the proteins behind, especially 
when applied as 2-DE blots: most proteins consist of multiple spots or spot chains, but 2-DE quanti-
fication only picks single differentially regulated spots in comparisons of two different groups of sam-
ples. Other spots of the same protein may be regulated in a similar or diverse manner, and knowledge 
about that leads to different conclusions. In addition to detection of specific isoforms, 2-DE blots also 
give information on protein size and intactness / degree of fragmentation.
Besides sample selection and study design, appropriate sample collection and preparation are key 
issues. Prefractionation (based on subcellular fractionation, chromatography, preparative electropho-
resis, affinity methods) helps to reduce the complexity of specimens and to focus on selected sub-
proteomes whose variation may otherwise have escaped our notice 3.
For a given project, ideally, a variety of methods should be used to investigate different aspects: e.g. 
histology, metabolomics, enzymatic or immunological assays, additional specific tests characterizing 
health status, or different methodological approaches, in order to get a (more) global picture or to 
investigate mechanisms (e.g. 4).
References:
1 Miller, I. Protein Separation Strategies, in: Methods in Animal Proteomics (Eckersall, P.D., Whitfield, P.D, eds.), 2011, John Wiley & Sons, 
Chichester, UK; p.41-76. ISBN: 978-0-8138-1791-0.
2 Miller, I., Eberini, I., Gianazza, E. Other than IPG-DALT: two-dimensional electrophoresis variants. Proteomics 2010, 10, 586-610.
3 Posch, A. (ed.). 2D PAGE: Sample Preparation and Fractionation, Methods Mol. Biol. 2008, 424, Springer, Heidelberg.
4 Nürnberger, S, Miller, I, Duvigneau, JC, et al. Impairment of endoplasmic reticulum in liver as an early consequence of the systemic inflam-
matory response in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, doi: 10.1152/ajpgi.00056.2012.
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DISCOVERY BASED AND TARGETED MASS SPECTROMETRY IN FARM ANIMAL 
PROTEOMICS
Emøke Bendixen
Dept. of Molecular Biology, Aarhus Universitet (Denmark)
Technological advances in mass spectrometry have greatly improved accuracy and speed of analyses 
of proteins and biochemical pathways. These proteome technologies have transformed research and 
diagnostic methods in the biomedical fields, and in food and farm animal sciences proteomics can be 
used to investigate and monitor specific marker proteins and peptides within complex food matrices, 
as for example, for guaranteeing safety and quality of processed and stored foods like cheese and 
cured meat. Likewise, specific diagnostic markers associated with compromised welfare, or with early 
infections can be monitored to improve welfare in large industrial settings of current livestock industry. 
The combination of discovery based LC-MS/MS methods and the more hypothesis-based targeted 
mass spectrometry method commonly referred to as selected reaction monitoring or SRM, provide 
a powerful approach for investigating farm animal biology. SRM is particularly important for validation 
biomarker candidates.
This talk will introduce the use of different mass spectrometry approaches through examples related 
to food quality and animal welfare, including studies of gut health in pigs, host pathogen interactions 
in the bovine mammary gland, and the monitoring meat and milk quality markers. Also work related 
to collecting farm animal proteome information within the PeptideAtlas frame (www.peptideatlas.org) 
will be discussed. The PeptideAtlas database currently includes data from shotgun proteomics experi-
ments from tissues and body fluids from pig, cow and horse, and currently provides the primary public 
resource for designing SRM methods for farm animal applications. 
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PROTEOMICS AND INFLAMMATION: AN OPEN DOOR IN THE STUDY OF FARM ANIMAL 
DISEASES 
Idoia Alonso-Fauste, Marta Andrés, Lourdes Soler, Natalia García, María Iturralde, Matilde Piñeiro, Fermín 
Lampreave and María A. Álava
Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Pedro Cer-
buna, 12, 50009-Zaragoza, Spain
Acute phase proteins (APP) have been identified in whey and sera from healthy and mastitic cows 
through the proteomic analysis using two-dimensional electrophoresis (2-DE) coupled with Matrix-
Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS). Although 
normal and mastitis serum samples show relatively similar protein composition, marked differences in 
expression levels and patterns can be observed. Conversely, normal and mastitis whey showed a very 
different composition, likely due to extravasation of blood proteins to the mammary gland. Different 
isoforms from the most abundant protein in milk, casein, were detected in both normal and mastitis 
whey. Other proteins, such as lactotransferrin, were only detected in the inflamed animal samples. 
Immunoglobulins showed different patterns but not increased levels in the inflamed whey. Also, many 
cellular proteins present in mastitis cow’s whey were absent from healthy cow’s milk. They are respon-
sible for the great change in composition between normal and mastitis whey, especially those which 
exert a biological function related to immune defense. Data collected in this work are of interest for 
gaining information about physiological changes in protein patterns in different fluids as a result of an 
acute phase process in farm.
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UNRAVELING THE MILK PROTEOME: PERSPECTIVE IN HUMAN NUTRITION AND ANIMAL 
PRODUCTION
Paola Roncada
ISILS-Department of Veterinary Science and Public Health, University of Milano, Milano, Italy
Milk composition in mammalian species is higly specific and it is design to the needs of the newborn. 
It contains proteins, and numerous biologically active substrates such as lipids, vitamins and mineral 
salts. Through their major proteins components, milk fat globule, caseins, and serum proteins, milk 
is able to cover the nutritional needs of the newborn in all mammalian species  and  it  protect the 
baby against infection, inflammation and oxidative stress. The newborn is particularly immature: inna-
te immunity, adaptive immunity and intestinal immaturity are needed to be enforce and milk proteins 
rapresents  exogenous protective help and a strong immunomodulating source. Moreover, the deve-
lopment of the composition of the intestinal microflora of the neonate is modulated ad selected by 
characteristic milk proteins. Several works highlighted interdependency of different milk components, 
as well as  ontogeny of the intestinal function, development of the mucosal intestinal immune system, 
colonization by the intestinal microbiota and protection against pathogens. Milk proteins influence 
medium and long term heath status, for this reason is strongly mandatory to assure a quality and deep 
knowledge about proteomics of milk of both human and mammalians use for nutrition. Nowadays, it is 
clear that besides the immunoglobulins, milk also contains a wide range of minor immune-related pro-
teins that represents the real first line of defence against pathogens. We have used proteomics scien-
ce to characterise the repertoire of milk proteins in detail, in human, in formula, in ruminants, to better 
understanding complexity and different biological functions between species. Milk can represent in 
animal production a simple and accessible sample to monitor health status of animals. This study is 
a contribute to a better exploring of health properties of milk, as well as to build the basis to stress 
and to promote high-value ingredients from milk useful also for  dairy products and nutrition industry.
Roncada P, Piras C, Soggiu A, Turk R, Urbani A, Bonizzi L. Farm animal milk proteomics. J Proteomics. 2012 75: 4259-74. doi: 10.1016/j.
jprot.2012.05.028. 
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BIOMARKERS OF BEEF SENSORY QUALITIES: FROM PROTEOMICS TO 
PHENOTYPING TOOLS
Brigitte Picard 
INRA, VetAgro Sup, UMR1213 Herbivores, F-63122 Saint-Genès-Champanelle
For beef producers, it is of interest for breeding or finishing purposes to predict the ability of live ani-
mals to produce good meat, with specific attention towards tenderness. Today tenderness can be 
estimated only after slaughter, by sensory analysis tests and/or mechanical measurements. Thus, the 
Beef sector is looking for biological or molecular indicators that would identify live animals with desira-
ble quality attributes, in order to direct them towards the most appropriate production system. Tender-
ness is a complex trait with high and uncontrolled variability at the origin of a dissatisfaction of the beef 
consumers. For several years, various genomics programs have been conducted at the national and 
international level in order to reveal genomic markers of tenderness (Cassar-Malek et al., 2008). Com-
parative transcriptomic (Bernard et al., 2007) and proteomic analysis, conducted on bovine muscles 
with low or high tenderness scores estimated by sensory analysis and/or mechanical measurements, 
bring up a list of potential biological markers which may be used as phenotypic biomarkers to predict 
the “tenderness potential” of an animal or a carcass (for review see: Picard et al., 2010, 2012). 
The strategy  developed in our team for few years is: (1) to validate the relationship between meat 
tenderness and the protein biomarkers on a large number of cattle types as the most representative 
of the French production systems and beef consumption (male and female, beef and dairy breeds); (2) 
to determine the effects of management factors (age and diet) on the expression of these biomarkers; 
(3) to develop an antibody micro-array tool for molecular phenotyping of beef tenderness from the list 
of validated biomarkers. We have developed a prototype which is internationally the first phenotyping 
tool for meat tenderness. We are completing it with biomarkers of other sensory qualities.
This antibody micro-array will be available for the Beef industry for evaluation of meat quality and for 
optimization of cattle breeding for meat production. This tool could also be used for sensory quality 
phenotyping in genomic breeding schemes. 
References
Bernard C., Cassar-Malek I., Le Cunff M., Dubroeucq H., Renand G., Hocquette J.F. 2007. New indicators of beef sensory quality revealed 
by expression of specific genes. Journal of Agricultural and Food Chemistry, 55(13):5229-5237.
Cassar-Malek I., Picard B., Bernard C., Hocquette J.F. 2008. Application of gene expression studies in livestock production systems: a 
European perspective. Australian Journal of Experimental Agriculture, 48: 701-710.
Picard B., Berri C., Lefaucheur L., Molette C., Sayd T. Terlouw C. 2010. Skeletal muscle proteomics in livestock production. Briefings in 
Functional Genomics and Proteomics, 9: 259-278.
Picard B., Lefèvre F., Lebret B. 2012. Meat and fish flesh quality improvement with proteomic applications. Animal Frontiers, October 2012: 
18-25. 
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Bad Time for Science
A S.L.
In my song a rhyme
Would seem to me almost like insolence.
Fighting within me are
Enthusiasm about the blooming apple tree
And the horror of the house painter’s speeches.
But only the second thing
Drives me to my desk.
Bertolt Brecht 
(Schlechte Zeit für Lyrik, “Malos tiempos para la lírica”)
Now that I write
I cannot ignore the evidence,
I cannot deny
That we feel the moan of defeat,
That roads are closing and hopes shut down
And a thick despondency clouds us.
It is bitter to face that harsh reality,
That woodworm
That undermines decades of effort,
The building
We built with the cement of enthusiasm,
The stone of imagination,
And that devastates
Our fresh sap, the flower of our youth.
All around I find nothing
But autumn’s traces,
A misty horizon, a leafless wind.
And the slow, insidious,
Damp of discouragement leaks in.
Where is the dawn, the air? The light flees,
Cracks, unravels. And the haunting
Shadows of doubt lurk.
I wonder
If there is any use
To this stubborn struggle
Against all the obstacles and all
The impossibilities,
These long detours that hardly advance us,
This endless movement toward a goal
That is never within sight,
This tenacity that steadies us,
Keeps us trustworthy
Guardians of an idea,
This captive and measureless time, 
This crucible where we forge
In our image
The new face of nature,
This slow walk toward the origin,
Discovering a step in a cloud
And creating a past in the sand,
This learning from hidden evidence
And symmetry’s silent edge,
This fight against errors that rise up,
Against a wave of chance, the liquid noise,
I wonder if it is any use,
If it has any worth.
And a breath rises,
A sudden impulse,
A resentment that smolders, a cry still
Suppressed in its birth, the seed of rage,
The desperation that struggles and sparks,
The lash of anger.
A certainty emerges,
Dark and torrential, in the marrow,
With a jolt,
With the crack of a branch. I’m sure now,
Convinced.
I affirm. I place myself. Everything 
Becomes solid, takes shape, has a place, makes 
sense. 
We have not come here to hunker down.
The mountain is there, but clear in contour.
And with it, the evidence,
The clear inertia of our own weight,
The passion of our hands. Yes, surely
And emphatically, I trust.
And so, strengthened and free,
I rejoin the effort
On the common front of fortitude,
Following
Our nearest
And decisive example: the river of life
Moving ever forward.
Jesús Vázquez
English version by Jess Jackson
Bad Time for Science
A S.L.
In meinem Lied ein Reim
Käme mir fast vor wie Übermut.
In mir streiten sich
Die Begeisterung über den blühenden Apfelbaum
Und das Entsetzen über die Reden des Anstrei-
chers.
Aber nur das zweite
Drängt mich, zum Schreibtisch.
[En mi canción una rima
casi me resultaría una insolencia.
En  mí luchan
el entusiasmo por el manzano en flor
y el espanto ante los discursos del pintor de bro-
cha gorda.
Pero sólo lo segundo
me impulsa a escribir.]
Bertolt Brecht 
(Schlechte Zeit für Lyrik, “Malos tiempos para la lírica”)
Ahora que escribo
No puedo ignorar la evidencia,
No puedo negar
Que sentimos el clamor de una derrota,
Que se ciegan caminos y se truncan esperanzas
Y nos nubla un espeso desaliento.
Es amargo enfrentarse a esa cruda realidad,
A esa carcoma
Que desmorona un esfuerzo de décadas,
El edificio
Que construimos con el cemento del entusiasmo,
La piedra de la imaginación,
Y que también desola 
Nuestra savia más joven, nuestro mejor retoño.
Alrededor no encuentro
Sino huellas de otoño,
Un horizonte en brumas, un viento deshojado.
Y se filtran, insidiosas,
Las lentas humedades del desánimo.
¿Dónde está la claridad, el aire? La luz huye,
Se agrieta, se deshila. Y amenazan
Las inquietantes sombras de la duda.
Me pregunto
Si sirve de algo esta obstinada lucha
Contra todas las barreras y todos
Los imposibles,
Este largo rodeo para avanzar apenas,
Este constante progresar hacia una meta
Que no se avista nunca,
Este tesón que nos mantiene
Enteros, fidedignos
Guardianes de una idea,
Este tiempo cautivo y sin medida, 
Este crisol donde forjamos 
A nuestra imagen
El nuevo rostro de la naturaleza,
Este lento caminar hacia el origen
Descubriendo un peldaño en una nube
Y creando un pasado entre la arena,
Este aprender de la evidencia oculta
Y el filo callado de la simetría,
Este luchar contra el error que aflora,
La ola de un azar, el ruido líquido,
Me pregunto si vale para algo,
Si vale
De algo.
 
Y surge un hálito,
Un repentino impulso,
Un resquemor que prende, un grito todavía
Callado en su nacer, el germen de la ira,
La desesperación que puja y que crepita,
El latigazo de la rabia.
Una certeza emerge,
Torrencial y oscura, entre la médula 
Con una sacudida,
Con un crujir de rama. Estoy seguro
Ahora, convencido.
Me afirmo. Me sitúo. Todo adquiere
Opacidad, contorno, rol, cordura. 
No hemos llegado aquí para agacharnos.
La montaña está ahí, mas despejada.
Y con ella, la evidencia,
La clara inercia de nuestro propio peso,
La pasión de nuestras manos. Sí, seguro
Y rotundo, ya confío. 
Y así, fortalecido y libre,
Me sumo de nuevo a nuestro esfuerzo
En el frente común de la entereza,
Siguiendo 
Nuestro más cercano
Y decisivo ejemplo: el río de la vida,
Avanzando siempre hacia adelante.
Jesús Vázquez
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